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ABSTRACT 
 
 Voice is produced by the conversion of aerodynamic energy from exhalation to 
acoustical energy for voice production by the vocal folds (membranous connective tissue) 
located in the larynx.  The quality of voice depends on the biomechanical properties of 
the multi-layered vocal fold tissue which derive from its extracellular matrix (ECM) 
organization and composition.  The wound healing response to vocal fold injuries is 
characterized by scarring and subsequent dysphonia due to alterations in the 
biomechanical properties of the tissue.   
 The work presented here is motivated by the importance of voice in maintaining 
quality of life and the inability of current treatment techniques to restore long-term, 
normal phonatory voice following injury induced scarring.  We hypothesize that vibration 
is the epigenetic stimulus regulating the unique extracellular matrix (ECM) composition 
of the human vocal fold tissue and that rapid restoration of the vibratory 
microenvironment using mechano-mimetic scaffolds will facilitate:- (a) inhibition of 
scarring and (b) stimulation of fibroblast regeneration of the normal vocal fold tissue 
architecture/ECM composition and thereby restore long-term, normal phonaory voice.  
Our objective was to create in situ photopolymerizable, degradable, mechano-mimetic 
hydrogels/semi-interpenetrating networks (semi-IPNs) which may be introduced into 
critical size vocal fold defects using minimally invasive methods.   
 Towards this end, we created hyaluronic acid (HA) based hydrogels and 
polyethylene glycol (PEG)-diacrylate based hydrogels/semi-IPNs, which were found to 
approximate the viscoelastic mechanical properties of the native human vocal mucosa 
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(vibratory component) and the vocal ligament (strain component), respectively.  Cell 
culture studies indicated that these hydrogel/semi-IPN materials supported cell spreading, 
cell proliferation, and ECM deposition throughout the 3-dimensional crosslinked 
network.  In an attempt to assess the ability of the HA-based hydrogels to support human 
fibroblast formation of vocal mucosa-specific matrix in response to physiologically 
relevant high frequency vibration, fibroblast encapsulated hydrogels were subjected to 2 
hrs of vibration per day using a custom built vibrational bioreactor.  Our results indicated 
that the exposure of HA hydrogel-encapsulated fibroblasts to physiologically relevant 
high frequency vibration stimulated a pattern of gene expression and ECM synthesis 
(upregulation of GAGs, downregulation of fibrous matrix proteins) consistent with the 
composition of the human vocal mucosa.  In the future, these HA-based hydrogels 
introduced into the human vocal mucosa during the acute phase of wound healing by 
minimally invasive methods may bring about regeneration of the native human vocal 
mucosa ECM composition and thereby restore normal phonation.   
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CHAPTER ONE 
INTRODUCTION 
 
Voice is critical to the quality of life and is the primary „tool of trade‟ for 25% of 
the US work force (teachers, singers, sales personnel etc) [1].  Phonation (voice 
production) is a co-ordinated biological process involving the vocal folds, lungs, brain, 
peripheral nervous system, and muscles of the respiratory tract synergistically 
transducing aerodynamic energy from exhalation to acoustic energy.  The vocal folds are 
the dynamic mechanical element of the phonatory system and possess a spatially 
organized ECM composition that is fundamental to the tissue biomechanics and in turn 
the quality of voice [2].  The highly differentiated human vocal fold tissue is comprised 
of a matrix rich lamina propria anchored to the vocalis muscle, and covered by a 
squamous epithelium.  The fibroblast is the primary matrix producing cell type in the 
vocal fold tissue and is responsible for maintaining tissue homeostasis and regulating 
injury response [2].  The squamous epithelium and the superficial lamina propria together 
form the vocal mucosa (vibratory component) which is abundant in hyaluronic acid, and 
proteoglycans like fibromodulin, decorin and versican which regulate the water content 
of the tissue and impart viscous shear properties to it [3, 4].  The vocal mucosa vibrates at 
frequencies between 100 – 1000Hz, and amplitudes of ~1mm [5].  The intermediate and 
deep layers of the lamina propria together form the vocal ligament (strain component).  
The vocal ligament ECM is comprised mainly of elastin fibers which impart flexibility to 
the tissue and collagen fibers which impart resistance to tensile stresses [6, 7].  The 
 2 
human vocal ligament operates at low strain levels (0 – 15%) during normal phonation 
[8].  Vocalization times can vary between 1 to 2hrs per day for heavy voice users like 
classroom teachers and opera singers [9-12].     
Vocal fold damage can be brought about by a multitude of factors like chronic 
vocal overuse, chemical/thermal trauma, non phonatory mechanical trauma such as 
surgical intubation and surgical treatment of infectious laryngeal diseases, laryngeal 
cancer, and benign pathologies like vocal folds polyps, nodules and edema [13-15].  
Injury of the lamina propria elicits a wound healing response that is characterized by the 
replacement of native parenchymal matrix with fibrous scar tissue.  This change in the 
ECM composition leads to alterations in the tissue biomechanics which subsequently 
leads to dysphonia.  Approximately 23% of the voice dependent USA workforce is 
afflicted by problems like increased effort to sustain phonation, decrease in the quality of 
voice and total loss of audible voice as a result of vocal pathologies [16].  Vocal 
pathologies can jeopardize social interaction, job security, and employment opportunities.  
Dysphonia secondary to vocal pathologies is a result of hoarseness, breathy voice, stridor 
(high pitched, loud respiration), and dyspnea.  Incidence of voice related problems is as 
high as 20% amongst teachers [17].   
Treatment of scarring related voice probems is a major challenge faced by 
otolaryngologists today [18].  Voice therapy combined with the administration of steroids 
is the first line of therapy when presented with vocal fold defects and scars [13, 18].  
However, voice therapy is ineffective when presented with scars in combination with 
pathologies like vocal polyps, nodules and edema despite rigorous adherence to the 
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prescribed habits [19].  Synthetic, non degradable materials like teflon [20-22], 
polyhydroxyethylmethacrylate (pHEMA) hydrogels [23], ePTFE [24, 25], calcium 
hydroxyapatite [26], dacron [27], polydimethylsiloxane [28-31] have been injected into 
the vocalis muscle in an attempt to overcome scarring-induced glottic incompetence 
through vocal fold medialization.  However, physiological limitations such as migration 
from the site of implantation, foreign body granuloma formation, and fibrous 
encapsulation posed by these materials, and the theoretical advantages of natural, 
degradable biomaterials injected into the lamina propria have led to the use of materials 
like collagen, fat, fascia and HA for vocal fold augmentation purposes.  In human 
subjects, though evaluations after six months of collagen injections indicated 
improvements in vibrational amplitude of the mucosal wave and amelioration of glottic 
incompetence, no perceptual improvement (acoustic analyses) was recorded [32].  
Autologous fat [33-36] and fascia [37] injections yielded positive results short term but 
reports of these studies are inconsistent in terms of evaluations of glottic closure, 
amplitude of the mucosal wave and the effect on the stiffness of scar tissue.  Injectable 
crosslinked HA gels (Hylan B gels) have been shown to improve mucosal wave 
amplitudes and glottic closure for approximately 12 months [38-40].  Material resorption 
and the need for re-injection were the disadvantages associated with the use of natural 
materials like collagen, fat, fascia, and HA [41].  Current regeneration strategies have 
investigated the use of crosslinked composites of polyethylene glycol diacrylate 
(PEGDA)/derivatized HA [42, 43], composite collagen hydrogels [44], and HA-based 
microgels [45] as scaffolds for cell transplantation and matrix formation, as well as the 
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administration of hepatocyte growth factor (HGF) [46-48] and basic fibroblast growth 
factor (bFGF) [49] to reduce scarring during natural healing.  The above mentioned 
current treatment techniques, although effective in improving short term voice quality, 
have been unable to achieve complete restoration of voice due to their inability to bring 
about regeneration of the native vocal fold tissue architecture/ECM composition. 
Matrix composition and mechanical properties of human tissues are influenced by 
their mechanical environment [50, 51].  Physiologically relevant mechanical loading not 
only upregulates synthesis of tissue-specific ECM proteins but also plays a vital role in 
matrix modeling (native tissue homeostasis) or remodeling (tissue engineering scaffolds) 
and cellular organization [51].  Recently, Min and co-workers reported that 
physiologically relevant compressive loading of chondrocyte seeded, mechano-mimetic 
poly (l-lactide-co-ɛ -caprolactone) scaffolds upregulated the synthesis of cartilage 
specific ECM proteins like collagen II and proteoglycans like aggregan [52].  Studies 
performed by Hsieh and co-workers indicated that mRNA levels of collagens type I and 
III produced by anterior cruciate ligament (ACL) and medial collateral ligament (MCL) 
fibroblasts showed significant differences in after physiologically relevant biaxial 
stretching [53].  Durante and co-workers reported an increase in collagen I synthesis by 
smooth muscle cells in response to 10% cyclic strain [54].  The effect of cyclic strain on 
gene/protein expression in cell seeded substrates is widely investigated but that of 
physiologically relevant high frequency vibration is relatively less explored.  Studies 
reported previously by Tanaka and co-workers indicated that the effects of vibration on in 
vitro cell culture are varied.  For example, mRNA expression levels of MMP-9 were 
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upregulated when osteoblasts were cultured in 3D collagen gels under conditions of 
broad frequency vibration (0-50Hz) 3min/day for 4 to7 days [55].  Contrastingly, the 
mRNA expression levels of MMP-9 were unaffected by a single frequency (3Hz) 
vibration 3min/day for 4 to 7 days.  Titze and co-workers [11] highlighted the importance 
of the vibratory epigenetic stimulus in the vocal fold tissue by indicating a similarity 
between the normal matrix composition of the human vocal mucosa and the gene 
expression levels of fibroblasts cultured under vibratory stimulation within 3D, porous, 
elastomeric tecoflex substrates.  Thus one may infer that the type of mechanical regimen 
dictates alterations in protein expression which ultimately influences matrix remodeling.   
We therefore hypothesize that the rapid restoration of the vibratory 
microenvironment using mechano-mimetic scaffolds will facilitate vocal fold-like ECM 
deposition by the transplanted/endogenous cells.  This will potentially yield improved 
functional outcomes by preventing the onset of fibrosis during the acute stage of wound 
healing.  Towards this end, the objective of our research was:- (a) to create injectable, 
photopolymerizable, hydrogel formulations matching the viscous and elastic mechanical 
properties of the vocal mucosa and vocal ligament, respectively, (b) to investigate the 
cytocompatibility of the potential scaffold materials in terms of encapsulated cell 
viability, proliferation, and de novo ECM synthesis under static conditions, and (c) to 
assess the ability of the methacrylated HA (GMHA) based hydrogels to support human 
fibroblast formation of vocal mucosa-specific matrix in response to physiologically 
relevant high frequency vibration using a custom-built vibrational bioreactor.      
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CHAPTER TWO 
LITERATURE REVIEW 
 
Vocal folds are the same as vocal cords.  The two terms refer to the exact same 
part of the body performing the exact same functions.  Scientists and otolaryngologists 
refer to this organ as “vocal folds” whereas “vocal cords” is a widely used lay term.  The 
term “vocal cords” lacks technical accuracy.  Many years ago the vocal folds were 
thought of as being two cords stretched across the airway in the trachea akin to the strings 
of a musical instrument.  In 1974, pioneering research by Hirano led to the understanding 
that the vocal folds are multilayered folds of tissue that are continuous with other tissues 
in the laryngeal framework [56].  Therefore, vocal "folds" is a more accurate term. 
 
2.1 Anatomy of the vocal folds & physiology of voice production 
2.1.1 Anatomy of the larynx 
The larynx is located anteriorly in the human neck immediately below the 
pharyngeal division which gives rise to the trachea (windpipe) and the gullet (food pipe).  
Figure 2.1 illustrates the longitudinal section of the human larynx.  The larynx comprises 
the cricoid cartilage (smaller), thyroid cartilage (larger), arytenoid cartilages, vocal folds, 
glottis, epiglottis and the hyoid bone.  In males the prominent anterior bulge of the 
thyroid cartilage is known as the Adam’s apple.  The vocal fold tissue is located anterio-
posteriorly in the center of the laryngeal framework.  Figure 2.2 indicates that the vocal 
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fold tissue in an intermediate position is a symmetrical “V” shaped structure when 
viewed from the top.  Posteriorly the vocal folds are attached to the arytenoid cartilage.   
The vocal folds tissue is ~11 – 15mm long in females and ~17 – 21mm in males 
[57, 58].  Below the age of 10 there is no difference in the length of the vocal folds 
between men and women [57].  The membranous vocal fold tissue is ~8.5 – 12 mm long 
in females and ~14.5 – 18mm in males [57, 58].  In newborns the length of the 
membranous vocal fold is 1.3 – 2.0mm [57].  The cartilaginous vocal fold tissue is ~2.0 – 
3.0mm long in females and 2.5 – 3.5mm long in males [57].  In newborns the length of 
the cartilaginous vocal fold is 1.0 – 1.4mm [57].   
The space between the vocal folds is known as the glottis.  The glottis opens when 
the vocal folds adduct and closes when the vocal folds abduct i.e. vibration causes high 
frequency glottal opening and closure.  The epiglottis (soft cartilage) which lies superior 
to the vocal folds serves to protect the larynx during deglutition (swallowing) and 
prevents aspiration of food particles.  It is not involved in normal voice production.  The 
hyoid bone positioned above the thyroid cartilage provides an attachment site for many 
muscles of the tongue, jaw and neck.  It is the only bone that is not connected to another 
bone in the body.   
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Figure 2.1 Longitudinal section of the human larynx which houses the vocal folds 
 (http://www.hopkinsmedicine.org/voice/anatomy.html) 
 
 
 
 
 
 
 
 
Figure 2.2 Top view of the human vocal folds housed in the laryngeal framework 
(http://www.hopkinsmedicine.org/voice/anatomy.html) 
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2.1.2 Laryngeal muscles 
There are two types of laryngeal muscles namely, intrinsic and extrinsic.  The 
intrinsic and extrinsic laryngeal muscles together open and close the vocal folds as well 
as shape the vocal tract during phonation. 
(a) Intrinsic laryngeal muscles - These muscles serve to position the vocal folds during 
the phonatory cycle.  They are paired and symmetrically arranged on both sides of the 
larynx.  The five intrinsic laryngeal muscles and their functions are as follows:-    
 Posterior cricoarytenoids - These are the only muscles involved in abduction 
(“abduction” - process of pulling the vocal folds away from each other or vocal fold 
opening).  These muscles achieve glottal opening by pulling the back ends of the 
arytenoid cartilages together.  This pulls the front ends (where the vocal folds attach) 
apart, thus pulling the vocal folds apart.    
 Lateral cricoarytenoids - These muscles are involved in adduction (“adduction” - 
process of medialization of the vocal folds or vocal fold closure).  These muscles achieve 
glottal closure by pulling the back ends of the arytenoid cartilages apart.  This pulls the 
front ends together, thus medializing the vocal folds.      
 Thyroarytenoids - These muscles form the “body” of the vocal folds.  They are also 
known as the “vocalis muscle”.  These muscles bring about vocal fold shortening by 
pulling the arytenoid (back) end of the vocal folds toward the thyroid (front) end.   This 
manner of shortening causes the vocal folds to vibrate more slowly thus lowering the 
frequency (pitch).  The thyroarytenoid muscles provide force to strengthen glottic closure 
 10 
in an attempt to resist the exhaled airstream from the lungs in order to buildup subglottic 
air pressure to initiate phonation.  
 Cricothyroid - These muscle are antagonists to the thyroarytenoid muscles.  The 
cricothyroid muscles serve to lengthen the vocal folds.  They lengthen the vocal folds by 
pulling the thyroid cartilage down, which increases the distance between the arytenoid 
and the Adam's apple.  This causes the vocal folds to vibrate faster, thus raising 
frequency (pitch). 
 Interarytenoid - The transverse and oblique arytenoid are the two sets of arytenoid 
muscles.  These muscles bring the two arytenoid cartilages together to provide 
compression medialization for the vocal folds which along with the forces provided by 
the lateral cricoarytenoid and thyroarytenoid muscles allow buildup of the subglottic 
pressure necessary for the onset of phonation.   
(b) Extrinsic laryngeal muscles - These muscles are also known as the “strap” muscles 
since they are responsible for moving the entire larynx up and down during respiration, 
phonation and deglutition.  The extrinsic laryngeal muscles can be classified as the 
infrahyoid and the suprahyoid muscles.  The infrahyoid muscles comprise omohyoid, 
sternohyoid, sternothyroid and thyrohyoid muscles.  The suprahyoid muscles comprise 
digastric, geniohyoid, myohyoid, stylohyoid and stylopharyngeus muscles.   
 
2.1.3 Laryngeal innervation 
The vagus nerve which arises from the medulla oblongata in the brainstem 
provides control over the intrinsic laryngeal muscles.  The vagus nerve branches into the 
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superior laryngeal nerve and the recurrent laryngeal nerve.  The superior laryngeal nerve 
divides into the internal and external branches.  The internal branch further subdivides 
into two branches, one which innervates the epiglottis and the other which descends to 
anastomose with the posterior ramus of the recurrent laryngeal nerve.  This branch of the 
superior laryngeal nerve also serves as a pharyngeal sensory nerve.  The external branch 
supplies the cricothyroid muscle as the motor nerve.  The recurrent laryngeal nerve 
divides into two branches at the level of the second tracheal ring.  The first branch called 
the posterior ramus anastomoses with the superior laryngeal nerve as mentioned earlier.  
The second branch called the anterior ramus supplies the vocalis muscle [59].  All the 
intrinsic laryngeal muscles are innervated by the recurrent laryngeal nerve except the 
cricothyroid muscle which is innervated by the external branch of the superior laryngeal 
nerve. 
 
2.1.4 Arterial blood supply 
The larynx receives blood supply from the superior and inferior laryngeal arteries 
and to a small extent from the cricothyroid artery.  The superior laryngeal artery is a 
branch of the superior thyroid artery which originates from the carotid artery.  The 
inferior laryngeal artery is a branch of the inferior thyroid artery which originates from 
the subclavian artery.  The cricothyroid artery branches from the superior thyroid artery.  
The three laryngeal arteries freely anastomose with each other.   
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2.1.5 Venous blood drainage 
The superior laryngeal vein drains into the superior and middle thyroid veins 
which eventually empties into the jugular vein.  The inferior laryngeal vein empties into 
the middle and inferior thyroid veins which eventually empties into the superior vena 
cava. 
 
2.1.6 Lymphatic drainage 
The larynx except the free margins of the vocal folds (which is our focus area for 
research) is richly supplied with lymphatic drainage.  The area above the vocal folds 
drains into the superior and middle jugular nodes.  The remaining part drains into the 
paratracheal lymph nodes, middle and inferior jugular nodes.   
 
2.1.7 Physiology of phonation 
Conceptual statement :- The biomechanics of the vocal fold tissue underlies the quality 
of voice. 
The vocal folds are connective tissues located in the larynx which function to 
transduce aerodynamic energy from exhalation to acoustical energy for voice production.  
A healthy voice is contingent upon the balance maintained between the pressure exerted 
by the pulmonary system and the resistance offered by the vocal fold tissue [60].  In 
engineering terms, voice is a result of synchronous activity of the power source, oscillator 
and resonators [13].  The lungs, thoracic muscles, back muscles, diaphragm and 
abdominal muscles together constitute the power source which forces out the air during 
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exhalation.  The larynx functions as the oscillator.  The parts of the larynx above the 
glottis comprising pharynx, nasal cavity, oral cavity and paranasal sinuses together form 
the resonators.  Phonation is the net result of the co-ordination of a multitude of factors 
like subglottic air pressure, glottal air flow, glottal resistance, vocalis muscle contraction, 
vocal fold tissue biomechanics, Bernoulli‟s effect, and acoustic coupling of the cavities 
above and below the glottis [61].  During quiet respiration the vocal folds are in an 
intermediate position with slight glottal widening during inspiration [59].  The vocal 
folds are medialized and elongated at the beginning of each phonatory cycle.  The 
subglottic air pressure needed to initiate phonation is defined as the phonation threshold 
pressure [61, 62].  A rise in subglottic pressure just above the phonation threshold level 
which is approximately 7cm of water for conversational speech [13] pushes the vocal 
folds apart by progressively straining the vocal ligament (elastic component of the vocal 
folds) until a gap develops and the exhaled air begins to flow out thus vibrating the vocal 
mucosa (vibratory component of the vocal folds).  The vibrating vocal mucosa gives rise 
to a mucosal wave (shear wave) which underlies the quality of voice.  At this point the 
elastic properties of the vocal folds and the Bernoulli‟s forces generated by the air flow 
between the vocal folds begin to medialize the vocal ligament even as the vocal mucosa 
is still vibrating.  One phonatory cycle is completed when the vocal mucosa snaps back to 
the midline eventually.  Subglottic air pressure builds up again initiating yet another 
phonatory cycle.  Movement of the lips and tongue change this sound to create individual 
speech sounds.  The phonation threshold pressure is linearly related to the vocal fold 
tissue viscoelastic properties [7].  The fundamental frequency (pitch) of phonation 
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depends upon length and stiffness of the vocal fold tissue (mechanical properties), 
exhaled air pressure, and the mass of the vocal fold tissue [13].  Formant frequencies are 
achieved by altering vocal tract shapes with the help of extrinsic laryngeal muscles 
(formant frequencies are four or five resonant frequencies of the vocal tract [13].  The 
vocal fold tissue (vocal mucosa) vibrates at frequencies of 100 to 1000Hz at amplitudes 
of 1mm [11].  The vocal ligament experiences approximately 15% strain at normal 
phonatory frequencies [63].   
 
2.2 ECM and biomechanics of phonation 
Conceptual statement :- The ECM composition of the vocal fold tissue is fundamental 
to the biomechanics of voice production. 
Briefly, the vocal fold tissue is a good example of a tissue whose form and 
function are inter-related.  Most vocal pathologies arise from an altered ECM 
composition [2].   
 In engineering terms, the viscoelastic properties of the vocal fold tissues are purely 
responsible for the normal vocal fold vibratory behavior.   
 In biological terms, the unique matrix composition of the vocal fold tissue underlies the 
quality of human voice.   
 In layman terms, the quality of human voice depends upon the vocal fold tissue 
architecture.   
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Figure 2.3 The multi-layered structure of the human vocal folds 
 
The range of sounds a single pair of adult human vocal folds can produce is simply 
amazing especially in comparison to that of a musical instrument [64].  This ability or 
rather versatility stems from the fact that the matrix composition of the vocal fold tissue 
has tremendous functional significance in the context of phonation [65].  As indicated in 
figure 2.3, the adult human vocal fold is a highly differentiated membranous structure 
consisting of a lamina propria sandwiched between the stratified squamous epithelium 
and the vocalis muscle (thyroarytenoid muscle) [66].  Histologically the adult human 
vocal folds comprise six different layers :- epidermis (the outer epithelium), the basement 
membrane zone (BMZ), the superficial (LPs) , intermediate (LPi), and deep (LPd) layers 
of the lamina propria and the vocalis muscle [2, 66-69].  The LPs is also known as the 
“Reinke‟s space”.  The biomechanical performance of the vocal fold tissue correlates 
with the anatomic arrangement of structural scaffolding proteins and this leads to a 
“cover-body” theory of vibration [68, 69].  The epidermis and LPs together constitute the 
 16 
vocal fold “cover” which is popularly known as the vocal mucosa [69].  The LPi and LPd 
together constitute the vocal ligament.  The vocalis muscle (thyroarytenoid muscle) forms 
the “body” of the cover-body structure.  Animals and new born infants lack the vocal 
ligament [70-72].    
 
2.2.1 Epidermis 
The stratified squamous epithelium forms the epidermis or the outer cover of the 
vocal fold tissue whereas ciliated pseudocolumnar epithelium forms the outer covering of 
the remaining parts of the larynx [2].  This epidermis serves as the protective covering 
which gives shape and consistency to the underlying lamina propria.  The epidermis is 
primarily cellular with the cells attached to each other through desmosomes (attachments 
between cytoskeleton of the adjacent cells).  The ability to resist repetitive collisions the 
vocal folds are subjected to over several decades can be attributed to the presence of the 
desmosomes.  The stratified squamous epithelial cells are metabolically active until 
desquamation unlike epithelial cells of the skin.  Desquamated cells in the uppermost 
layer are replenished by the dividing basal cells.  The luminal surface of these epithelial 
cells is covered with a microridge pattern.  The microridged pattern may assist in 
increased mucus adherence, water absorption (due to an effective increase in surface 
area) and increased traction during vocal fold vibration.  A mucociliary blanket (layer of 
mucus) which comprises the mucinous layer and the serous layer covers the epithelial 
lining [2, 73].  The mucinous layer which is the luminal layer prevents dehydration of the 
underlying serous layer and the epithelial cells.  The serous layer which has a much 
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higher degree of hydration (in comparison to the mucinous layer) is in direct contact with 
the cilia which can beat freely within the less viscous serous layer than when it is in 
contact with the thick, viscous mucinous layer.  This mucociliary blanket travels upwards 
in a circular fashion at the rate of 4 to 21 mm/minute in a normal person.  One puff of 
cigarette, cold and dry conditions can slow down mucociliary clearance enough to expose 
the mucus to inhaled environmental toxins, inflammatory agents, allergens and 
dehydration [2, 74].  Thereby the mucociliary blanket is responsible for keeping the vocal 
fold healthy, moist and lubricated under normal conditions. 
 
2.2.2 Basement membrane zone (BMZ) 
It is also referred to as the submucosal BMZ.  The BMZ is necessary for the 
ordered development of the multilayered vocal fold tissue [75].  The BMZ secures the 
overlying epidermis (stratified squamous epithelial cells) to the underlying lamina propria 
(primarily acellular amorphous ECM components) through anchoring fibers composed of 
collagen types IV and VII [2].  The BMZ is a four layered structure comprising the 
plasma membrane of the basal epithelial cells, the lamina lucida (immediately below the 
basal cells of the epidermis), the lamina densa and the sub lamina densa (above the LPs) 
[2, 75-78].  The anchoring filaments composed of collagen type IV anchor the 
hemidesmosome of the basal cells to the lamina lucida and the lamina densa [75].  The 
anchoring fibers composed of collagen type VII loop from the lamina densa through the 
sub lamina densa to the LPs and back again to the lamina densa.  The concentration i.e.  
population density of anchoring fibers is genetically influenced [79, 80].  An average 
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person may have 80 to 120 anchoring fibers per unit area of BMZ whereas a person with 
a recessive gene for collagen VII may have only 40 to 50 anchoring fibers per unit area of 
BMZ.  A person who is homozygous for the recessive gene will have almost no 
anchoring fibers [81].  Heparan sulfate proteoglycan is found in the BMZ, and it serves to 
bind collagen type IV, laminin, and fibronectin [4].  It is reported that in normal 
conditions the BMZ appears rectilinear but pathology lends a non uniform distorted 
appearance to the BMZ [75].  The extent of non uniformity explains the degree of 
structural tissue damage. 
 
2.2.3 Lamina propria 
In adults the lamina propria is a hypocellular structure whose ECM 
composition plays a significant role in maintaing normal phonatory voice.  However, 
in newborns the lamina propria is characterized as a single layer of cells [82].  In 
adults the lamina propria is a loose connection of ECM components which comprises 
structural glycoproteins, fibrous proteins, non fibrous proteoglycans, glycosaminoglycans 
(GAGs) like HA, sparsely interspersed fibroblasts, myofibroblasts (differentiated 
fibroblast), and occasionally macrophages [2, 68, 69].  In 2001, Sato and co-workers, 
confirmed that some cells which had a stellate (star like) morphology with slender 
cytoplasmic processes (broadly classified as fibroblasts) were distinctly different from the 
conventional fibroblasts both in terms of morphology and differentiated functions i.e.  
protein expression [83-87].  These cells came to be known as vocal fold stellate cells 
named after their peculiar star-like morphology.  The vocal fold stellate cells are widely 
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distributed in the macula flavae (junction/transition region between the vocal ligament 
and thyroid cartilage which bears maximum tension in the vocal ligament) but are absent 
in the LPs [83].  It is reported that the stellate cells actively synthesize elastic and 
collagen fibers and are responsible for the development of the vocal ligament after birth 
[71, 88, 89].  The interaction between structural glycoproteins like fibronectin and fibrous 
proteins like elastin and collagen serves to stabilize the matrix  scaffolding of the 
biomechanically important lamina propria [2, 68, 83, 90].  Conventional fibroblasts are 
found in the vocal mucosa interspersed within the ECM.  Originally, it was widely 
accepted that the bipolar spindle shaped fibroblasts produced the vocal fold tissue matrix 
[64, 65, 70, 91, 92].  However, in 1996 Pawlak and co-workers demonstrated cytoplasmic 
staining for proteoglycans in macrophages and myofibroblasts [4].  It was observed that 
the concentration of macrophages and myofibroblasts was highest in the superficial fifth 
and that of the conventional fibroblasts was maximum in the deepest fifth of the lamina 
propria [65].  Interestingly, women have a significantly higher concentration of 
macrophages in the superficial fifth of the lamina propria [65].  Macrophages are the cells 
which respond to and may cause inflammation.  They are mainly found in the 
submuscosal BMZ (between the epidermis and the LPs).  The location of the 
macrophages suggests that they are present to counter agents like bacteria, viruses and 
other inhalants that cross the epithelium and can be harmful to the vocal fold tissue [2].  
Macrophages produce and release the cytokine IL-1 which plays a central role in the 
mediation of inflammation.  IL-1 causes the vocal fold fibroblasts to produce more HA 
and less versican [93, 94].  The myofibroblasts are a differentiated form of fibroblasts 
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containing smooth muscle alpha actin and are found in areas of damage and function as 
repair cells [95].  They are anchored to the matrix by a transmembrane complex between 
the intracellular and extracellular fibronectin fibers called a fibronexus [96].  The actin 
and fibronectin aid myofibroblasts in reorganization of the tissue during the reparative 
stage [97].  Interestingly, these cells are also found in normal human vocal folds.  The 
concentration of myofibroblasts decreases as the depth of the vocal fold tissue increases 
(highest in the LPs and absent in the LPd) [2].  This indicates the presence of 
microtrauma and constant repair efforts in the vocal fold tissue as a result of the constant 
impact from phonation (normal use of vocal folds) [2, 65].   
From the above observations one may infer that the synergistic action of the 
following helps in restoring the microscopic injury without any significant alteration in 
the vocal fold ECM composition :-  
- myofibroblasts (elevate collagen levels leading to scar formation)  
- increased synthesis of HA due to IL-1 activity (helps in retaining elevated levels of 
HA during the acute phase of wound healing to prevent scarring)  
- deposition of fibronectin (mediates wound healing by acting as a chemoattractant       
for monocytes and fibroblasts, by promoting cell-matrix interactions through its cell 
and matrix macromolecule binding domains) [2, 90, 93, 94, 98, 99].   
It is reported that microinjury repair can take up to 48 hours to heal [2].  However chronic 
vocal abuse may lead to the onset of vocal pathology due to a vigorous (macroscopic) 
unresolvable injury to the vocal fold tissue catalyzed by inadequate healing time.   
 21 
One may thus infer that the macrophages, myofibroblasts, conventional fibroblasts 
and the vocal fold stellate cells together are actively involved in matrix synthesis of the 
vocal fold tissue.   
 
2.2.3.1 Vocal mucosa 
(a) ECM composition of the human vocal mucosa - The matrix of the vocal mucosa 
(epithelium and LPs) is abundant in glycoproteins like fibronectin, small interstitial 
proteoglycans like decorin, large proteoglycans like versican, GAGs like HA, and small 
amounts of elastic fibers like elaunin and oxytalan [2-4, 6, 7, 90, 100].  Fibronectin is a 
ubiquitous glycoprotein which plays a vital role in cellular functions and presents binding 
sites for matrix macromolecules as well as cells [19, 90].  Fibroblasts deposit fibronectin 
in response to interstitial tissue damage [19].  Fibronectin binds to fibrous proteins like 
collagen and proteoglycans and thereby plays a vital role in vocal fold tissue matrix 
assembly.  However, it was reported in 1999 by Chan and co-workers [101] that although 
abundant in the vocal fold tissue, fibronectin does not play a vital role in the maintenance 
of the vocal fold tissue viscoelasticity.  It is counterintuitive that though fibronectin has 
binding sites for HA it does not affect the biomechanics of the tissue.  The reason behind 
this may be the use of an inappropriate isoform, a smaller molecular weight or a lower 
approximation of  the biological concentration of fibronectin [90].  On the other hand the 
sole function of fibronectin may be to assemble and maintain the matrix and the cells in 
the vocal fold tissue [90].  Decorin is found mainly in the LPs and its main function is to 
bind and regulate the thickness of collagen fibrils [2, 4, 7, 15].  Decorin mainly binds 
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collagen types I and II [4].  The presence of decorin in the LPs not only delays but also 
reduces the concentration of collagen fibrils in the vocal mucosa.  HA differs from other 
GAGs in that it does not occur covalently bound to proteins, and is usually considered 
unique though it is described along with the proteoglycans in the context of the vocal 
folds [7].  HA is the only GAG present in the vocal fold tissue.  HA is a porous, high 
molecular weight, polyanionic molecule which is responsible for regulation of osmosis 
by attracting sodium ions and therefore water.  HA in turn controls the tissue viscosity by 
regulating the hydration levels of the vocal mucosa [2, 7].  Thereby HA lends the vocal 
fold tissue ability to resist the pounding and vibratory shocks sustained during phonation 
[7].  Thus, the viscoelastic properties of the mucosal wave (shear wave) which underlies 
the quality of voice is largely dependent upon the levels of HA in the vocal mucosa.  HA 
is a space filling molecule which serves to regulate the fibrillogenesis of collagen in 
combination with decorin and thereby helps in regulating the size of the vocal mucosa [2, 
4, 7].  In short, HA contributes to tissue viscosity and the initiation and propogation of 
vocal fold oscillations [102].  Versican appears to play a vital role in the lamina propria 
of the vocal fold.  Versican possesses an HA binding domain and thus interacts with HA 
in the matrix of the vocal mucosa [4].  The HA levels in the vocal mucosa seem to 
correlate more with gender than with age.  Males are reported to have three times more 
HA than females and subsequently have a thicker lamina propria [3].  This may 
contribute to increased molecular interactions leading to an increase in tissue elasticity 
and viscosity [103].  Elastic fibers like oxytalan and elaunin are believed to be 
interruptions in elastogenesis varying in the degree of crosslinking [3, 104, 105].  
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Oxytalan, a fibrillar, hydrophilic protein contains very little amorphous elastic material 
and hence does not elongate under mechanical stress [105, 106].  Elaunin is an 
intermediary between fibrillar hydrophilic oxytalan and large amorphous hydrophobic 
elastic fibers.  Elaunin fibers are shorter and smaller than complete elastic fibers [107].  
Elaunin exhibits elastic properties intermediate to those of oxytalan and complete elastic 
fibers [105]. 
(b) Biomechanics of the human vocal mucosa - In terms of biomechanics, the vocal 
mucosa is isotropic due to the random arrangement of the matrix macromolecules [103].  
The vocal mucosa (surface of the vocal fold tissue) propogates in the form of a shear 
wave (mucosal wave) during phonation.  Steady shear deformation and oscillatory shear 
deformation are the two standard rheological techniques to assess the viscoelastic shear 
properties of materials.  The human vocal mucosa is neither “Hookean elastic” (ideal 
solid) nor “Newtonian viscous” (ideal liquid) [103].  For a Newtonian fluid like water the 
steady-state viscosity is independent of the strain rate (it is dependent only on 
temperature).  But non-Newtonian materials like biological tissues and polymeric 
materials have viscoelastic properties that depend upon the strain rate.  The vocal mucosa 
is viscoelastic, exhibiting both elastic and viscous properties.  Thereby, the viscoelastic 
properties of the human vocal mucosa are characterized rheologically using sinusoidal 
oscillatory shear deformation [103].  Rheological properties of the human vocal mucosa 
are a macroscopic manifestation of the microscopic and molecular arrangements.  The 
viscoelastic shear properties of the human vocal mucosa are quantified in terms of 
complex shear modulus which includes the elastic shear modulus and the viscous shear 
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modulus.  The elastic shear modulus is also known as the storage modulus and is a 
measure of the amount of energy stored in the vocal fold tissue during one cycle of 
oscillation/phonation.  The viscous shear modulus is also known as the loss modulus 
which is a measure of the amount of energy dissipated in the form of heat during one 
cycle of oscillation/phonation.  The viscoelastic shear properties of the vocal mucosa are 
often reported in terms of dynamic viscosity which is obtained by dividing the viscous 
shear modulus by angular frequency over the entire range of frequencies tested.  The 
dynamic viscosity response of the human vocal mucosa shows a „shear thinning‟ 
response (decrease in frequency is linear on a log scale) [103].  In some cases an order of 
magnitude difference has been reported between males and females [103].  This may be 
attributed to the gender related difference in ECM composition.  The phonation threshold 
pressure and dynamic viscosity of the vocal mucosa share a linear relationship [7].  Vocal 
fold tissue viscosity and elasticity depend upon the ease with which slippage can occur 
between and within molecules.  This in turn depends upon the intermolecular and 
intramolecular interactions between matrix macromolecules such as:-  
- hydrogen bonds (electrostatic bonds) 
- physicochemical interactions (covalent crosslinks) 
- hydrophilic and hydrophobic interactions (interactions between polar and non 
polar functional groups) 
Thereby, the concentration, molecular weight, and molecular structure of the matrix 
macromolecules which contribute to the 3D tissue architecture are the most important 
factors in regulating the viscoelastic properties of the vocal mucosa.     
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2.2.3.2 Vocal ligament 
(a) Matrix composition of the human vocal ligament - The human vocal ligament 
comprises the LPi and LPd.  It forms the transition region between the cover (vocal 
mucosa) and the body (vocalis muscle) of the vocal fold tissue.  The vocal ligament runs 
between the anterior and posterior macula flavae [89].  The macula flavae is the 
junction/transition region between the vocal ligament and the thyroid cartilage, which 
bears the maximum tension in the vocal ligament.  The anterior and posterior macula 
flavae are connected to the thyroid and arytenoid cartilages, respectively, and are 1.5mm 
x 1.5mm x 1.0mm in size.  Conventional fibroblasts and vocal fold stellate cells make up 
the matrix producing cellular component of the macula flavae [89].  The cell density of 
the macula flavae is lesser than that of the LPs [64].  The fibroblasts and vocal fold 
stellate cells actively produce an ECM rich in elastic and collagen fibers.  At the macula 
flavae ends of the vocal ligament, there are gradual changes in the stiffness of the 
junction region between the vocal ligament and the hard cartilages [108].  The macula 
flavae is present in new born infants but the vocal ligament is absent [70, 89].  The cell 
density in the macula flavae of infants is much higher than that of an adult [71].  It is 
widely accepted that phonation after birth stimulates the fibroblasts in the macula flavae 
which eventually leads to the development of the vocal ligament [89].  The human vocal 
ligament matures after puberty [109].  The macula flavae is essential for growth, 
development, and aging of the vocal fold tissue [71, 88, 89].  One might infer that the 
fibroblasts in the macula flavae produce collagen and elastic fibers in response to 
mechanical stress which is the epigenetic stimulus regulating the matrix composition of 
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the macula flavae itself and thereby the vocal ligament.  The ECM of the vocal ligament 
is abundant in small interstitial  proteoglycans like fibromodulin and fibrous proteins like 
elastin and collagen, small amounts of HA and glycoproteins like fibronectin [2-4, 6, 7, 
14, 65, 90, 100].  Fibromodulin is concentrated in the vocal ligament and it serves to bind 
and regulate the thickness of collagen fibrils [2, 4, 7].  Interactions between glycoproteins 
like fibronectin and fibrous proteins like elastin and collagen provide scaffolding to the 
vocal fold tissue.  The elastin and collagen fibers of the vocal ligament are also produced 
by the vocal fold stellate cells located in the macula flavae [83, 89].  The concentration of 
elastin fibers is reported to correlate more with age than with gender [110].  Native 
elastin which can otherwise be stretched to five times its original length without any loss 
of resilience can be stretched to only twice its normal length in the vocal fold tissue due 
to its association with collagen [92, 111, 112].  Collagen imparts tensile strength to the 
vocal ligament.  Tensile strength arises from the crosslinking present within collagen 
which is due to covalent bonds formed between the lysine and hydroxylysine residues on 
adjacent molecules [111].  Lack of elastin and collagen may result in unco-ordinated 
vibration of the vocal fold tissue resulting in dysphonia [110].  Proteoglycans influence 
the interaction between  elastin and collagen fibers [6].  Therefore, interactions between 
fibronectin, fibromodulin, HA, and primarily elastin and collagen impart elasticity and 
tension bearing properties to the vocal ligament. 
(b) Biomechanics of the human vocal ligament - Young‟s modulus (elastic modulus) 
accurately represents the elasticity of the human vocal ligament [8].  Elasticity of the 
vocal ligament plays a key role in control of phonation since the mucosal wave first 
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begins from the deeper layers of the lamina propria, then propogates to (transverse 
direction), and along the surface (vertical direction).  It was reported that the vocal fold 
tissue stress-strain relationship is linear at low strain levels (<15% strain) and non linear 
at higher strain levels [63].  Low strain levels (<15% strain) represent normal phonatory 
strain levels [8].  Min and co-workers, characterized the longitudinal elasticity of the 
human vocal ligament using excised tissue from human larynges and reported the 
Young‟s modulus to be approximately 33kPa at low strains (<15%) [63].  At higher 
strains (>15%) the Young‟s modulus values were 135kPa (25% strain), and 600kPa (40% 
strain).  The elastic moduli of the human vocal ligament at higher strains (>15%) 
predominates over the vocal mucosal stress thereby playing a fundamental role in 
controlling frequency at high strain.  Tran and co-workers, reported the transverse 
elasticity of the human vocal ligament using an in vivo measurement technique on human 
patients‟ vocal fold tissue under general anesthesia [8].  The recurrent laryngeal nerve 
was stimulated with 2 different currents 3.8mA and 3.2mA at 80Hz for a pulse duration 
of 1.5ms.  At high stimulation the transverse elasticity was reported to be approximately 
21kPa and at low stimulation it was reported to be 19kPa.  Though there is a significant 
difference in the values of the longitudinal moduli and transverse moduli, one cannot 
infer that the vocal ligament is anisotropic (longitudinal vs transverse).  Further studies 
need to be performed in order to characterize the transverse moduli at varying levels of 
stimulation.  It is important to characterize transverse elastic moduli of the vocal ligament 
because initial mucosal wave movement (LPd to LPs) is in the transverse direction 
(though the surface mucosal wave propogates in the vertical direction).   
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From the ECM composition of the vocal mucosa and the vocal ligament it is 
evident that the vocal mucosa is sparsely populated with elastin and collagen fibers 
whereas the vocal ligament has an abundance of these fibers.  The linear and non linear 
elasticity at low and high strains correlate to the unique collagen ultrastructure of the 
human vocal ligament [113].  The helical collagen fibers function as a buffer at low 
strains so that elongations of the vocal ligament occur without much resistance [113].  At 
high strains, the unique collagen structure absorbs the stress and serves as a shock 
absorber along the length of the fibers.   
From these observations one might wonder what causes the matrix producing 
cells to produce a certain kind of matrix in the vocal mucosa (~1mm below the surface) 
and yet another different matrix in the vocal ligament (~3 to 4mm below the surface of 
the vocal folds).  Chemical signals in different tissues are thought to determine the 
location and extent of ECM protein deposition [114].  However, bearing in mind the 
mechanical function and vibratory microenvironment of the vocal fold tissue, one might 
hypothesize that vibration and strain are the epigenetic stimuli regulating the unique 
matrix composition of the human vocal fold tissue (especially the lamina propria).  In 
other words, differences in gene expression (ultimately leading to a correspondingly 
different protein expression assuming there are no factors causing post translational 
modifications) in the vocal mucosa and vocal ligament may be a direct result of 
differences in the magnitude of mechanical stimulation experienced by the vocal mucosa 
(vibration) and the vocal ligament (strain). 
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2.3 Aging and matrix regulation by fibroblasts 
 2.3.1 Why does our voice change (presbyphonia) as we age? 
As we age, the membranous vocal folds shorten in males, the vocal mucosa 
thickens in females and edema develops in the LPs of both males and females [115].  It 
had been reported that non pathological loss of voice quality sets in every five years for 
males above fifty years of age [116].  Aging causes matrix producing fibroblasts to 
senesce thereby resulting in less efficient functions.  In other words, as we age the density 
of cells in the vocal fold tissue and their cytoplasmic components like golgi apparatus and 
rough endoplasmic reticulum (site for active protein synthesis) decrease in number [88].  
The number of fibrous proteins (elastin and collagen fibers) synthesized by the senescent 
resident cells of the macula flavae also decreases.  This alteration in balance leads to a 
change in the biomechanical performance of the tissue, ultimately leading to an aging 
voice.  The process of degrading old proteins and synthesis of new proteins is referred to 
as “ECM turnover”.  ECM turnover slows down as age progresses.  Fibroblasts are 
implicated in ECM turnover by virtue of the enzymes they secrete which in turn degrade 
the matrix proteins.  These enzymes are called matrix metalloproteases (MMPs).  MMPs 
include collagenases, gelatinases, and elastases.  MMP-1 (collagenase) degrades collagen 
types I and III.  MMP-2 (gelatinase) degrades collagen type IV and VII which are BMZ 
proteins.  Elastases degrade elastin molecules.  The catabolic activity of the MMPs is 
inhibited by the tissue inhibitors of metalloproteases (TIMPs) [117].  Vocal fold tissue 
ECM regulation involves the interplay between MMPs (degrade matrix proteins) and 
TIMPs (inhibit the activity of the MMPs) [2].  Unfortunately, studies examining the 
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interaction between the MMPs and TIMPs in the human vocal fold have not been 
performed [2].  However, such studies have been performed in animal models.  In these 
models the production of collagen and MMPs decreases with age but the production of 
TIMPs remains relatively constant throughout the life span [2].  The cumulative 
physiologic effect of decreased protein and MMPs expression coupled with a constant 
TIMPs secretion is slower protein turnover.  This causes the existing proteins to become 
older (more crosslinked in case of collagen and elastin) before they are replaced.  A 
higher degree of crosslinking further delays degradation by normal processes due to 
increased intra and intermolecular bond formation and also hampers biological activity of 
these molecules [2].  Elastin molecules become less elastic and the collagen molecules 
become stiffer due to increased crosslinking [118].  Fibronectin concentration in the 
vocal fold tissue increases as a result of constant repair throughout a lifetime [90].  In the 
context of the vocal fold tissue, as one ages, slower matrix turnover coupled with 
elevated levels of fibronectin causes the vocal fold tissue to become less elastic and more 
stiff, signaling a change in the biomechanical properties of the tissue which ultimately 
leads to slight a change in voice or in more chronic cases leads to dysphonia.  For 
example, a stiffer, thinner vocal fold tissue will cause the vocal folds to vibrate faster and 
with smaller amplitude.   
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2.3.2 Collagen and senescence 
As mentioned earlier, collagen types I, II and III are found in the lamina propria 
and collagen types IV and VII are found in the BMZ.  As we age, increased collagen 
crosslinking and reduced ECM turnover rate makes the lamina propria stiffer [6].  It was 
reported that infant vocal folds had about 51% of the collagen found in all adults and in 
geriatrics.  There was no significant difference between adult and geriatric folds.  
However, female adult and geriatric vocal folds had approximately 59% of the collagen 
found in male adult and geriatric vocal folds i.e.  male vocal ligaments showed about 
twice the concentration of collagen in the female vocal ligament [119].  Thereby, the 
concentration of collagen fibers correlates more with gender than with age. 
 
2.3.3 Elastin and senescence 
Hammond and co-workers, reported that infants (smaller, thinner elastic fibers) 
had approximately 23% and geriatrics (larger, thicker elastic fibers) had approximately 
879% of the elastin found in a normal adult human vocal fold [110].  Consistent with this 
finding the geriatric vocal ligament was reported to be larger than that of infants and 
adults [110].  However, Sato and Hirano, reported that the concentration of elastic fibers 
in geriatrics is lesser than that of normal adults [120].  Hirano and co-workers, also 
reported a similar reduction in elastin levels when geriatrics were compared to adults 
[109].  These contradictory results have not been discussed by these groups in later 
publications.  Gray and co-workers, hypothesized that variable observations could be 
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attributed to differences in the quantitation techniques, specimen number and racial 
variations among subjects [6].   
 
2.3.4 Hormones and aging 
Newman and co-workers, reported the presence of androgen, estrogen, and 
progesterone in the human vocal fold tissue in varying concentrations and locations thus 
lending a hormonal angle to the aging voice [121].  The concentration of the progesterone 
receptor was higher in younger subjects across both genders in comparison to older 
subjects.  It was also reported that variations in the estrogen/androgen ratio was 
responsible for voice changes in post menopausal women.  The concentration of 
androgen and progesterone receptors is higher in males than in females.  It must be stated 
that the relation between hormone levels and aging is yet to be fully understood. 
 
2.4 Vocal fold damaging factors 
Vocal fold tissue damage can be brought about by a multitude of factors such as 
[2, 13-15, 65, 122, 123] :-  
(a) Vocal misuse/overuse  
- chronic vocal overuse 
- excessive exposure to cold and dry environments 
- smoking 
(b) Non phonatory mechanical injury 
- trauma (head or neck injuries)  
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- surgical intubation  
- improper use of CO2 laser during surgery  
(c)  Vocal pathology 
- benign lesions (nodules, polyps and Reinke‟s edema) 
- laryngeal cancer 
- medical problems like allergies of the upper respiratory tract, nasal and sinus 
regions, and laryngophayrngeal reflux (gastroesophagal reflux)   
- infectious laryngeal diseases, for example - respiratory papillomatosis 
 
2.5 Diagnosis/Assessment of vocal fold tissue damage 
(a) Vocal fold tissue examination - Assessment of voice problems includes a detailed 
evaluation of patient history, perceptual voice assessments, laryngeal endoscopy (rigid 
endoscopy or transnasal flexible endoscopy), examination of the vocal fold tissue 
vibratory pattern using a videolaryngostroboscope, evaluation of aerodynamic efficiency 
(information about the efficiency of the larynx), pulmonary function and acoustical voice 
analysis (information about the physical aspects of voice) [18, 60].   
(b) Vibratory tests - Vibratory tests are conducted with the help of video-
laryngostroboscopes, fiberoptic-laryngoscopy, electroglottography / laryngomyography 
or ultra-high speed photography [13, 18, 60].  This kind of physical examination 
facilitates detection of asynchronous vibrations, vibration asymmetries, structural 
abnormalities like small masses and submucosal scars.  Transnasal flexible laryngoscopy 
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helps identify compensatory behavior of the extrinsic laryngeal muscles by detecting 
muscle tension dysphonia arising secondary to glottic incompetence [18]. 
(c) Aerodynamic studies - Aerodynamic efficiency of the vocal fold tissue is examined 
using a pneumotachograph which measures air volume, air flow rate and phonation time 
[60].  Respiratory function is analyzed using a plethysmograph.  Increase in vocal fold 
tissue stiffness results in a decrease in both the mean air flow rate and air volume.   
(d) Voice analysis - Minor changes in the vibratory pattern of the vocal fold tissue can be 
detected by careful voice/acoustic analysis [60].  Vocal pathologies tend to contract the 
vocal frequency range in an adult human patient.  The patient‟s normal phonatory 
frequency (pitch) and vocal range can be assessed using frequency measurements.   
 
2.6 Vocal pathologies 
Rapid strides in communications during the 20
th
 century and in the ongoing 21
st
 
century involving media like radio, television, telephone and computers which have 
brought about upliftment of our society are based on the impact of voice [60].  Urban 
pollution and high stress levels can cause irritation to the fine lining of the vocal fold 
tissues [60].  Rapid transportation resources result in lack of time for globe trotting 
performers (singers, actors and teachers) to acclimatize their voice producing organ.   
The six most frequently reported dysphonia-inducing vocal pathologies are vocal 
fold scarring, nodules, polyps, Reinke‟s edema, laryngeal cancer, and vocal fold paralysis 
[124].  The three most commonly diagnosed vocal pathologies are benign lesions like 
vocal fold polyps, nodules and Reinke‟s edema [125]. 
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2.6.1 Vocal fold scar 
Scarring is implicated as the single largest cause for the loss of voice quality after 
surgery [18].  Scarring of the vocal fold tissue is a result of blunt trauma, penetrating 
neck injuries, iatrogenic injuries, surgical intubation, radiation therapy for removal of 
lesions, pro-inflammatory conditions like laryngopharyngeal reflux and laryngeal 
infections [13].  Vocal fold scar may or may not co-exist with benign lesions.  The 
functional result of a vocal fold scar is dysphonia due to decreased ability of the stiff 
unresponsive vocal fold tissue to vibrate freely and rapidly during phonation coupled 
with complications like aspiration (related to glottic incompetence).  When viewed by a 
stroboscope the mucosal wave produced by the scarred tissue appears to be irregular and 
reduced in both frequency and amplitude as compared to that of a normal vocal fold 
tissue.  Scarring-induced reduction in vibrational amplitude of the mucosal wave leads to 
decreased intensity of voice.  The phonation threshold pressure (subglottic pressure 
required to initiate phonation) is increased as a result of an altered ECM composition of 
the vocal fold tissue.  Thereby, in addition to dysphonia, patients complain of vocal 
fatigue, breathlessness, and increased phonatory effort [18].  The subject will attempt to 
overcome scar induced voicing difficulties by :- (a) altering the length and tension 
(mechanical properties) of the vocal fold tissue with the help of the intrinsic laryngeal 
muscles and (b) by changing the position and shape of the larynx with the extrinsic 
laryngeal muscles to increase the phonation threshold pressure [13].  This leads to 
compensatory muscle tension induced dysphonia secondary to scar induced dysphonia at 
a later stage [18].   
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Scar tissue is seldom diagnosed in the nascent stage due to virtually no evidence 
of mass lesion or visible abnormality.  Treatment of the scarred vocal fold tissue is one of 
the most challenging voice problems faced by otolaryngologists today [18].  Any kind of 
injury to the vocal fold lamina propria elicits a wound healing response which is 
characterized by disorganized deposition of collagen which eventually results in scar 
formation.  The acute phase of wound healing which includes the proliferative phase is 
very important in the context of scar formation [48, 126].  The proliferative phase begins 
2 to 3 days after initial injury and lasts for 2 to 3 weeks [48].  During the proliferative 
phase fibroblasts migrate into the site of injury and actively synthesize matrix comprising 
mainly collagen.  HA being a space occupying molecule in the matrix, affects collagen 
fibrillogenesis [127].  The balance between matrix molecules (collagen vs HA) produced 
during the proliferative phase is the defining difference between scar formation and 
regenerative-type wound healing [128].  Adult dermal wound healing is characterized by 
scar formation attributed to decreased HA levels by day 10 [129].  Scarless fetal wound 
healing is attributed to consistent elevated levels of HA leading to regenerative repair 
[128, 130].  It has been reported that HA levels in the vocal fold wounds decrease to sub 
normal levels after day 5 of injury resulting in vocal fold scarring [131].  However, 
chronic vocal fold scars (2 to 6 months post injury) reveal HA levels similar to that of 
normal tissue [132-134].  As mentioned earlier, elevated levels of HA throughout the 
wound healing process would help in regulating the fibrillogenesis of collagen and could 
thus play a vital role in averting scar formation primarily due to its space occupying 
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property.  In addition to being disorganized and scattered, elastin levels are decreased in 
matured scars (2 to 6 months post injury) [132, 133].   
 
Physiological effects of scar formation :- Thus scar formation leads to an altered matrix 
composition of the vocal folds tissue which subsequently causes dysphonia. 
 
2.6.2 Benign vocal fold lesions 
Injuries like vocal fold polyps, nodules, and Reinke‟s edema (also known as vocal 
fold granulomas) arising out of chronic vocal overuse and inadequate hydration affect the 
lamina propria [14, 19, 65, 75, 135-137].  Vocal fold polyps and nodules are benign 
convex lesions along the midline of the vocal folds caused by increased mechanical stress 
generated by high velocity impact between the vocal folds during phonation [14].  
Mechanical stress coupled with structural disruptions of the BMZ is the main cause of 
benign lesions which have a purely negative impact on the quality of voice.  Among 
otolaryngologists there is no uniformity of vocabulary regarding benign vocal fold 
lesions like polyps, nodules, and Reinke‟s edema.  This arises from the fact that clinical 
diagnosis is hampered by the varying macroscopic appearances of these non life 
threatening pathologies [125, 137].  Transformation of vocal polyps, nodules, and 
Reinke‟s edema from one form to another (for example from polyps to nodules) does not 
occur [137]. 
(a) Vocal fold polyps - Vocal polyps are defined as lesions on the anterior third of the 
vocal folds, often on the free edge, sessile or pedunculated, and very mobile when 
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pedunculated [136] (peduncle is a stalklike base to which a polyp or tumor is attached).  
The polyp-inducing phonotrauma is often an acute event which causes capillary damage 
leading to edema, bleeding, and fibrin leakage.  Complete repair and recovery is often 
hampered by recurrent movements of the lesion during phonation, inducing recurrent 
capillary trauma.  From these observations one might hypothesize that the age of the 
lesion cannot be estimated accurately since signs of recent/fresh bleeding could be 
misleading.  Accumulation of HA [137] and fibronectin [135] around blood vessels is a 
unique feature of vocal fold polyps.  A possible reason for elevated levels of HA around 
vasculature is the induction of fibroblasts and smooth muscle cells to deposit HA in 
response to inflammation and mechanical stress/trauma [138, 139].  The thickness of the 
submucosal BMZ remains unaltered [135].  Increased vasculature due to capillary 
proliferation lends a reddish color to the vocal polyps [136].  Severe disruptions of the 
endothelial lining are characteristic of vocal polyps.  The combination of signs of 
recent/fresh bleeding, depositions of iron and fibrin, and thrombosis confirms the clinical 
diagnosis of vocal fold polyps [136].   
(b) Vocal fold nodules - Vocal nodules are defined as small lesions occurring on both 
sides of the larynx, strictly symmetric on the border of the anterior and middle third of 
the vocal fold, and usually immobile during phonation [136].  These superficially located 
lesions move as fast as the frequency of phonation.  Medially directed tearing forces 
generated as a sequelae of the Bernoulli‟s forces generated during the phonatory cycle are 
primarily responsible for vocal nodules.  Glottic incompetence which preexists in this 
pathologic condition serves to increase the tearing forces/Bernoulli‟s forces [136].  Vocal 
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nodules cause submucosal BMZ thickening and less often capillary wall thickening [56].  
Nodules are characterized by increased amounts of collagen type IV and fibronectin in 
the BMZ and the LPs [2, 135].  This kind of protein deposition is indicative of a 
repetitive injury to the tissue which results in abnormal and incomplete healing 
eventually leading to scar formation [2].  Elevated fibronectin levels in vocal nodules 
cause a reduction in mucosal wave motion [90].  Vocal nodules is a pathology that is 
more common in women than in men [3].  The combination of BMZ thickening, absence 
of hemorrhage, and absence of edematous lakes (increased levels of vasculature) 
confirms the clinical diagnosis of vocal fold nodules [136].  Women have a higher 
fundamental frequency of vibration than men.  The higher frequency leads to shocks of 
higher impact when the vocal folds collide during the phonatory cycle.  Also, three times 
higher HA content in the vocal fold tissue plays a vital role in preventing vocal nodules in 
men [3].   Increased capillary proliferation is not observed in vocal nodules [136].  
Increased capillary thickness and disorganized fibronectin deposition is characteristic of 
vocal nodules [135].  No endothelial lining disruptions were observed in vocal nodules 
[136].  It is hypothesized that the perpendicular orientation of the elastic fibers in these 
lesions may be induced by the tearing/Bernoulli‟s forces [137].    
(c) Reinke’s edema - Reinke‟s edema is defined as a unilateral or bilateral swelling of 
the vocal fold, filled with fluid, sessile, and very mobile during phonation [136].  
Reinke‟s edema swellings are reported to be white in color.  During phonation the motion 
of this lesion is far more coordinated than that of a polypoid lesion.  The edematous 
outgrowth is observed to roll over the medial edge of the vocal fold once every phonatory 
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cycle.  Talkative people and heavy smokers are almost exclusively vulnerable to Reinke‟s 
edema though smoking has not been implicated as the leading trauma to this pathology 
[137].  This pathology is not gender specific.  Reinke‟s edema is characterized by an 
increase in the thickness of the vocal mucosa, a decrease in tissue viscosity, an increase 
in fibrin and fibronectin deposition [7, 75, 90, 135-137].  Reinke‟s edema is associated 
with an increased mucosal wave pliability which can be attributed to elevated levels of 
fibronectin.  It may seem counterintuitive that elevated levels of fibronectin in two 
different pathologies are responsible for two contrasting outcomes.  Fibronectin isoforms 
could be a possible explanation for this observation [90].  Increased capillary 
proliferation is not observed in Reinke‟s edema [136].  But the vessel walls show an 
increase in thickness i.e thickness of the vessel wall is greater than the normal capillary 
basement membrane.  Pericyte recruitment is also observed [136] (Pericytes are slender, 
contractile, mesenchymal-like cells found in close association with capillary walls.  They 
are relatively undifferentiated and may differentiate into fibroblasts, macrophages, or 
smooth muscle cells (from Stedman‟s Medical Dictionary, 26th edition)).  Slight 
disruptions of the endothelial cell lining are observed but these disruptions are much 
smaller than the those observed in case of polyps [136].  Smoke induced trauma is not 
severe enough to induce endothelial lining damage.  The combination of submucosal 
BMZ thickening, edematous lakes, erythrocyte extravasation, and increased thickness of 
submucosal vessel walls confirms the clinical diagnosis of Reinke‟s edema.   
Histological evaluations of vocal fold tissues afflicted by polyps, nodules, and 
Reinke‟s edema reveal increased or decreased levels of fibronectin.  Increased fibronectin 
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deposition is a precursor for increased collagen deposition which heralds the onset of scar 
formation [19].  Interestingly, benign vocal lesions like polyps, nodules and Reinke‟s 
edema may or may not exhibit scar formation [19].  Abnormal levels of fibronectin in 
these pathologies indicate that a sufficient extent of matrix disruption had been caused 
and that the cellular response to bring about matrix repair was initiated.  This fibroblastic 
response (increased fibronectin deposition) may be downregulated before scar formation 
sets in.  But it must be noted that these benign neoplastic lesions can co-exist with vocal 
fold tissue scarring. 
(d) Vocal fold cyst - A vocal fold cyst is defined as a unilateral undulation with a smooth 
surface, immobile during phonation, usually on the middle third of the vocal fold [136].  
It is characterized by a normal or slightly thickened submucosal BMZ and a fairly normal 
distribution of fibronectin [135].   
(e) Vocal fold pseudocyst - A vocal fold pseudocyst is defined as a swelling resembling 
a cyst, usually located on the junction of the anterior and the middle third of the vocal 
fold, the macroscopic wall of which is thin and translucent [136]. 
These observations suggest that the initiating trauma for vocal polyps is acute 
phonotrauma, cigarette smoke for Reinke‟s edema and tearing forces (Bernoulli‟s forces) 
for vocal nodules [136].  Vocal polyps are mechanically the most compromised of the 
three common vocal pathologies.  Continual forces maintaining these lesions could cause 
thickening of the capillary basement membrane and persistent endothelial damage may 
lead to platelet adhesion and thrombosis.  In summary, these vocal pathologies are the 
human vocal fold tissue (primarily the lamina propria and BMZ) response to 
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phonotrauma.  Another striking observation is that the degree of BMZ disruptions 
witnessed in vocal pathologies is more severe than that witnessed in pathologies of any 
other organ.  This reveals the extent of the destructive nature of repetitive mechanical 
stresses the vocal fold tissues are subjected to during a lifetime of phonation which 
hampers the wound healing process.    
Finally, phonotrauma to the vocal fold tissues induces BMZ disruption and injury 
to the vocal mucosa.  Vocal pathologies arising out of incomplete wound healing lead to 
dysphonia secondary to altered mucosal wave pliability or decreased vocal fold tissue 
vibration brought about by either scar formation (disorganized collagen deposition) or 
excessive fibronectin deposition (biological characteristics of strength, binding and 
adhesion do not contribute to efficient tissue pliability [19]).  Benign vocal fold lesions 
may or may not co-exist with scarred vocal fold tissue. 
 
Physiological effects of benign vocal fold lesions:- Polyps, nodules, and Reinke‟s edema 
lead to dysphonia secondary to an altered ECM composition of the vocal fold tissue.   
 
2.6.3 Malignant vocal fold lesions and infectious diseases 
Malignant tumors due to neoplastic lesions are detected by biopsy, direct 
laryngoscopy, and physical examinations.  Early and advanced neoplastic lesions may 
partially or completely prevent (metastasis into vocalis muscle) vocal fold motion.  
Treatments include surgical removal of lesions and non surgical options such as radiation 
and chemotherapy.  Surgical removal of malignant lesions may be followed by dysphonia 
 43 
secondary to scar formation.  Radiation therapy induced swelling and dryness results in 
destruction of the mucosal lining thereby exposing the vocal fold tissue to toxic inhalants 
and inflammatory agents which eventually damage the tissue.  Respiratory papillomatosis 
is an infectious disease characterized by wart-like growths (papillomas) on the surface 
lining of the respiratory tract, which includes the throat, larynx, and trachea.  The human 
papilloma viruses also known as genital warts cause respiratory papillomas.  These 
papillomas may be mobile and pedunculated (slim stalk) or sessile (stalkless).  Treatment 
methods include surgical removal of the papillomas and therapies to slow or stop viral 
regrowth.  Till date none of the techniques have been able to prevent recurrence of 
respiratory papillomatosis.  Surgical removal of the papillomas may cause dysphonia 
secondary to scar formation due to lack of regenerative-type wound healing. 
 
2.6.4 Sulcus vocalis 
Sulcus vocalis, a genetic disease/condition reveals bowed vocal folds [140].  This 
pathology presents a total loss of the LPs or a depression or vergeture extending into the 
vocal ligament or sometimes even into the vocalis muscle.  Also in some cases of sulcus 
vocalis, the epithelium is directly attached to the vocal ligament [141].  Sulcus vocalis 
pathology presents increased BMZ thickness and a lack of normal elastic and collagen 
fibers in the lamina propria [140].  Sulcus vocalis is classified into three types of which 
types II and III can be treated clinically and are characterized by replacement of normal 
lamina propria by scar tissue [142].  Clinically, sulcus vocalis presents bowed shaped 
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vocal folds leading to glottic incompetence, breathy voice, decrease in maximum 
phonation time, and vocal fatigue.   
 
2.6.5 Vocal fold paralysis 
Branches of the vagus nerve which innervate the intrinsic laryngeal muscles are 
susceptible to injury due to trauma, surgery, or other causes.  Unilateral vocal fold 
atrophy occurring secondary to recurrent laryngeal nerve paralysis results in highly 
attenuated motion of the mucosal wave.  Partial existence of the mucosal wave could be 
attributed to the cricothyroid muscle which serves to adjust the tension of the vocalis 
muscle (thyroarytenoid muscle) [143].  Vocal fold paralysis also results in bowed vocal 
folds due to symmetric muscular atrophy eventually causing dysphonia (absent mucosal 
wave) and aspiration due to glottic incompetence.  It is thereby evident that vocal 
pathologies arising out of muscular dysfunction/dystrophy mostly have a neuromuscular 
basis.  Such disease conditions are beyond the scope of this review since our research 
objective does not focus on pathologies of neurologic origin.   
 
2.7 Current treatment techniques 
A normal phonatory voice is contingent upon the existence of near perfect 
approximation of the following four vocal fold tissue properties such as:- (i) mass, (ii) 
elasticity (stiffness), (iii) resistance, and (iv) symmetry.  A variety of techniques have 
been developed for restoration, preservation, and improvement of laryngeal and vocal 
fold tissue function.  Currently, voice/speech therapy, laryngeal reinnervation, and vocal 
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fold medialization/augmentation (injections) procedures are used to treat vocal 
pathologies.  The various surgical procedures for voice improvements are collectively 
termed as “phonosurgery”.  Phonosurgial techniques include implantation of prosthetics, 
plastics, and reconstructive laryngoplasty using both synthetic and natural materials.   
 
2.7.1 Voice therapy 
Voice therapy combined with the use of antibiotics and steroids is the initial line 
of treatment for vocal fold scars [13].  Mild scar-related loss of frequency, and voice 
quality can sometimes be ameliorated with voice therapy.  Under conditions of 
significant scarring (scars take approximately six months to mature into a stiff white 
mass) voice therapy may not be very effective.  Voice therapy is effective in treating 
dysphonias secondary to compensatory behavior of the extrinsic laryngeal muscles [18].  
Voice therapy is ineffective when presented with pathologies like vocal nodules, polyps 
and Reinke‟s edema despite rigorous adherence to the prescribed habits [19].  Surgical 
procedures immediately followed by a voice therapy program can effectively help in 
improving and restoring normal vocal behavior [13].  The voice therapy program takes 
into account scar-induced factors like vocal fold incompetence due to increased stiffness 
of vocal mucosa, reduction of mechanical decoupling of the vocal mucosa and vocalis 
muscle, and turbulence in the exhaled air stream.  Singing voice therapy in combination 
with conventional voice therapy is a new method of voice rehabilitation [18].  This 
method involves warm-up exercises traditionally used by vocalists to enhance voice 
efficiency. 
 46 
2.7.2 Laryngeal reinnervation 
Injuries to the superior or the recurrent laryngeal nerves may result in 
compromised glottic function.  The superior and/or recurrent laryngeal nerves can be 
injured during surgical procedures or may be subjected to traumatic crush or stretch 
injuries [144].  This technique involves use of a highly modified diagnostic microscope to 
detect small lesions in the vocal fold tissue [60].  Laryngeal reinnervation involves a 
careful microscope-aided search for the two severed ends of the nerve and precise 
approximation of the freshened nerve endings [60].  Currently, various research groups 
are focused on implantation of nerves into the different muscles and the indentification of 
specific nerve bundles in the vagus nerve for reconstructive surgery.  Reinnervation of 
the paralyzed vocal fold tissue is achieved by anastomosing the recurrent laryngeal nerve 
to the ansa hypoglossi (bunch of nerves which innervate the extrinsic laryngeal muscles) 
[145].  This method is reported to yield good voice quality since it restores tension to the 
vocal ligament and maintains bulk of the vocalis muscle.  This method facilitates 
adduction of the vocal folds by pulling the back ends of the arytenoid cartilages apart.  
Thereby motion of the paralyzed vocal folds may be restored.  One disadvantage 
associated with laryngeal reinnervation is that the ends of the nerves to be anastomosed 
may not be readily available, for example the posterior stump of the recurrent laryngeal 
nerve may be deeply embedded in a scar tissue following tissue response to the inducing 
trauma.  Laryngeal reinnervation procedures do not result in immediate improvement of 
glottic functions [143].  Therefore resorbable gelfoam paste is injected into the paralyzed 
 47 
vocal fold tissue to provide temporary medialization of the vocal fold tissue.  Benefits of 
laryngeal reinnervation procedures usually manifest themselves within 2 to 4 months. 
 
2.7.3 Vocal fold medialization/augmentation procedures 
Vocal fold augmentation procedures involve medialization surgeries and 
augmentation injections.  Payr in 1915, for the first time brought about vocal fold 
medialization by a technique called laryngeal framework surgery using a medially 
depressed pedicled cartilage flap [146].  Thereafter, Isshiki reintroduced, and popularized 
laryngeal framework surgical techniques (Thyroplasty type I ) in 1974 [147], and also 
refined it in 1989 [148].  Koufman refined the technique involved in laryngeal framework 
surgery and popularized it in the USA [149].  Thyroplasty type I necessitates external or 
internal incisions and the procedure is carried out under general anesthesia.  Thyroplasty 
type I involves creation of an incision in the thyroid cartilage which facilitates insertion 
of a space filling material (usually an inert substance) to push the atrophied vocalis 
muscle (thyroarytenoid muscle) thereby medializing the vocal folds.  In other words, this 
technique is used for ameliorating glottic incompetence arising out of pathologies such as 
unilateral paralysis and vocalis muscle dystrophy using silastic and autologous cartilage 
[147].  Thyroplasty type I is effective in realizing vocal fold medialization and thus 
restoring laryngeal function when injection augmentation fails to bring about a reparative 
effect.  The positive effects of this kind of medializaton surgery are limited since the 
normal viscoelastic  properties of the vocal mucosa are not restored [150].  Vocal fold 
medialization surgeries aim to restore original vocal fold tissue geometry in an attempt to 
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cure voice impairment.  Medialization procedures entail the use of a non physiological, 
alloplastic implant which may result in problems like obstruction of airway due to 
migration or extrusion of the implant [151].  Vocal fold medialization procedures are 
recommended for patients presenting glottic incompetence of 1.5mm or more [13].  It 
must be noted that these medialization procedures are aimed at vocal improvement by 
ameliorating glottal incompetence and are not aimed at alleviating pathology [18].  It is 
widely accepted that only post voice therapy must scar tissue be subjected to 
medialization (augmentation) procedures.  Medialization procedures achieve a reduction 
in phonatory effort associated with glottic incompetence but have no improvement in 
voice quality.  For glottal gaps measuring lesser than 1.5mm augmentation injections are 
recommended [13].  Medialization procedures serve to increase the mass of the vocal fold 
tissue.  Medialization procedures must be followed by voice and singing therapy during 
the immediate post-operative period [18].  Medialization surgeries and injection 
augmentation procedures have employed a wide variety of natural and synthetic materials 
to achieve glottic closure and restoration of the mucosal wave.  Vocal fold medialization 
procedures began in 1911 when a German scientist, Bruning, injected paraffin into the 
vocal fold tissue seeking a cure for voice impairment [152].  The medialization materials 
are assessed in terms of Arnold‟s criterion which states that an ideal vocal fold 
augmentation material should be easily injectable, long lasting and well tolerated by the 
host tissues [153].  Material resorption and need for re-injection were the disadvantages 
associated with the use of natural materials like collagen, fat, fascia, and HA [41].  The 
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synthetic and natural materials used for vocal fold medialization will be discussed in the 
following section. 
 
2.7.3.1 Synthetic materials and metals used for vocal fold medialization purposes 
Injection laryngoplasty to correct glottic incompetence began in 1910 – 11 when a 
German otolaryngologist, Wilhelm Brunings injected paraffin into the vocal folds [144].  
Since then paraffin injections have been discarded due to problems associated with 
implant extrusion and paraffinoma formation [154, 155].  The injected paraffin also 
caused problems by migrating to other tissues of the head and neck via the lymph nodes.  
This led to the discontinuation of vocal fold injections.  The criterion for an ideal vocal 
fold implant as described by Godfrey Arnold is that the injected material should be 
injectable, long lasting and well tolerated by the host tissues.  In 1955, Godfrey Arnold 
revived the dormant technique of vocal fold tissue rehabilitation by injecting autologous 
cartilage paste into the vocal fold tissue using the Brunings injector.  However, problems 
like donor site morbidity and tedious purification processes led to the need for synthetic 
materials.  Teflon was the first synthetic material to be injected into the vocal fold tissue.  
Teflon paste injections for vocal fold applications were introduced by Arnold in 1962.  
Teflon did not satisfy the criterion for an ideal vocal fold implant.  Thereafter, collagen, 
fat, fascia, silicone, and HA have been used for vocal fold injection augmentation.  In 
1985, Ward and co-workers [144], developed a new technique for injecting augmentative 
(space fillers) materials into the vocal fold tissue.  This technique which involves 
introduction of the material into the vocal fold tissue via transcutaneous placement of a 
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needle through the cricothyroid membrane allows vocal fold injection in almost any 
patient.  A wide variety of materials like ceramics, hydroxyapatite, Teflon, ePTFE, PET, 
silicon, titanium, and vitalium have been used for vocal fold medialization procedures.   
(a) Teflon (polytetrafluoroethylene - PTFE) - Teflon paste was first injected into the 
vocal folds by Arnold and co-workers., 1962, in an attempt to bring about vocal fold 
medialization [20, 21].  Since then Teflon (Teflon®, Mentor, Santa Barbara, CA) has 
been used to cure glottic incompetence and restore mucosal wave motion in paralyzed 
vocal fold tissues [41].  If the amount and technique of Teflon injected are perfect then 
excellent phonatory results follow [143].  Under-injection results in a hoarse breathy 
voice while over-injection may cause breathlessness and problems associated with 
reduction in glottic aperture.  Excessively injected Teflon may be removed by a spot 
curing CO2 laser or tracheotomy which may eventually lead to dysphonia secondary to 
scar formation.  Extrusion from the implant site can cause obstruction of the airway [22, 
156-159].  Migration from the implant site into regional lymph nodes resulted in 
granuloma formations.  Teflon injections result in foreign body reactions (due to 
phagocytosis of Teflon particles by macrophages) and tissue fibrosis [160, 161].  Once 
injected, removal from the injected site is very difficult due to significant soft tissue 
reaction.  Teflon injections were dispensed by a Bruning‟s injector and were targeted at 
the vocalis muscle (thyroarytenoid muscle) [162].  The main disadvantage of Teflon and 
most other non physiological materials is that they can never restore the normal mass and 
tension (mechanical properties) of the native vocal fold. 
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(b) ePTFE (expanded PTFE) - ePTFE (Gore-Tex®, WL Gore, Flagstaff, Az) is 
implanted into the vocalis muscle (thyroarytenoid muscle) and not injected like Teflon.  
Thus ePTFE implantation is classified as a laryngeal framework surgery or more 
popularly thyroplasty type I.  ePTFE was widely used for cosmetic purposes but in 1997-
98 its application was extended to curing vocal fold insufficiencies by McCulloch and co-
workers [25].  This group implanted a 25mm long, 2mm wide, and 0.6mm thick strip of 
ePTFE, folded over 5 times into the vocalis muscle (thyroarytenoid muscle).  Histological 
analysis of the explanted graft revealed the presence of isolated foreign body giant cells 
and a thin fibrous capsule around the ePTFE implant.  It was reported that after 6 months 
when the rabbits were sacrificed, the implants were removed fairly easily but with 
application of slight traction.  From these observations one may infer that the slight 
amount of tissue ingrowth (due to the porous nature of ePTFE) prevents implant 
extrusion.  It was observed that unlike Teflon, ePTFE is less susceptible to granuloma 
formation.  In 2000, Tamplenizza and co-workers [163], injected rolled ePTFE tubes 
(2.5mm average diameter) through a 4mm fenestration in the thyroid cartilage into the 
vocalis muscle (thyroarytenoid muscle).  The tubular shape combined with the porous 
nature of the implant facilitated extensive tissue ingrowth which in turn anchored the it to 
the implantation site and prevented problems like airway obstruction associated with 
migration and extrusion [164].  Thus implanted ePTFE was reported to provide 
appreciable phonatory improvement over traditional thyroplasty (using Teflon) [165].  
The ePTFE implant is easy to handle, and unlike other materials its shape can be altered 
even after placement in the implant site [24].  Implantation of ePTFE can be easily 
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combined with another procedure like arytenoid adduction to restore glottic closure and 
its easy removal from the site of implantation is a real advantage.  Zeitels and co-workers 
[166], and Giovanni and co-workers [124], have reported vocal fold medialization 
procedures with minimal complications [24].  None of the above studies have reported 
problems associated with implant extrusion and migration. 
(c) Calcium hydroxyapatite - Calcium hydroxyapatite is a biologically inert ceramic 
composed of phosphorous and calcium [167].  Calcium hydroxyapatite gel (Radiance®, 
BioForm, Frankesville, WI) is FDA approved for vocal fold augmentation applications 
[168].  This preparation comprises calcium hydroxyapatite spherules dispersed in a 
mixture of water and glycerin and is easily injectable and non resorbable [41].  Calcium 
hydroxyapatite spherules of varying sizes are available :- (a) Standard radiance spherules 
measure between 75 and 125µm and can be injected through a 21 gauge needle, (b) 
Radiance FN measures between 25 and 45µm and can be injected through a 27 gauge 
needle.  These particle sizes prevent phagocytosis of the implant material.  One of the 
main indications for calcium hydroxyapatite based injections is unilateral paralysis and 
presbyphonia due to bowed vocal folds [168].  Calcium hydroxyapatite gel is injected 
deep into the lateral portion of the vocalis muscle (thyroarytenoid muscle).  Calcium 
hydroxyapatite is reported to be non inflammatory and non antigenic since it is formed 
from calcium and phosphate ions which exist normally in our body [167].  Chhetri and 
co-workers, performed a time course study evaluating the calcium hydroxyapatite gel 
(Coaptite®, BioForm, Frankesville, WI) implant performance in canine vocal folds upto 
a period of 12 months [26].  The spherules were 38 to 63µm in size dispersed in a 
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hydrogel (70% volume) comprising water, glycerin, and 3% carboxymethylcellulose 
which could be injected with a 23 gauge needle.  Histological evaluation revealed some 
foreign body giant cells but no other signs of chronic inflammation.  Post implantation, a 
decrease in the degree of medialization/increase in glottic incompetence was observed 
progressively over the various time points (1, 2, 3, 6, 9, and 12 months).  This is due to 
resorption of the aqueous based carrier vehicle leading to increasing compactness of the 
implant material.   
Thereby, one may infer that since over-injection may cause airway obstruction 
and associated problems, re-injection may be the only way to circumvent increasing 
glottic incompetence.  But unlike injecting natural materials which are resorbed by the 
body calcium hydroxyapatite can be injected a certain limited number of times since it is 
not resorbed by the body.  Contrasting opinions exist about the need for over-injection of 
calcium hydroxyapatite into the lateral aspect of the vocalis muscle (thyroarytenoid 
muscle).  One might infer that experience is the best teacher with calcium hydroxyapatite 
injections for vocal fold medialization procedures.   
Rosen and Thekdi, used both the endoscopic vocal fold injection (EVFI) and 
percutaneous vocal fold injection technique (PVFI) in an attempt to compare the efficacy 
of both the techniques for calcium hydroxyapatite injections into the vocalis muscle 
(thyroarytenoid muscle) or the thyroid cartilage [167].  They reported that the EVFI 
provided more precise placement of the implant material. 
(d) Polydimethylsiloxane (PDMS) – PDMS was first used for vocal fold augmentation 
laryngoplasty in 1983 [169].  PDMS gel (Bioplastique ®, Bioplasty, Geleen , 
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Netherlands) is both readily injectable and non resorbable.  Unlike Teflon, the PDMS 
particles do not cause granuloma formation since they are too large to be taken up by 
macrophages [41].  PDMS gels alleviate glottic incompetence but the improvement in 
physical aspects of voice is not significant due to reduced mucosal wave pliability.  This 
occurs due to the lack of approximation of the implant viscoelastic properties to that of 
the human vocal mucosa.  Therefore, PDMS injections were limited to the LPd.  PDMS 
based implants elicit minimal to no soft/host tissue response and can be removed fairly 
easily from the implant site.  PDMS based materials are widely used in Europe but do not 
have FDA approval for use in the USA [41].   
(e) Silicon - Silicon is one of the most frequently employed materials for vocal fold 
medialization [149].  Silicon poses problems with positioning and placing the implant in 
the site of interest [27].  If the implant dimensions do not match those of the implantation 
site then a new implant has to be prepared.  Problems associated with migration of silicon 
from the implant site have also been reported [13].  Carcinogenic properties lend yet 
another disadvantage to silicon based vocal fold medialization.   
(f) Titanium - In 1999, for the first time titanium was implanted into the vocalis muscle 
(thyroarytenoid muscle) and anchored to the thyroid cartilage (to prevent implant 
migration) by Friedrich and co-workers [170].  The rationale behind using titamium for 
medialization of the vocal fold tissue was retention of the lamina propria tissue 
architecture.  Unilateral vocal fold paralysis and bowed vocal folds were indications for 
titanium based medialization of vocal folds.  Titanium implants may be used in 
combination with another technique like arytenoid adduction to bring about glottic 
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closure and thereby improvements in voice.  Schneider and co-worers, reported 
observations from a study involving titanium implants in human subjects suffering from 
incomplete glottic closure secondary to unilateral vocal fold paralysis [171].  The length 
of the implant was 15mm for men and 13mm for women.  They observed an 
improvement in the motion of the mucosal wave of all patients 1 week after the 
procedure.  The fundamental frequency of normal phonation and the voice intensity were 
unaffected by the medialization procedure. 
 (g) Dacron (polyethylene terephthalate - PET) – Keskin and co-workers reported 
observations from a study involving injection of PET into the vocal fold tissue of a rabbit 
model [27].  Histological evaluation on excised tissue 6 months after implantation 
revealed a discontinuous fibrous capsule surrounding the implant.  Macrophages invaded 
the network structure of PET through the areas where capsule continuity was 
compromised which eventually resulted in foreign body giant cells surrounding PET 
fibrils.  This study concluded that PET is inferior to titanium in terms of vocal fold tissue 
implant applications. 
(h) Gelfoam - Gelfoam powder (prepared from gelatin) is mixed with saline and injected 
into the vocal fold tissue for temporary medialization [172].  Gelfoam (UpJohn, 
Kalamazoo, MI) has been used to cure glottic incompetence in vocal fold tissues afflicted 
by paralysis.  However, it is reported to last only for approximately 2 months before it is 
resorbed (6 to 8 weeks).  This entails over-correction or even multiple re-injections. 
(i) Lactosorb (Polylactic acid (PLA)/Polyglycolic acid (PGA) copolymer) - Lactosorb 
is a PLA/PGA copolymer [173].  PLA (MW 180 – 530kDa) is a pale, semicrystalline 
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material whereas PGA (MW 20 – 145kDa) is a hard, crystalline polymer which is 
insoluble in most solvents.  A PLA/PGA copolymer has variable degradation rates 
depending upon the ratio of PLA to PGA.  Copolymer degradation occurs via cleavage 
(hydrolysis) of the ester bonds.  Additionally, molecular weights of the participating 
polymers, crystallinity, and degree of purity of the material contribute to the degradation 
rates.  PLA has a longer half-life and lesser strength in comparison to PGA which has 
shorter half-life and more strength.  Lactosorb comprises 20% PGA and the remaining 
80% is PLA, thereby it retains 80% of its strength after 6 weeks.  Dufresne and 
Lafreniere, implanted Lactosorb into the vocalis muscle of rabbits and evaluated the 
implant morphology (implant resorption), host tissue response, maintenance of vocal fold 
medialization, and airway patency after 1, 3, 6 and 9 months [173].  Briefly, the recurrent 
laryngeal nerve was transected, a Lactosorb implant of dimensions 5mm x 4 mm x 3mm 
was introduced into the vocalis muscle (thyroarytenoid muscle) and secured to the 
thyroid cartilage using nylon sutures.  Gross examination revealed a thick fibrous capsule 
surrounding the implant post 1 and 3 months.  A foreign body response characterized by 
the presence of small number of macrophages and multinucleated giant cells was 
observed in addition to cells like lymphocytes, and fibroblasts.  One might infer that these 
macrophages and giant cells were functioning to resorb the implant.  Yet there was no 
significant change in the implant bulk volume and vocal fold medialization was 
maintained.  Replacement of muscle tissue by adipose tissue, and a decrease in muscle 
fiber size suggested vocalis muscle atrophy.  Post 6 months of implantation, a thin fibrous 
capsule surrounded the barely visible implant.  A large number of macrophages and 
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foreign body giant cells were once again identified at the host-implant interface 
suggesting further implant degradation was in progress.  Post 9 months of implantation 
the implant was completely resorbed (macroscopically and histoligically invisible) yet the 
augmented vocal fold maintained both its bulk volume and airway patency.  The authors 
hypothesized that the observed adipose cell invasion, muscle cell swelling, and 
thyroarytenoid hypertrophy may have contributed to sustained vocal fold medialization 
despite complete resorption of the implant.   
This material does possess some disadvantages in terms of processability.  
Lactoborb is very hard and brittle which makes shaping at the time of implantation 
impossible, for example heating may cause the material to melt away.  Lactosorb will 
need to be manufactured according to specific dimensions dictated by patient needs and 
the slightest need for alteration entails preparation of a new implant.   
The above study reports the presence of huge amounts of uncharacterized 
intercellular material within the implanted muscle tissue.  One might hypothesize that this 
is an inflammatory response to the acidic degradation products produced by the 
copolymer degradation.  Since the study spanned nine months it is not possible to 
comment on the long-term fate and efficiency of vocal fold tissue medialization.  Also, 
implantation in a canine model will throw some light on the effect of Lactosorb 
implantation on the physical aspects of voice.  Considering a hypothetical situation 
wherein Lactosorb is implanted into the vocalis muscle of a patient with severe 
gastroesophagal reflux.  Acidic conditions (pH of gastroesophagal reflux is between 3 
and 6) could bring about an autocatalytic effect i.e. degrade the implant faster than 
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normal.  Degradation of the implant material could result in a heightened local 
inflammatory response which may eventually lead to scar formation.  This may cause 
dysphonia secondary to scar and glottic incompetence. 
(j) Botulinum toxin - Benign lesions like polyps, nodules, and Reinke‟s edema as 
mentioned earlier are the result of increased mechanical stress due to the „hammer-on-
anvil‟ pounding effect on the vocal fold tissue during phonation.  Otolaryngologists seek 
to alleviate vocal impairments arising from these lesions through surgical or CO2 laser -
based excision of these convex lesions.  But it must be stated that surgical or cold 
excisions of these lesions aim to cure the symptom and not the cause.  In other words, 
excision based methods eliminate the lesion but leave the cause unaltered.  In the case of 
these vocal fold granulomas the main cause is chronic vocal abuse.  Even complete vocal 
rest does not prevent vocal fold adduction and arytenoid contact which occurs during 
coughing and swallowing.  In an attempt to completely avoid contact between the two 
vocal folds Orloff and Goldman [174], injected botulinum toxin into the vocalis muscle 
(thyroarytenoid muscle) aiming to provide much needed rest and recovery time to the 
abused vocal fold tissue.   
Briefly, botulinum toxin is a very toxic peptide protease that binds to nerve 
endings at the point where the nerves join muscles [174].  This blocks the release of 
acetylcholine and thereby prevents the nerves from signaling the muscles to contract.  
The result is weakness and paralysis in the injected muscle.  They also reported that the 
inhibitory effects of botulinum toxin are gradually overcome as axonal outgrowth, which 
occurs by collateral and non collateral sprouting, leads to reinnervation.  It was observed 
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that botulinum toxin injection induced rest period helped cure vocal granulomas and 
prevented recurrence in patients who had previously reported instances of lesion 
recurrence post surgical excision.  Orloff and Goldman recommend the use of botulinum 
toxin (Botox A; Allergan Inc, Irvine, CA) in combination with excisional surgery and 
voice therapy to yield optimum results.  One of the proven disadvantages of botulinum 
toxin injections into the vocal fold tissue is the potential to permanently alter a patient‟s 
voice [174].  Evaluation of observations mentioned above must be carried out bearing in 
mind that botulinum toxin is one of the most poisonous substances known to mankind.  
The above study suggests no dosage limits and advocates multiple injections to achieve 
complete muscular relaxation in an attempt to prevent vocal fold apposition.  Excessive 
levels of the toxin may have deleterious effects on other muscles of the body especially 
the respiratory muscles which could be fatal.   
(k) Mitomycin-C - Garrett and co-workers, injected an antibiotic mitomyocin-C into 
injured vocal folds in an attempt to cure scarring [175].  The results were not encouraging 
since the site of injury demonstrated poor healing, reduced number of fibroblasts 
subsequently leading to a decrease in the collagen concentration.  It is hypothesized that 
mitomycin-C causes a reduction in the number of fibroblasts which leads to reduction in 
the amounts of protein synthesized [150].  Thereby wound healing was compromised for 
want of adequate proteins that bring about resolution of wounds.   
The above study promotes the understanding that alleviation of scarring 
associated pathologies can be achieved by stimulating fibroblasts to synthesize the 
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appropriate amounts of proteins in the appropriate locations and not by reducing 
the fibroblast cell number.   
 
2.7.3.2 Natural and synthetic biomaterials used for  
vocal fold augmentation purposes 
Physiological limitations of non degradable synthetic materials and theoretical 
advantages of natural degradable biomaterials have led to the use of materials like 
collagen, fat, fascia and HA for vocal fold augmentation purposes.   
(a) Collagen - Collagen is useful in treating atrophied vocal fold tissue, scarred vocal 
fold tissue, minimal glottic incompetence, and focal fibrosis [162].  Collagen injections 
can be placed anywhere in the lamina propria or the vocalis muscle  (thyroarytenoid 
muscle) [153, 176].  These collagen injections (approximately 0.75ml) can be 
administered with a 26 or 27 gauge needle which allows precise placement in the plane of 
interest [153, 162].  Ford and co-workers, administered collagen injections by indirect 
laryngoscopy or direct microlaryngoscopy with topical anesthesia [162].   
 Bovine collagen preparations - The various forms of available bovine collagen 
preparations are Zyderm, Zyplast, Phonagel, Koken Atelocollagen, Gelfoam, Collastat, 
and Avitene [177].  Of these the biological properties of Zyderm, Zyplast, and Phonagel 
are the most suitable for vocal fold applications.  ZCI-collagen (Zyderm collagen 
implant) :- ZCI-I and ZCI-II (Zyderm, Collagen Corp, Palo Alto, CA) are composed of 
35mg/ml and 65mg/ml of highly purified bovine dermal collagen in PBS with 0.3% 
lidocaine [153].  Zyderm collagen was first used in 1985 [178].  GAX-collagen 
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(Gluteraldehyde crosslinked collagen) is 35mg/ml bovine dermal collagen crosslinked by 
0.0075% glutaraldehyde [179].  GAX-collagen is marketed as Phonagel® (Palo Alto, 
CA).  These collagen preparations contain approximately 95% collagen type I and 5% 
collagen type II [153].  Zyplast-collagen (Collagen Corp, Palo Alto, CA) is the same as 
Phonagel but for the lidocaine concentrations [180].  Indication for use was glottic 
incompetence due to vocal fold paralysis.  It was reported that GAX-collagen injections 
into the vocal ligament [153] as well as the LPd alone [181]  were well tolerated.  Also, 
these collagen injections into the LPs do not have any negative effect on mucosal wave 
pliability [182, 183].  Since 1986, ZCI-collagen has been replaced by GAX-collagen 
which is advantageous due to crosslinking [181].  Crosslinking provides the following 
advantages :- (a) heightened insensitivity against collagenase thereby minimizing risk of 
resorption (b) no loss of injected volume due to in situ consolidation and (c) less 
antigenicity.  Thereby, there is no need for over correction or re-injection.  GAX-collagen 
induces minimal necrosis and inflammation in the surrounding tissues [179].  Both 
collagen injections into the vocal ligament showed varying degrees of cellular infiltration 
and minimal inflammatory response [153].  Histological examination after two months of 
injection reveals a higher degree of both structural homogeneity and cellular infiltration 
in ZCI collagen than GAX collagen.  The reason behind increased structural homogeneity 
of ZCI collagen is that once injected the saline solution is resorbed and the collagen 
fibers are arranged into a homogenous mass.  Crosslinking in GAX collagen prevents any 
such volume reduction.  Increased resistance to collagenase activity and crosslinking is 
the reason behind the relatively acellular appearance of the GAX collagen.  But Ford and 
 62 
co-workers, reported a significantly higher degree of cellular colonization of GAX 
collagen after two months of injection [179].  This discrepancy may be explained in 
terms of reliance of homogeneity, function, fate, and future of collagen implants upon the 
location of injection [179].  It must be noted that Remacle and co-workers, injected GAX 
collagen into the vocal ligament [153], where muscular activity is more in comparison 
with the LPs which was the location for injection by Ford and co-workers [179].  
Increased muscular activity caused the collagen fibers to break resulting in faster 
resorption.  Also, it is thought that when injected into the vocal ligament the collagen 
fibers may get dispersed due to muscular activity and may migrate into less compact 
tissue [176].  On the contrary, collagen injection into the LPs minimizes breakdown of 
collagen fibers and facilitates cellular colonization of the implant.  Most investigators 
have injected collagen into the LPs due to problems of rapid resorption associated with 
injection in the deeper layers of the vocal mucosa [162].  Also, since the superficial 
layers of the vocal fold tissue are devoid of lymphatic drainage it contributes to the 
longevity of the injected collagen [180].  Inherently, GAX-collagen may also impair 
cellular function to a certain degree due to the presence of small amounts of the 
glutaraldehyde crosslinker.  At time periods of over one year, GAX collagen showed an 
appreciable increase in cellular infiltration and neovascularization.  3 to 4% of the 
patients treated with ZCI-collagen showed hypersensitivity reaction whereas only 1% of 
the patients treated with GAX-collagen showed a similar reaction [184].  Collagen 
injections have been used to correct irregular free edges of the scarred vocal fold tissues 
post Teflon granuloma removal [162].  Failure to gain FDA approval due to concerns 
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regarding immune reactions has limited the number of clinical trials in USA but this 
technique has been used successfully elsewhere in the world [162].   
GAX-collagen yielded good results even after 4.5 years of initial injection [180].  
It was widely accepted that GAX-collagen (and later Zyplast) is a better vocal fold tissue 
bioimplant than ZCI-collagen because of properties like reduced antigenicity, no need for 
over correction (no loss of volume in situ), increased resistance to collagenase and 
subsequent long-term stability [153].  These collagen implants come close to fulfilling 
Arnold‟s criterion of being easily injectable, long lasting and well tolerated by the host 
tissue.  Collagen is the first material that was aimed at softening the vocal fold scar tissue 
[162] since it has been shown to reduce dermal scarring [185]. 
 Allogeneic collagen preparations - Alloderm and Dermalogen are cadaveric 
acellular human dermal (collagen + elastin) preparations which provide advantages of 
autologous grafts and nullify problems associated with donor site morbidity.  The 
Alloderm and Dermalogen injections vary in terms of modes of preparation and 
concentrations of collagen and elastin particles [176].  A micronized version of Alloderm 
called Cymetra (Lifecell ©, Branchburg, NJ) is used for vocal fold tissue augmentation 
[186].  It is an acellular dermal allograft that can be injected into the vocal fold tissue 
whose collagen and elastin framework facilitates cellular colonization and 
neovascularization.  Unlike bovine collagen preparations, a test injection is not necessary 
for delayed allergic reaction assessment.  Though long-term data is unavailable, Cymetra 
is believed to provide better long-term biointegration than bovine collagen preparations 
[41].  Alloderm based augmentation of the vocal fold tissue shows peak cellular 
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(fibroblast) infiltration at day 4 which declines at day 7 and levels off by day 30 [176].  
Contrastingly, Dermalogen (Collagenesis, Beverly, MA) [18] based injectables showed 
peak cellular infiltration at day 30 which eventually leveled off by day 60 [176].  The 
Dermalogen graft remained stable until day 180 when fat cells were observed peripheral 
to the graft and neovascularization was detected within the graft.  The Alloderm and the 
Dermalogen grafts became progressively more compact by day 7 due to resorption of 
water.  Unlike what was mentioned earlier, Alloderm and Dermalogen based collagen 
injections into the vocalis muscle (thyroarytenoid muscle) caused a change in the normal 
vibratory patterns of the vocal folds.  Allogeneic cadaveric collagen preparations last 
twice as long as bovine collagen injectables.  The intact telopeptides in allogeneic 
collagen preparations increase resistance to proteolytic degradation. 
(b) Autologous fat - Autologous fat implantation for vocal fold tissue augmentation is a 
safe technique since neither short term nor long-term complications have been reported 
till date [187].  Autologous fat injections are directed into the vocalis muscle 
(thyroarytenoid muscle), with overinjection to correct for loss of bulk due to resorption.  
One must be careful to avoid injection into the subglottic space.  Indication for fat 
injection is unilateral paralysis.  The first reported autologous fat injection (1991) was 
performed in the vocalis muscle  (thyroarytenoid muscle) of 3 patients, the location being 
similar to that of Teflon injection [188].  Sataloff and co-workers, performed autologous 
fat implantation in a pocket created above the scarred tissue along the vibratory margin 
and co-workers [36].  Both these techniques yielded improved voice intensity, lower 
phonation threshold pressures and better stability in terms of acoustic output.  It is 
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observed that 40% of the fat cells survive for approximately a year [13].  The 
unpredictable nature of fat resorption entails overinjection/overcorrection and also re-
injections.  Long-term studies have been unable to ascertain whether the fat cells in the 
graft were from the host or surviving cells from the initial injection.  Studies by Shindo 
and co-workers, suggest that injected autologous fat does survive for 6 months but the 
intensity of voice is lowered after the first 3 months which is indicative of loss in tissue 
bulk due to resorption [187].  Autologous fat graft survival depends upon the survival of 
fat cells which in turn is contingent upon the harvesting process, microinjection technique 
(18 gauge needle) and mechanical stress [187, 189].  Purification process results in 
reduced fat graft survival.  During purification, the fat cells are subjected to 
homogenization which destroys the fibrovascular scaffolding of the fat cells thus making 
neovascularization of the graft more difficult [189].  The two fat cell processing 
techniques are :- (a) morselization, centrifugation and aspiration of resulting pure fat cells 
and (b) liposuction.  It is observed that the liposuction derived fat cells had better survival 
rates [190].  Since there are no adverse side effects, fat injections may be performed as a 
temporary procedure to improve vocal performance until a permanent procedure like 
thyroplasty or arytenoid adduction is performed [187].  The size of the autologous fat 
cells depends upon the body mass index (BMI) [189].  Smaller fat cells maintain graft 
volume better than large spaced out fat cells i.e. large fat cells are resorbed faster.  The 
rate of fat resorption and decrease in graft bulk volume depends upon the size and density 
of fat cells and matrix around it.  Fat injections satisfy Arnold‟s criterion only partly since 
they are resorbed fairly quickly. 
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(c) Autologous fascia - Injection augmentation with collagen and fat posed problems 
associated with reduction of bulk volume due to resorption.  Since the early 20
th
 century 
fascia had been used for facial surgery but only in 1998 was its application extended to 
vocal fold tissue augmentation [191].  Fascia implantation was first introduced in 1998 
for curing glottic incompetence [191].  Indications for fascia injection augmentation are 
glottic incompetence due to recurrent laryngeal nerve paralysis.  Fascia can be easily 
harvested and is very stable.  Fascia comprises mainly fibroblasts interspersed in a 
collagen matrix.  Similar to autologous fat, fascia injections were placed in the vocalis 
muscle (thyroarytenoid muscle).  Insufficiencies arising out of unilateral vocal fold 
paralysis require only very small amounts of space filling materials.  Thereby, chopped 
autologous fascia injections which do not enhance tissue 3D bulk significantly can be 
used to ameliorate minimal glottic incompetence.  Unlike autologous fat injections, fascia 
injections are not over corrected.  Care is taken to prevent fascia extrusion into the vocal 
mucosa.  Since the metabolic requirements of the fibroblasts in fascia tissue are low the 
free fascia graft can survive as a living tissue.  Fascia processing techniques can affect the 
physiological viability of the fascia to be implanted [141].  The procedure for fascia 
injection is short and is done as an outpatient procedure.  It is assumed that autologous 
fascia is free of infection and immunologically safe [141].  Long-term (3 years) results 
suggest that fascia injections are infection free, immunologically safe, bring about an 
increase in maximum phonation time.  Temporal fascia is highly suitable for 
transplantation into the Reinke‟s space (LPs).  Even though fascia is not considered to 
add to 3D bulk as mentioned earlier, long-term results showed a restoration of the vocal 
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fold tissue bulk.  Based on the above observations it has been hypothesized by Tsunoda 
and co-workers [141] that fascia implantation facilitates regenerative-type repair of the 
vocal mucosa by a mechanism similar to stem cell transplantation in other organs. 
(d) Autologous cartilage - Caballero and co-workers, conducted studies on rabbit 
models and suggested that implantation of autologous auricular cartilage by thyroplasty 
type I is desirable for correction of vocal impairments arising out of incorrect tissue 
geometry [192].  Lee and co-workers, extended the use of auricular cartilage for vocal 
fold augmentation injections [193, 194].  They reported that a mixture of minced 
auricular cartilage and autologous fat injected 3 to 5mm deep into the vocalis muscle  
(thyroarytenoid muscle) had a very high survival rate and allowed correction of glottic 
incompetence even after 3 years.  No foreign body reaction (granuloma formation) was 
reported.  Also, histological evaluation revealed no significant differences in implant 
morphology, and host tissue reaction between 1 and 3 years.  There was no evidence of 
implant resorption since the implant volume remained the same even though the 
chondrocytes seemed to have lost viability and there was some evidence of fibrosis 
around the implant.   
It seems counterintuitive that the presence of equal amounts of fat and auricular 
cartilage (elastic cartilage) resulted in the implant maintaining its 3D bulk for 3 years 
since it has been widely reported that resorption is the single largest reason for 
autologous fat injections failing in the context of vocal fold tissue augmentation.   
 
 
 68 
2.7.4 Tissue engineering approach for regeneration of the vocal fold tissue 
Extensive literature review suggests that voice therapy and surgical augmentation 
are the primary methods for treating vocal fold scarring and subsequent dysphonias.  
Although effective in improving vocal quality, neither technique achieves regeneration of 
native tissue ultrastructure and composition or complete restoration of normal phonation.  
The techniques discussed earlier were mainly aimed at curing glottic insufficiency 
secondary to vocalis muscle atrophy due to unilateral vocal fold paralysis, and bowed 
vocal folds.  However, the materials based approach of these techniques encouraged 
detailed discussion.  Ensuing discussion focuses mainly on the materials used or 
proposed to be used to bring about regenerative-type repair of the human vocal folds.  
Some of these materials are injected/proposed for injection into the vocal mucosa (LPs) 
in an attempt to soften scar/prevent scarring, and thereby realize regenerative-type wound 
healing in the vocal folds.  Restoration of the native tissue matrix composition through 
these methods may facilitate restoration of the normal phonatory voice.   
(a) Hyaluronic Acid (HA) - HA is widely accepted to be the key molecule that regulates 
vocal fold tissue viscoelasticity [7].  It has been demonstrated by Chan and co-workers, 
that particular concentrations of HA have viscoelastic properties similar to that of the 
human vocal mucosa and that removal of HA from the vocal fold tissue matrix 
compostion by way of injury leads to alteration in tissue viscoelastic properties secondary 
to scarring  [195].  Dahlqvist and co-workers, reported results from a comparative study 
which involved injecting rabbit vocal folds with HA and collagen separately [38].  It was 
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observed that the viscoelastic properties of HA injected rabbit vocal folds very closely 
approximated those of the normal tissue.   
Hallen and co-workers, injected a mixture of dextranomere microspheres in a 
sodium hyaluronan solution (carrier) (DiHA) into the vocalis muscle  of rabbit vocal 
folds  [196].  Both dextran based microspheres and HA are non immunogenic.  
Indications for DiHA injections include unilateral vocal fold paralysis and bowed vocal 
folds.  It was observed that the carrier was resorbed within the first week whereas the 
dextran microspheres persisted within the tissue 6 months after implantation.  
Histological evaluation of excised tissue 6 months after implantation revealed that the 
dextran microspheres were embedded in endogenous connective tissue comprising 
mainly collagen.  These microspheres acted as an attractant for fibroblasts which 
subsequently produced collagen thereby resulting in soft tissue augmentation.  In 2001, 
Hallen and co-workers, injected DiHA into the vocalis muscle  of human subjects who 
presented insufficient glottic closure arising from unilateral vocal fold paralysis and 
bowed vocal folds [197].  In some patients, multiple injections were necessary due to 
resorption of the carrier.  It was reported in this study that over a period of 12 months the 
physical aspects of voice as well as perceptual voice assessment showed considerable 
signs of improvement.   
In 2002 Hertegard and co-workers, used Hylan B gel (Hylaform®, Genzyme, 
Biosurgery Inc.) to improve the laryngeal function of patients presenting laryngeal 
dysfunction arising out of unilateral vocal fold paralysis [40].  Hylan B gel is a pure HA 
gel crosslinked using Michael type addition reaction with divinyl sulfone.  Hylan B gels 
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retain the non allergic, non antigenic and non inflammatory properties of native HA.  
This study involved comparison of results obtained by Hylan B gel injections to those 
from bovine collagen injections.  Both these materials were injected into the vocalis 
muscle (thyroarytenoid muscle).  A 20% correction was made for collagen injections 
[180] as compared to a very small overinjection performed for the Hylan B gels (since 
the resorption characteristics were unknown) [40].  Previously, the same group had 
shown that the viscoelastic properties of augmented rabbit vocal folds tissue closely 
approximated those of the normal rabbit vocal fold tissue [198].  Periodic patient 
assessment (1, 6, and 12 months after injections) revealed improvements in phonation 
time parameters, glottic closure, and patient‟s perceptual assessments of voice.  
Resorption of the injected Hylan B gel was minimal in the first 6 months with no further 
resorption between months 6 and 12.  The regeneration of collagen fibers based 
connective tissue seemed to be similar to those observed by Hallen and co-workers [39].  
This group proposes a 2 year study in the future to assess the long-term resorption 
characteristics of Hylan B gel.   
Finck and co-workers, injected esterified HA (Merogel) into the vocal mucosa 
(LPs) after  surgical removal of benign lesions caused by Reinkes‟s edema [199].  Post 
removal of the edematic lesion a flap was created in the LPs by microdissection within 
which esterified HA fibers were placed and then fibrin glue was used to seal the opening.  
The main reason behind using esterified HA was to ensure that the material degrades with 
time.  The injection was made in the LPs of human patients to allow a physical barrier 
between the submucosal BMZ and the vocal ligament which would thereby provide 
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optimal healing conditions for the LPs.  Briefly, the pliability of the mucosal shear wave 
which underlies the quality of voice depends upon the matrix composition of the vocal 
fold tissue.  The purpose behind using esterified HA and not any other material is that 
HA plays a vital role in eliminating scar formation and its elevated levels during the acute 
stage of injury (immediately post surgery) would facilitate regenerative-type repair.  This 
material is resorbed within 3 to 4 weeks.  The patients reported improved perceptual 
voice assessments and better phonation times.  Laryngoscopic examinations revealed 
improvements in vibrational amplitudes, glottic closure, motion of the mucosal wave, and 
no inflammation.  The study did not report any histological analysis since implantation 
procedures were performed in human subjects, each one of which reported alleviated 
vocal pathology and perceptual voice improvements.  A major shortcoming of the above 
study was the lack of a control group in the absence of which obtained results cannot be 
interpreted correctly.  Evaluation of matrix composition of the endogenously formed 
tissue could be of value.  Assessment of the host/soft tissue response to the implanted 
esterified HA fibers and their in vivo degradation products may provide valuable insight 
about the efficacy of this material in vocal fold wound healing.  It is widely accepted that 
polymeric HA is non inflammatory.  But one may tend to infer that degradation of high 
molecular weight HA to lower molecular weights may lead to an inflammatory response.  
An inflammatory response may ultimately lead to increased collagen deposition 
following fibroblast recruitment.  Restoration of normal voice secondary to regeneration 
of the LPs using exogenous HA suggests mimicking conditions of fetal wound healing to 
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achieve regenerative-like repair which is the “holy grail” for tissue engineering 
researchers.   
The HA injections and implants were found to be non toxic and free of foreign 
body reactions.  Minimal inflammation was observed in some patients after the 
administration of Hylan B gels.  The main difference between Hylan B gels (Hylaform) 
and esterified HA (Merogel) is that the Hylan gels are crosslinked, injectable liquids 
whereas the Merogel is in the form of solid fibers.  Also, Hylan B gels are injected into 
the vocalis muscle (thyroarytenoid muscle) while the esterified HA is implanted into the 
LPs.   
Hansen and co-workers, have manipulated HA into injectable forms in an attempt 
to aid vocal fold wound healing and to prolong residence in the tissues to help maintain 
optimal viscoelasticity of the matrix [43].  The two injectable forms of HA used by this 
group as proposed materials for alleviation of vocal fold tissue scar are:- (i) HA-DTPH-
PEGDA (thiol derivatized HA such that the free thiol groups can react and crosslink with 
polyethylene glycol diacrylate (PEGDA)), (ii) Carbylan-SX (carboxylic acid groups on 
HA are modified using carbodiimide chemistry to yield free thiol groups which facilitate 
crosslinking).  These crosslinked materials (crosslinking increases the tissue residence 
time to approximately 2 weeks as opposed to 3 to 5 days with native HA) were aimed for 
injection into the vocal mucosa [43].  Klemuk and Titze, compared the rheological 
properties of ZCI-collagen, Cymetra, and HA-DTPH-PEGDA  [200].  It was reported 
that the viscoelastic properties of HA-DTPH-PEGDA very closely approximate those of 
the human vocal mucosa.  Prior to implantation, rheology revealed that Carbylan-SX had 
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higher levels of elasticity and viscosity than HA-DTPH-PEGDA [43].  These materials 
were injected into rabbit vocal folds following a biopsy injury.  Saline treated 
contralateral vocal folds formed the controls.  The animals were euthanized after 3 weeks 
and the vocal fold tissues were subjected to rheology and ELISA.  The extent of healing 
and the effect of injected HA on tissue biomechanics were assessed by rheology.  
Rheology revealed significant viscosity improvements in tissues injected with HA-
DTPHA-PEGDA.  However, elasticity of the tissues treated with HA-DTPH-PEGDA 
was similar to that of the control group.  In contrast, both elasticity and viscosity were 
markedly improved in tissues treated with Carbylan-SX in comparison with the saline 
treated control group.  ELISA revealed similar HA levels in all the three groups (HA-
DTPH-PEGDA, Carbylan-SX and saline treated control groups).  The authors 
hypothesized that similar levels of HA detected by ELISA (after 3 weeks of implantation) 
was due to complete degradation of the scaffold material within 2 weeks.  Also, since 
Carbylan-SX is less readily degradable than HA-DTPH-PEGDA it may contribute to 
maintaining superior viscoelastic properties of the vocal fold tissues post 3 weeks.  HA-
DTPH-PEGDA may have degraded earlier than 2 weeks (acute phase of wound healing) 
thus leading to degraded levels of HA similar to scar based wound healing of the vocal 
fold tissue post injury.  This is confirmed by histological evaluations which indicate 
increased fibrosis in the HA-DTPH-PEGDA groups in comparison to Carbylan-SX 
groups.  Thus it was inferred that Carbylan-SX is a potential injectable material for 
amelioration of scar tissue based vocal impairments.   
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From the above observations one may infer that a long-term time course study 
could lead to better evaluation of the soft tissue response to HA degradation products 
since it is well known that oligomeric HA is pro-inflammatory.  Use of a porcine, canine 
or sheep models may facilitate assessment of the physical aspects of sounds produced 
(for example voice intensity) because a rabbit does not vocalize effectively.   
(b) Cell based regenerative approach - This is a regenerative approach aimed at 
alleviating vocal impairments by altering the matrix composition of the tissue thereby 
improving its functional outcome.   
 Fibroblasts - Vocal fold scarring is the main indication for injection augmentation 
with autologous fibroblasts [201].  The fibroblasts are expected to bring about a 
regenerative-like repair by reconstituting the matrix of the lamina propria in the site of 
scar and thus influence restoration of normal mucosal wave motion [201].  Autologous 
fibroblasts are harvested from the patient by skin or mucosal biopsy, and then expanded 
in culture.  The fact that injected fibroblasts do not migrate away from the site of 
injection is encouraging.  It was reported that the administration of three weekly 
injections of fourth, fifth and sixth passage mucosal fibroblasts (95% – 100% confluence) 
into the scarred lamina propria (CO2 laser induced scar) of 9 beagle dogs (animals lack 
vocal ligament) resulted in restoration of the mucosal wave [201].  The laser-induced 
injury caused re-epithelialization but not regeneration of the damaged tissue resulting in 
partial or total loss of the mucosal wave prior to fibroblast injections.  Chhetri and co-
workers, inferred that since fibroblast injections do not bring about appreciable alteration 
of the tissue 3D bulk volume,  the favorable functional outcome was a direct result of a 
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replenished lamina propria  [201].  Histological studies do indicate presence of native 
matrix components but in aberrant concentrations.  In fact histology indicated an increase 
in the densities of collagen fibers and a corresponding decrease in elastin.  These 
observations are similar to those of a scarred vocal fold tissue [150].   
From the above observations one might infer that the study has scope for further 
advancements.  It seems counterintuitive that though the technique is aimed at 
eliminating the ill-effects of a scar tissue, therapy itself could lead to a more matured scar 
in time to come.  It is widely accepted that the cell density in the lamina propria is very 
low.  In this study each weekly injection involves introduction of 25 million mucosal 
fibroblasts (suspended in 0.8 – 1ml of PBS) into the otherwise paucicellular lamina 
propria.  This is a very high cell density which may contribute to the irregular amounts of 
matrix components detected.  The study was limited in the context of measuring 
acoustical parameters like maximum phonation time, and dysphonia due to the use of a 
canine model.  Hence all observations are based on the videostroboscopic analysis of the 
mucosal wave which may be inconclusive.  No rheological data of the post mortem 
beagle vocal fold tissues was provided to back up the claim that the fibroblast injection 
helped to restore tissue viscoelastic properties.  Future publications from this group 
addressing issues like long-term results in human subjects could be really interesting.   
  Mesenchymal stem cells (MSCs) - It is a widely accepted fact that stem cells can 
differentiate into a variety of cell types depending upon the epigenetic stimuli they are 
subjected to.  In 2003, Kanemaru and co-workers, injected mesenchymal stem cells into 
injured vocal folds of a canine model and reported observations on wound healing in 
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terms of morphological appearance and histological composition [202].   This study 
comprised vocal fold tissue (animals lack vocal ligament) injection of bone marrow 
derived stem cells dispersed in a 1% HCl atelocollagen scaffold.  This is the first attempt 
at vocal fold regeneration consistent with the tissue engineering approach.  The 
mesenchymal stem cells were autologous, thereby eliminating fears of immunological 
safety and ethical issues [202].  Four days post MSCs injection, the vocal fold tissue was 
damaged with an electrocautery with the injury extending into the vocalis muscle in some 
cases.  Morphological examinations evaluating vocal fold surface irregularity and 3D 
tissue bulk volume reveals that regeneration of the experimental group (MSCs injection) 
was more encouraging than that of the control group (1% HCl atelocollagen i.e. scaffold 
injection).  Histological evaluations suggested that apart from cellular nuclei staining in 
the experimental group (due to the presence of MSCs) there was no significant difference 
between the control and the experimental groups.  Tissue engineering aims to bring about 
organ regeneration by manipulating the interaction between variables like the scaffold, 
cells, regulating factors (exogenous/endogenous growth factors), and the appropriate 
epigenetic stimuli [203-206].  From what was reported [202], the above study did not 
include any exogenous growth factors like HGF or TGF-β1.  It was reported that unlike 
the left vocal fold there were no atrophic changes in the right vocal fold [202].  It seems 
counterintuitive that despite marked differences in the bulk volume and tissue appearance 
of the MSCs injected tissue, histology did not reveal any significant difference in terms 
of matrix composition.  It seems unlikely that MSCs injection could be causing the space 
filling effect in the experimental group.   
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One could interpret these findings in terms of glottic incompetence arising in a 
manner similar to unilateral vocal fold paralysis.  In unilateral paralysis motion of the 
mucosal wave of both the vocal folds is partially or completely impaired.  A similar 
situation may be arising in this study wherein glottic incompetence due to atrophy in the 
left vocal fold may be causing reduction of the mucosal wave in both the vocal folds thus 
eliminating the epigenetic stimuli regulating the unique vocal fold tissue matrix 
composition.  This may be the reason behind no appreciable difference in the matrix 
composition of the right and left vocal folds even though the right vocal fold tissue 
morphologically appeared to have a much higher degree of regeneration than the left 
(MSCs dispersed in a 1% HCl atelocollagen scaffold was injected into the right vocal 
fold and the scaffold alone injected into the left vocal fold).   
(c) Growth factor therapy - It is a widely accepted fact that growth factors are potent 
regulators of cellular functions.  Growth factors have been identified as one of the most 
potent factors regulating cellular function in the vocal fold tissue [49].  Exogenous 
application of growth factors to repair tissue injuries may require multiple injections to 
maintain physiologically relevant levels of the growth factor in order to compensate for 
losses due to rapid metabolization. 
 Hepatocyte growth factor (HGF) - It has been reported that HGF is responsible for 
prevention of scarring in the lungs, liver, and kidneys of animal models [207].  HGF is a 
potent mitogen for mature hepatocytes and is a multifunctional polypeptide involved in 
embryogenesis, angiogenesis and tissue repair [207].  However, the role of HGF in vocal 
fold wound healing is not well understood [208] though HGF has been implicated in 
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suppressing expression of TGF-β1 and stimulating protease activity that is responsible for 
degradation of the excess matrix laid down in case of scar formation [207].  HGF activity 
in acute vocal fold tissue wound healing of rabbits was shown to be activated by day 10 
and lowered slightly by day 15 [207].  In case of wound healing in artificial wounds 
created in a rat model, the mRNA levels of HGF increased steadily form day 1 to day 14 
[209].  Contrastingly, peak mRNA expression levels of HGF was reported at day 3 of 
epithelial wound healing [210].  These observations suggest that HGF activation depends 
upon the site and the extent of tissue damage.  Briefly, it is hypothesized that the 
mechanism of action of HGF is paracrine [207], in that the fibroblasts in the lamina 
propria produce HGF which is then transferred to epithelial cells with receptor c-
Met[208].  Once the HGF is bound to the c-Met it is said to modulate interactions 
between stromal epithelial cells associated with scarring.  Autocrine production of HGF 
by epithelial cells is neither proven nor has it been ruled out.  Thus, HGF functions to 
regenerate the epithelial cells through stromal-epithelial interactions [48].   
Hirano and co-workers, have demonstrated that HGF upregulates HA synthesis 
and downregulates collagen synthesis by both canine and human vocal fibroblasts in vitro 
thus strengthening claims that HGF prevents scar formation [46].  In another study, the 
same group injected HGF into rabbit vocal folds to evaluate the effect of HGF on 
scarring [48].  The procedure involved unilateral vocal fold stripping, immediately 
followed by HGF administration into the injury site.  In this study HGF was administered 
only once in the beginning of the study. 
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A similar study was undertaken by Hirano and co-workers, to study the 
therapeutic effects of HGF injections on canine vocal fold tissue scarring [47].  In this 
study, HGF was injected into the vocal fold tissue one month post induction of scarring 
by stripping.  Histological  examination of tissues (from both the above studies) 6 months 
later showed a reduction in both elastin and collagen deposition (precursor to scarring) 
and a corresponding reduction in tissue contraction (onset of scarring) in comparison to 
the untreated control group.  Though the vibratory and viscoelastic properties of the 
treated tissue were better than the untreated control group the phonation threshold 
pressure and physical aspects of voice were still below normal levels.  
One might infer that HGF should be introduced into the injury site as early as 
possible to coincide with the onset of the proliferative stage of wound healing.  Rapid 
degradation in the levels of HGF may necessitate multiple injections. 
 Basic fibroblast growth factor (bFGF) - It has been reported that bFGF plays a vital 
role in upregulating HA synthesis and downregulating collagen synthesis by aged rat 
fibroblasts [211].  As we age, the collagen levels in our vocal fold tissue increase (due to 
reduced rate of ECM turnover) and HA levels decrease leading to dysphonia secondary to 
increased stiffness and altered viscoelastic properties of the vocal fold tissue.  Hirano and 
co-workers, attempted to reverse negative changes in the matrix protein levels leading to 
presbyphonia by administering bFGF 4 times weekly in a time course study spanning 2 
months  [49].  At the various time points (1 week, 1 month, and 2 months) there was a 
consistent increase in the HA levels of the bFGF treated tissue in comparison with 
untreated tissue (control group).  But comparison of HA levels across the 3 time points 
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revealed that the HA levels in treated vocal folds was significantly reduced 2 months 
after injections as compared to that after 1 week.   Collagen levels remained similar in 
both the bFGF treated tissue and the untreated tissue across all the time points.   
From the above observation, one may infer that therapy based on bFGF delivery 
may require re-injections to bring about a favorable outcome.  On the flipside, exogenous 
growth factor injections result in their rapid metabolization in tissues before the desired 
effect is achieved in most cases.  In the aforementioned study, this may be a reason 
behind unchanged collagen levels despite repeated injections.  In aged subjects, 
depolymerization of collagen is time consuming since protease production by senescing 
fibroblasts is less efficient.  Rapidly degrading levels of exogenously applied growth 
factors like bFGF and HGF therefore do not produce the desired stimulatory effect on 
senescent fibroblasts.    
The above study may incorporate the use of a canine model or even human 
patients and then subjecting the excised tissues to rheological tests to see how well the 
viscoelastic properties of the treated vocal fold tissue approximate those of the non 
pathological native tissue.  Motion of the mucosal wave should be assessed by 
videolaryngostroboscopy.  In case of human subjects, where tissue excision is not a 
possibility, the physical aspects of voice like phonation threshold pressure, maximum 
phonation time, vocal efficiency, and voice intensity should be assessed.   
Use of gene therapy or controlled release methods which may maintain elevated 
growth factor levels in the tissue will enhance the efficacy of delivered growth factors in 
vivo [49].  However, in the context of HGF and bFGF based attempts at vocal fold 
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regeneration, one must bear in mind that there exists no example of single growth factor 
delivery mediated alleviation of pathology.   
(d) ECM scaffold - Porcine-derived xenogeneic ECM scaffolds have been used to bring 
about repair and reconstruction in numerous animal and human studies [212].  These 
porcine-derived scaffold materials maintain their 3D ultrastructure due to the presence of 
fibrous proteins like collagen types I, III, IV, V, and VI, structural glycoproteins like 
fibronectin, GAGs, growth factors like VEGF, TGF-β1 and bFGF [212].  These ECM 
based scaffolds are acellular and so cell-mediated immune response is minimal if any.  
Moreover, any persistent antigenic response is eliminated by the rapid degradation of the 
scaffold.  Head and neck reconstruction procedures and surgeries to alleviate laryngeal 
cancer are indications for use of porcine derived ECM scaffold for laryngeal 
reconstruction.  In the time course study reported by Huber and co-workers [212], the 
entire vocal fold tissue and 70% of the thyroid cartilage of a canine model were 
surgically excised and replaced anatomically by the porcine-derived ECM scaffold as 
correctly as possible.  Interestingly at all time points beyond 3 months to 1 year, presence 
of collagenous connective tissue with submucosal glands with an overlying intact 
squamous epithelium marked the remodeling of the scaffold material.   
One might hypothesize that either the scaffold showed good biointegration with 
the native host tissue or the scaffold had been remodeled completely by host tissue since 
it was reported that the boundary between the scaffold and the host tissue was invisible 
after 3 months.  This study claims that microstructure and macrostructure of the newly 
formed tissue was similar to that of the original tissue.  Since this review is focused on 
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the membranous vocal fold tissue, it must be pointed out that the canine vocal fold tissue 
not only lacks the vocal ligament but also possesses a dense collagenous lamina propria.  
This is vastly different from the composition of the human vocal fold tissue.  Therefore 
successful porcine-derived ECM based reconstruction of the 3D anatomic structure of the 
human vocal fold tissue may not yield positive results to the extent reported in this study.   
Also, this study aimed only to obtain an acceptable speaking voice in patients who 
have lost phonatory ability due to surgical removal of lesions.  It thereby clarifies that 
restoration of normal voice was not a priority.  Future long-term studies involving human 
subjects post surgeries for removal of benign or cancerous lesions may tell us a lot more 
about the ability of the human body to remodel the porcine-derived ECM scaffold into 
functional vocal fold tissue.  Another advantage of conducting such studies on human 
subjects is that the physical aspects of voice such as voice intensity, maximum phonation 
time, and fundamental frequency of phonation can be assessed.   
 (e) Collagen-HA and collagen-alginate hydrogels - From the observations, above one 
could infer that due to problems associated with resorption and allergic response an 
alternative to allogeneic and bovine collagen preparations needs to be found.  Since 
maintenance of tissue geometry is critical for production of normal voice it is important 
for injectables to be able to maintain their 3D structure relatively intact in situ even when 
being remodeled by the host or the encapsulated cells if any.  Hahn and co-workers, have 
reported the advantages of collagen-alginate hydrogels over collagen-HA hydrogels 
which could be potentially useful for restoring normal matrix composition of the vocal 
fold tissue in the future [44].  Briefly, this group encapsulated vocal fold fibroblasts in the 
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collagen-HA as well as collagen-alginate hydrogels, and performed a time course study 
in order to evaluate cell density and morphology, matrix (collagen and GAG synthesis) 
production, lateral gel compaction and mass loss.  After 28 days of culture, the collagen-
HA hydrogels showed extensively interconnected fibroblasts whereas those in the 
collagen-alginate hydrogels were spindle shaped with few interconnections.  The 
collagen-HA hydrogels showed significant mass loss (50%) associated with gel 
compaction between weeks 4 and 7 with little evidence of matrix deposition (collagen 
fibers and GAGs).  Contrastingly, the collagen-alginate hydrogels resisted compaction 
and mass loss for at least 6 weeks (last time point) in culture while facilitating ECM 
deposition (elevated levels of collagen and GAGs in comparison to week 4).  
Interestingly, the matrix protein levels detected in collagen-HA gels after 7 weeks were 
comparable to those in porcine vocal fold tissue.  Thus the collagen-alginate hydrogels 
appear to be promising materials for vocal fold restoration.    
From the above observations, one might hypothesize that the collagen-alginate 
hydrogels are promising potential scaffolds for vocal fold tissue regeneration.  It must be 
pointed out that there exists a slight discrepancy in the assessment of cell density in the 2 
hydrogel types at the end of week 4.  It was reported that there was no significant 
difference in cell density from day 0 to week 4.  But the BrdU stain showed positive 
results for the collagen-HA hydrogels, which indicates uptake of the stain by cells in the 
“S” phase of the cell cycle which is when DNA duplication occurs.  Cell proliferation 
leads to heightened cell migration, and increased cellular interconnections within the 
scaffolding (personal observations) resulting in heightened contractile forces exerted by 
 84 
the fibroblasts which explains the compaction of the collagen-HA hydrogels.  A negative 
BrdU stain in the collagen-alginate hydrogels corresponds to a lack of cell proliferation 
(and therefore less cell migration) which explains single spindle shaped cells without any 
interconnections eventually leading to maintenance of original gel dimensions even after 
6 weeks of culture.  One might hypothesize that a DNA quantitation analysis may be 
performed for additional confirmation of the results previously obtained.  In vivo studies 
using canine models may provide additional insight into the performance of these 
collagen based composite hydrogels in environments where hydrogel degradation rates 
could be heightened due to elevated levels of proteases (in case of inflammation) and 
macrophage activity.   
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CHAPTER 3 
PROJECT RATIONALE 
 
3.1 Hypothesis 
The techniques/approaches described earlier have been unable to achieve 
complete restoration of voice quality due to their inability to bring about regeneration of 
the native vocal fold tissue architecture/ECM composition.  Our long-term hypothesis is 
that rapid restoration of the mechnical microenvironment using mechano-mimetic 
scaffolds will minimize scarring, facilitate vocal fold tissue-specific ECM production, 
and ultimately restore normal phonation.  The long-term objective of our research is to 
prevent vocal fold scarring following injury, achieve regeneration of the vocal fold tissue 
architecture/ECM composition and thereby restore normal phonation through the use of 
mechano-mimetic scaffolds.  Consistent with the tenets of tissue engineering we aim to 
use 3D, biodegradable, polymeric scaffolds; in vivo vocal fold tissue manipulation with 
which will yield biomechanically optimal functional results.  We believe that minimally 
invasive therapeutic intervention/manipulation of the acute stage of vocal fold tissue 
injury using mechano-mimetic materials could potentially ameliorate vocal fold tissue 
scarring sequelae and restore long-term normal phonatory voice.  We aim to target the 
acute stage of a vocal folds injury (which leads to the onset of fibrosis) by injecting :- (a) 
HA-based hydrogels (aimed at restoring viscous shear properties of the vocal mucosa), 
(b) polyethylene glycol diacrylate (PEGDA) based hydrogels (aimed at restoring elastic 
integrity of the vocal ligament).  Various studies have elucidated the use of in situ 
photopolymerizable, water soluble macromers with functionalized end groups that can be 
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crosslinked to realize hydrogels upon exposure to UV light using cytocompatible 
photoinitiators [213-215].  We opted for HA due to its abundance in the lamina propria, 
viscoelastic properties, chemical processability, enzymatic degradability, wound healing 
properties and ability to interact with certain fibroblast cell surface receptors (CD44).  
PEG has been selected as the starting material among other available synthetic materials 
due to its FDA approved status, ease of chemical modification, lack of specific cellular 
interactions and biocompatibility thus providing a “blank-slate” for inducing cell-
biomaterial interactions by incorporating synthetic peptides [216].  Observations from 
our preliminary experiments as well as previously reported studies [213, 217-219] 
sufficiently indicated that cell viability, proliferation, and ECM production are not 
adversely affected by UV based hydrogel photopolymerization processes.  One must bear 
in mind that though these in vitro studies dealt with direct UV illumination of the cell-
macromer suspensions in order to realize cell encapsulated hydrogel constructs, the 
efficacy of transdermal injections which assume importance particularly in the context of 
the proposed vocal folds application has been amply demonstrated by Elisseeff et al [220, 
221].  
 
3.2 Specific Aims 
Aim 1: To enhance cellular remodeling of PEGDA hydrogels through the 
creation of PEG based semi-IPNs in order to facilitate improved cell spreading and 
proliferation in the PEGDA based three dimensional networks.  Based on previously 
published studies [222-224] and observations from our preliminary cell culture 
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experiments we inferred that the nanometer-scale mesh size of the PEGDA based 
hydrogel networks restricts encapsulated cells to a rounded morphology that can inhibit 
cellular processes such as proliferation and migration that are essential for the early 
stages of remodeling and tissue formation.  Hence in the intial phase of the vocal fold 
regeneration project we aim to investigate an approach for accelerating cellular 
remodeling based on the creation of semi-IPNs composed of hydrolytically degradable 
PEGDA macromers and native, enzymatically degradable ECM components (collagen, 
gelatin, and HA).   
Aim 2: To create degradable hydrogels/semi-IPNs approximating the 
mechanical properties of the vocal mucosa and the vocal ligament that may be 
photopolymerized in situ following vocal fold injury or surgery using minimally 
invasive techniques to fill defects.  We aim to create mechano-mimetic, degradable, 
PEG-based semi-IPNs (approximating the elastic stress-strain properties of the human 
vocal ligament) and GMHA hydrogels (approximating the viscous shear properties of the 
human vocal mucosa) that may be photopolymerized in situ using minimally invasive 
methods.  We aim to assess cytocompatibility and the ability of these potential scaffolds 
materials to support cell proliferation and neo-matrix deposition by the resident cells. 
Aim 3: To assess the ability of fibroblast encapsulated GMHA hydrogels to 
support vocal mucosa-specific ECM deposition in response to physiologically 
relevant high frequency vibration.  Consistent with our long-term hypothesis, we 
believe that rapid restoration of the vibratory microenvironment using mechano-mimetic 
scaffolds will facilitate vocal mucosa-specific ECM production and minimize scarring, 
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thereby restoring normal phonatory voice in long-term.  Towards this end, we aim to 
assess the ability of the GMHA hydrogels to support human fibroblast formation of vocal 
mucosa-like ECM in response to vibration.  Fibroblast encapsulated GMHA hydrogels 
will be subjected to physiologically relevant high frequency vibration over a time course, 
using a custom-built vibrational bioreactor and Labview software.   
 
3.3 Clinical significance 
Voice is widely acknowledged as the “mirror of soul” and is significant in terms 
of the quality of life.  Voice is a primary “tool of trade” for 25% of the U.S. work force 
(teachers, singers, telephone marketers, sales personnel, counselors, etc.) [1, 16].  The 
quality of voice depends on the biomechanical properties of the vocal fold tissue which 
derive from its highly differentiated ECM organization and composition.  The wound 
healing response to vocal fold injuries is characterized by scarring and subsequent 
dysphonia due to alterations in the biomechanical properties of the tissue.  Dysphonia 
characterized by increased effort to sustain phonation, decreased vocal quality, and total 
voice loss affects approximately 23% of the voice-dependent US workforce [14]; and 
may jeopardize job security, employment opportunities, and social interaction [225, 226].  
Scarring-induced dysphonias are currently treated by voice therapy and surgical 
augmentation procedures which provide short-term improvement in voice quality.  
Nevertheless, these techniques have been unable to achieve long-term restoration of 
normal phonatory voice due to their inability to bring about regeneration of the native 
vocal fold tissue architecture/ECM composition.  The human vocal ligament is abundant 
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in fibrous structural proteins like elastin and collagen that impart elastic stress-strain 
properties to the vocal fold tissue.  The human vocal mucosa is abundant in HA and 
proteoglycans that impart viscous shear properties to the vocal fold tissue.  The long-term 
objective of our research is the in situ photopolymerization of autologous cell 
encapsulated, mechano-mimetic, degradable hydrogels/semi-IPNs to fill defects in 
specific layers of the human vocal fold tissue following injury.  This approach may help 
restoration of long-term normal phonatory voice by promoting regeneration of native 
tissue architecture/ECM composition and minimizing fibrotic scarring.  Through our 
research we aim to make a significant attempt to improve human lives that have been 
negatively impacted by scarring related vocal pathology.  Our contributions to vocal 
fold tissue engineering are :- (a) the proposed use of mechano-mimetic scaffolds for 
regenerating the human vocal mucosa (GMHA hydrogels) and the vocal ligament 
(PEG-based semi-IPNs) in an attempt to restore appropriate mechanical integrity to 
the vocal fold tissue following injury and (b) the demonstration of the importance of 
restoring the vibratory mechanical microenvironment in regenerating the unique 
ECM composition of the native tissue.  In the context of other tissue engineering 
applications these materials may serve as :- (a) a substrate for host cell infiltration and 
colonization,  (b) a delivery vehicle for autologous cells which will eventually bring 
about regeneration of the native tissue ECM composition, thereby aiding soft tissue 
repair.  
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CHAPTER 4 
INCORPORATION OF HYALURONIC ACID INCREASES FIBROBLAST 
SPREADING AND PROLIFERATION WITHIN PEG-DIACRYLATE SEMI-IPNs 
                                                
          4.1 Introduction 
Hydrogels are crosslinked polymer networks that have been widely studied as 
tissue engineering matrices for cell transplantation and sustained, site-specific delivery of 
bioactive molecules.  Properties such as minimally invasive introduction as aqueous 
solutions and in-situ gelation, conformation to irregular tissue geometry, high gas and 
metabolite permeability, and viscoelastic mechanical properties have rendered hydrogels 
useful for cartilage, bone, vascular, and soft tissue applications [214, 223, 227].  
Hydrogel matrices have been prepared from a variety of naturally-derived proteins and 
polysaccharides, as well as synthetic polymers.  Although naturally-derived materials are 
intrinsically degradable by physiological enzymes, limitations include availability, 
reproducibility, and limited control over degradation rate and mechanical properties. 
Hydrogels based on synthetic polymers offer an increased diversity of physicochemical 
properties that may be tailored in a reproducible manner for specific applications [215].  
Degradable synthetic hydrogels have been based on polymers incorporating or modified 
with hydrolytically susceptible ester bonds, such as poly(ethylene glycol)-polyester block 
copolymers [228-230], poly(propylene fumarate-co-ethylene glycol) (P(PF-co-EG)) 
copolymers [231], and poly(lactic acid)-grafted poly(vinyl alcohol) [232].  Although 
these synthetic hydrogels are biocompatible, synchronizing the rate of hydrolytic 
 91 
degradation with cellular growth and matrix accumulation poses a challenge to the 
realization of engineered functional tissue [223]. 
 At early time points following encapsulation, the 15-35Aº mesh size of these 
highly crosslinked matrices [222] has been shown to restrict cell spreading, resulting in a 
rounded morphology that can delay cell proliferation, migration, and ECM production 
[224]. Several approaches have been investigated for increasing cellular activity within 
synthetic hydrogel matrices.  Anseth‟s group demonstrated that appropriate tailoring of 
hydrogel degradation rate by mixing macromers of varying chemistry can improve 
cellular differentiated function and the synthesis and spatial distribution of ECM [233, 
234].  Hubbell and West have developed several elegant systems based on crosslinking of 
non-degradable polymers with synthetic peptides or recombinant proteins by 
photopolymerization and Michael addition [235-239].  These peptides were designed 
with reactive terminal groups that formed crosslinks in the polymer network and internal 
sequences based on cleavage sites recognized by physiological proteases involved in cell 
migration such as collagenase, elastase, and plasmin.  These matrices are chemically 
stable and undergo localized degradation in response to cellular proteolytic activity. In 
combination with grafted cell adhesion peptides and incorporation of soluble growth 
factors, these matrices successfully mimic multiple features of the native ECM and have 
shown efficacy for in vivo regeneration of bone [240].  One limitation of this approach is 
the small scale and high production cost of synthetic peptides and recombinant proteins. 
 Several groups have begun to investigate the utility of biosynthetic composite gels 
composed of both synthetic polymers and naturally occurring ECM components.  
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Almany and Seliktar have described a system comprised of chemically crosslinked 
PEGylated fibrinogen [224]. The fibrinogen component provides bioactivity for cell 
adhesion and enzymatic degradation, while variation in the content and structure of the 
PEG component allows flexible control over degradation rate and mechanical properties 
[241]. Compositions with appropriate degradation rate have been shown to support bone 
formation in rat tibial defects [242].  Sefton and coworkers have described the 
development of semi-synthetic collagen/poloxamine matrices that support the viability of 
encapsulated cells and the adhesion and spreading of various cell types on the gel surface 
[243, 244].   
The objective of the current studies was to investigate an alternative approach for 
accelerating cellular remodeling based on the creation of semi-IPNs of covalently 
crosslinked, hydrolytically degradable PEG-diacrylate macromers with native, 
enzymatically degradable ECM components homogeneously dispersed in the network.  
Low levels of hyaluronic acid (HA) are shown to facilitate 3-dimensional fibroblast 
spreading and proliferation through a mechanism of cell-mediated enzymatic 
degradation. 
 
4.2 Materials & Methods 
4.2.1 Materials 
 Polyethylene glycol (PEG, MW=3934) was purchased from Fluka (Seelze, 
Germany) and 2-chloropropionyl chloride, triethylamine, dichloromethane (HPLC 
grade), anhydrous sodium sulfate, and sodium acrylate were obtained from Aldrich (St. 
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Louis, MO, USA). Dimethyl formamide (extra dry) and ethyl ether were purchased from 
Acros (Morris Plains, NJ) and Fisher Chemical (Fair Lawn, NJ), respectively. 2-hydroxy-
1-(4-(hydroxyethoxy) phenyl)-2-methyl-1-propanone (I-2959) was purchased from Ciba 
Specialty Chemicals (Basel, Switzerland).  Adult normal human dermal fibroblasts 
(NHDF, CC-2511) obtained from a 39 year old Black woman were purchased from 
Biowhitaker (Rockland, ME, USA). DMEM F-12 50/50,1X with L-glutamine, 15mM 
HEPES/trypsin EDTA (0.05% trypsin/0.53mM EDTA in HBSS), and 
penicillin/streptomycin were obtained from Mediatech (Herdon, VA, USA).  Bovine 
growth serum was purchased from Hyclone (Logan, UT, USA).  Gelatin and collagen 
(Vitrogen 100) were purchased from Mallinckrodt Specialty Chemicals (Paris, KY, USA) 
and Angiotech Biomaterials (Palo Alto, CA, USA), respectively.  Hyaluronic acid (HA, 
MW=1.4 x 10
6
) was purchased from Genzyme (Cambridge, MA, USA). 
 
4.2.2 Synthesis of degradable PEG-bis-(2-acryloyloxy propanoate) (PEG-bis-AP) 
macromers 
PEG-diacrylate macromers with hydrolytically degradable ester bonds were 
synthesized by a two-step reaction as previously described [245]. 
 
4.2.2.1 Synthesis of PEG-bis-(2-chloropropanoate), (PEG-bis-CP) 
 15g of PEG (3.75mmol) was dissolved in 120ml of dry dichloromethane and 
introduced in a dry, three-neck-250ml flask under inert (argon gas) conditions.  Once the 
PEG was completely dissolved, 0.94ml of triethylamine (6.75mmol) was added to the 
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three-neck flask which was kept immersed in an ice bath.  1.5ml of 2-chloropropionyl 
chloride (15mmol) was added to 30ml of dry dichloromethane in a dropping funnel.  
Contents of the dropping funnel were introduced into the three-neck flask in a drop-wise 
manner within 2hours under constant agitation.  After approximately six hours, the ice 
bath which was never replenished, was removed and the reaction was allowed to progress 
overnight at room temperature.  The TEA-HCl salt was removed by filtration of the 
reaction mixture using a buchenel glass funnel (10 – 15µm pore size).  The filtrate was 
then reduced to 1/10
th
 of its initial volume using a rotary vacuum evaporator (Buchi 
Rotavapor®, Switzerland) and precipitated using 10X cold ethyl ether.  The precipitate 
was re-solubilized in 10X dry dichloromethane (150ml) and introduced into a 500ml 
separating funnel.  The product was washed twice with 15ml of 10% NaHCO3, followed 
by 3 washes with 15 ml distilled water.  At this point the pH of the product was neutral.  
Residual water was removed by the addition of anhydrous sodium sulfate until the 
physical state of sodium sulfate changed from clumps to a consistent powder.  Once 
again the dichloromethane was reduced to 1/10
th
 of its initial volume by vacuum 
evaporation and the product (PEG-bis-CP) was precipitated in 10X cold ether and washed 
twice in 300ml of ether.  PEG-bis-CP was then recovered, weighed, and stored in a 
dessicator under a continuous vacuum.  The structure of PEG-bis-CP and the degree of 
substitution were determined from the 
1
H-NMR (Brucker 300 MHz, CDCl3) spectra as 
previously described [246].  The reaction scheme for PEG-bis-CP is shown in figure 4.1. 
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Figure 4.1 Chemical reaction scheme for PEG-bis-CP (intermediate product). 
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4.2.2.2 Synthesis of PEG-bis-(2-acryloyloxy propanoate), (PEG-bis-AP) 
 10g of PEG-bis-CP (2.5mmol) was solubilized in a dry, three-neck-250ml flask 
by the addition of 100ml anhydrous dimethylformamide in the presence of small amounts 
of inhibitor 4-methoxyphenol.  1.18g of sodium acrylate (15mmol) was added to the 
contents of the three neck flask under constant agitation in an inert atmosphere (argon 
gas).  The reaction was refluxed for 30 hours at 85ºC under inert conditions, followed by 
cooling to room temperature and filtration of the reaction mixture through a buchenel 
glass funnel (10 – 15µm pore size) in order to remove unreacted sodium acrylate.  The 
dimethylformamide was reduced to 1/10
th
 of its initial volume by vacuum evaporation 
and the remaining contents of the reaction were precipitated in 10X cold ether and 
washed twice in 300ml ether.  The product (PEG-bis-AP) was recovered, weighed and 
stored under dark conditions in a vacuum dessicator.  The structure of PEG-bis-AP and 
the degree of acrylation were determined from the 
1
H-NMR (Brucker 300 MHz, CDCl3) 
spectra as previously described [246].  The reaction scheme for PEG-bis-AP is shown in 
figure 4.2. 
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Figure 4.2 Chemical reaction scheme for PEG-bis-AP macromers. 
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4.2.3 In vitro cell culture 
NHDF were routinely cultured in 182 cm² T-flasks using DMEM F-12 50/50,1X 
with L-glutamine and 15mM HEPES enriched with 10% v/v bovine growth serum and 
50U/ml penicillin and  50µg/ml streptomycin.  Culture medium was changed once every 
two days and cells were passaged weekly. All experiments were performed with cells 
from the 4
th – 6th passages. For hydrogel encapsulation, monolayers of fibroblasts (ca. 
95% confluence) were trypsinized, centrifuged, resuspended, counted in a 
hemacytometer, and adjusted to a final concentration of 1.6 x 10
7
cells/ml. 
 
4.2.4 Hydrogel/Semi-IPN photopolymerization 
PEG-bis-AP macromer solutions were prepared in 1X-PBS (0.1M, pH 7.4) and 
sterile filtered.  A 10% w/v stock solution of I-2959 was prepared in 70% ethanol.  A 
fibronectin-derived cell adhesion peptide, (GRGDS, Bachem, PA, USA) was conjugated 
to acrylate-PEG-NHS (MW=3400, Nektar) as previously described [216].  GRGDS-
PEG-acrylate was prepared as a stock solution in 1X PBS (10 µmol/ml) and sterile 
filtered.  PEG-bis-AP hydrogels and semi-IPNs (final concentration 6% w/v) containing 
varying types and concentrations of unmodified ECM molecules with 0.1% w/v I-2959 
initiator were photopolymerized between glass microscope slides separated by a 1mm 
Teflon spacer by exposure to low intensity UV illumination (365 nm, 10 mW/cm
2
, Black-
Ray B100-AP, Upland, CA) for 7½ minutes per side.  For cell encapsulation studies, 
acrylate-PEG-GRGDS and NHDF were included at final concentrations of 2.5µmol/ml 
and 4 x 10
6
cells/ml, respectively. 
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4.2.5 Effect of various ECM molecules on fibroblast morphology in PEG-based 
semi-IPNs 
NHDF were encapsulated as described above in 6% w/v PEG-bis-AP based 
hydrogels and semi-IPNs containing equal concentrations (0.12% w/v) of gelatin, 
collagen, and HA (n = 4 samples/condition).  Samples were cultured in 12 well plates for 
7 days, and then stained with 1µM fluorescein diacetate (FDA, Molecular Probes, 
Eugene, OR) and 2.5µM propidium iodide (PI, Molecular Probes), rinsed with PBS, 
visualized by fluorescence microscopy (Zeiss Axiovert 200) and digitally imaged.  
 
4.2.6 Effect of HA concentration on fibroblast morphology and proliferation in 
PEG-based semi-IPNs 
NHDF were encapsulated as described above in 6% w/v PEG-bis-AP based 
hydrogels and semi-IPNs containing 0, 0.06%, 0.12%, and 0.18% w/v HA (n=9 
samples/condition).  Samples were cultured for 1 – 14 days.   
 
4.2.6.1 Confocal analysis of morphology 
After 14 days in culture, 3 samples from each group were fixed in 4% 
paraformaldehyde (Sigma Chemical Co., St. Louis, MO, USA) in PBS, permeabilized 
with 0.1% Triton X-100 (Sigma), and stained with Alexa 594-phalloidin (Molecular 
Probes).  Samples were visualized and imaged using a Zeiss Confocal LSM510 
microscope.   
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4.2.6.2 Fibroblast proliferation 
 3 samples from each group were harvested at day 1 and day 14, rinsed twice with 
sterile PBS, snap-frozen in an ethanol-dry ice bath, and stored at -80ºC.  DNA 
solubilization and quantitation were based on modifications of previously described 
methods [247].  Briefly, the samples were subjected to 3 freeze-thaw cycles in 1.4ml of 
10mM EDTA, pH 12.3.  Once the hydrogels were completely dissolved, the pH was 
neutralized by the addition of 100µl 1M potassium phosphate (monobasic) solution. Total 
DNA content was measured using the Picogreen DNA-binding dye (Molecular Probes) 
and a fluorescence microplate reader (Tecan GENios, excitation: 485nm, emission: 
535nm).  DNA content was converted to cell number based on a DNA standard curve 
prepared from serial dilutions of NHDF.   
 
4.2.7 Volumetric swelling ratio 
PEG-bis-AP hydrogels and semi-IPNs (6% w/v) containing varying amounts of 
HA were photopolymerized as described above (n=4/group). Circular hydrogel samples 
(1mm thick, 8mm diameter) were punched out using a hole punch and equilibrated in 
distilled water for 24 hours to remove any unpolymerized macromer. Samples were 
lyophilized and dry weights (Wd) were measured.  The gels were immersed in distilled 
water and allowed to swell for 24 hours in order to record the wet weights (Ws). The 
volumetric swelling ratio and mesh were calculated as previously described [248, 249].  
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4.2.8 Elastic Modulus 
PEG-bis-AP hydrogels and semi-IPNs (6% w/v) containing varying amounts of 
HA were photopolymerized and cut into dumbbell shaped samples (gauge length 30mm, 
gauge width 5mm, and thickness 1mm).  The samples (n=4/group) were subjected to 15% 
strain at 5mm/min using an MTS Synergie 100 (MTS Systems Corporation) at room 
temperature.  Each sample was tested twice to prevent errors due to sample slippage.  
 
4.2.9 Degradation studies 
PEG-bis-AP hydrogels and semi-IPNs (6% w/v) containing varying amounts of 
HA were photopolymerized, equilibrated with water, lyophilized, and weighed (Wd0) as 
described above.  Samples were incubated with 4ml of 1X-PBS containing 0.01% sodium 
azide (Sigma) in scintillation vials under shaking at 37ºC.  Buffer was changed once 
every two days. At weekly intervals, samples (n=3/group/time point) were collected, 
washed with distilled water three times, lyophilized, and weighed (Wdt).  Percent mass 
loss was calculated as ((Wd0 – Wdt)/Wd0) x 100. 
 
4.2.10 Contribution of hyaluronidase activity to fibroblast spreading in PEG-bis-
AP/HA semi-IPNs 
NHDF were encapsulated in 6% w/v PEG-bis-AP/0.12% w/v HA semi-IPNs as 
described above and cultured in 12 well plates for 48 hours in the presence of the 
hyaluronidase (HAse) inhibitors neomycin trisulfate hydrate (0.1mM, Sigma, 10mM 
stock solution in PBS) and L-ascorbic acid 6-palmitate (0.1mM, Sigma, 10mM stock 
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solution in 70% ethanol) [250, 251].  Controls consisted on semi-IPN samples cultured in 
routine media without the addition of HAse inhibitors, as well as NHDF cultured on the 
surface of 12 well plates with and without the presence of inhibitors.  Cytotoxicity of the 
inhibitors was assessed by FDA/PI staining of monolayer cultures.  Fibroblast 
morphology and spreading within semi-IPNs was analyzed by confocal microscopy as 
described above.   
 
4.2.11 Reverse hyaluronan gel zymography 
The effectiveness of the inhibitors was confirmed by reverse hyaluronan gel 
zymography on two 10% polyacrylamide (Bio-Rad laboratories, Hercules, CA, USA) 
gels each containing 3.4mg/ml HA. The procedure was adapted from two other 
approaches previously described [252, 253]. Hydrogel samples were frozen and 
homogenized in 200µl extraction buffer (20mM TRIS buffer pH 7.5, 0.5% (w/v) Triton 
X-100, 1% sodium dodecyl sulfate (SDS, Fisher) containing 10µl/ml proteinase inhibitor 
(Complete Proteinase Inhibitor, Roche, Germany) and kept on ice for 10 minutes. The 
samples were centrifuged for 15 minutes at 15,000rpm and supernatants were collected.  
The protein content of the gel extracts was determined by BCA assay (Pierce) and diluted 
with extraction buffer to a final concentration of 40µg protein/60µl.  Pre-stained 
molecular weight markers (10 – 250 kDa) and 60µl gel extract samples were mixed with 
20µl Laemmli‟s sample buffer [254].  40µl aliquots were loaded on each gel and 
electrophoresed under non-reducing conditions.  After electrophoresis, the gels were 
washed in 2.5% w/v Triton X-100 for 30 minutes to remove SDS and then incubated in 
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the substrate buffers. One gel was incubated in a pH 3.75 substrate buffer (50mM citric 
acid, 50mM Na2HPO4, 0.15M NaCl, 0.02% w/v NaN3). The other gel was incubated in a 
pH 7.6 substrate buffer (50mM TRIS, 5mM Cacl2, 200mM NaCl, 0.02% v/v Brij). The 
gels were then stained with 0.5% Alcian blue (Anatech LTD, Battle Creek, MI, USA) in 
20% methanol/10% acetic acid in distilled water, and then destained by rinsing with 20% 
methanol/10% acetic acid in distilled water.  Active HAse was visualized as clear/white 
bands on the Alcian blue stained undigested HA background and imaged using an 
imaging densitometer (BioRad, GS 700). 
 
4.2.12 Statistical analysis 
Quantitative data for volumetric swelling ratio and elastic modulus were 
compared by ANOVA using Tukey‟s method for post-hoc comparisons.  DNA content at 
1 and 14 day time points were compared by two-tailed, unpaired t-tests.  P values <0.05 
were considered to be statistically significant. 
 
4.3 Results  
4.3.1 Synthesis of PEG-based macromers 
4.3.1.1 Synthesis of PEG-bis-CP 
PEG-bis-CP was synthesized by reaction of PEG and 2-chloropropionyl chloride 
in the presence of TEA in dichloromethane and the structure was characterized by 
1
H-
NMR using CDCl3 as solvent(δ=3.4~3.90 (m, PEG backbone -CH2), δ=4.3 (t, 2H, PEG 
terminal CH2), δ=4.45 (t, 1H, 2-CP -CH), δ=1.7 (d, 3H, 2-CP –CH3)).  The degree of 
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substitution of the 2-CP to the terminal alcohol groups of PEG was calculated as 97% 
from the ratio of the integrals of the PEG back bone (δ=3.45~3.90) and the terminal PEG 
methylene peaks (δ=4.3)   
 
4.3.1.2 Synthesis of PEG-bis-AP 
 PEG-bis-AP was synthesized by reaction of PEG-bis-CP and sodium acrylate in 
anhydrous DMF and the structure was characterized by of 
1
H-NMR using CDCl3 as 
solvent (Figure 4.3, δ=3.45~3.90 (m, PEG backbone -CH2), δ=4.3 (t, 2H, PEG terminal 
CH2), δ=4.45 (t, 1H, 2-CP -CH), δ=1.7 (d, 3H, 2-CP –CH3), δ=5.9 and 6.4 (d, 2H, acrylic 
–CH2), δ=6.15 (q, 1H, acrylic -CH)). The degree of acrylation of the PEG-bis-AP was 
calculated as 87% from the ratio of the integrals of the PEG back bone (δ=3.45~3.90) and 
the acrylate peaks (δ=4.3). 
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Figure 4.3 Structure and 
1
H-NMR spectrum of PEG-bis-AP macromer. 
 
4.3.2 Fibroblast spreading and proliferation in PEG diacrylate-based semi-IPNs 
NDHF were photopolymerized within PEG-bis-AP hydrogels and semi-IPNs 
containing immobilized RGD cell adhesion peptides and enzymatically degradable ECM 
components.  Fibroblasts in hydrogel controls exhibited a rounded morphology at 7 days 
(Figure 4.4A) and throughout extended periods in culture.  Fibroblasts cultured in semi-
IPNs containing collagen (Figure 4.4B) and gelatin (4.4C) retained a rounded 
morphology, similar to the hydrogel controls.  Incorporation of HA resulted in fibroblast 
spreading and the development of a polarized morphology with multiple thin processes 
(Figure 4.4D).   
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Based on this observation we performed a dose-response experiment to determine 
the effect of varying HA content on fibroblast spreading.  Confocal microscopy was 
performed to ensure that fibroblast spreading was occurring within the three-dimensional 
bulk of the materials as opposed to at the surface.  Semi-IPNs containing 0.12% (Figure 
4.5C) and 0.18% HA (Figure 4.5D) supported fibroblast spreading, while those 
containing 0.06% HA (Figure 4.5B) were comparable to control hydrogels (Figure 4.5A). 
Fibroblasts exhibited spread, polarized morphology throughout the three-
dimensional gel as shown in figure 4.6, which is a representative composite figure of 
confocal image sections taken at 100 µm intervals from 0 to 500 µm and pseudo-colored 
as a function of depth.   
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Figure 4.4 Viability and morphology of fibroblasts encapsulated in 6% w/v PEG-bis–AP 
hydrogels (A) and semi-IPNs containing 0.12 % w/v gelatin (B), collagen (C) and 
hyaluronic acid (D) visualized by staining with fluorescein diacetate after 7 days in 
culture.  All scale bars are 200µm. 
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Figure 4.5 Confocal analysis (200 µm depth) of fibroblast morphology and spreading 
within 6 % w/v PEG-bis-AP hydrogels (A) and semi-IPNs containing 0.06% w/v (B) 
0.12% w/v (C) and 0.18% w/v (D) hyaluronic acid after 14 days in culture.  All scale bars 
are 200µm. 
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Figure 4.6 Representative pseudo-colored composite of confocal image sections of 
fibroblasts at varying depths within 6% w/v w/v PEG-bis-AP based semi-IPN containing 
0.12% w/v hyaluronic acid after 14 days in culture.  Color scheme – red (0 µm), orange 
(100 µm), yellow (200 µm), green (300 µm), pink (400 µm) and blue (500 µm).  All 
scale bars are 200µm. 
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In order to determine whether the observed changes in fibroblast morphology 
corresponded with changes in cellular bioactivity, fibroblast proliferation was determined 
based on measurements of DNA content at 1 and 14 days.  No significant difference was 
observed in the number of encapsulated fibroblasts at the day 1 time point among the 
varying gel formulations (Figure 4.7).  After 14 days in culture, the number of fibroblasts 
significantly decreased in PEG-bis-AP hydrogels and semi-IPNs containing 0.06% HA.  
In contrast, a significant increase in cell number was observed for semi-IPNs containing 
0.12% and 0.18% HA. 
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Figure 4.7 Fibroblast proliferation within 6% w/v PEG-bis-AP hydrogels and semi-IPNs 
containing varying amounts of HA. 
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4.3.3 Physical properties of PEG-bis-AP hydrogels and semi-IPNs containing HA 
The effect of HA incorporation on hydrogel physical/chemical properties was 
assayed by measurements of swelling, tensile properties, and hydrolytic degradation.  
Incorporation of HA (0.06%, 0.12%, and 0.18%) significantly increased the volumetric 
swelling ratio of PEG-bis-AP/HA semi-IPNs relative to PEG-bis-AP hydrogels (Figure 
4.8).   
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Figure 4.8 - Volumetric swelling ratio and mesh size of 6% w/v PEG-bis-AP hydrogels 
and semi-IPNs containing varying amounts of HA. 
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Similarly, PEG-bis-AP semi-IPNs containing 0.12% and 0.18% HA exhibited 
significantly increased elastic modulus relative to hydrogel controls (Figure 4.9).   
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Figure 4.9 - Elastic modulus of 6% w/v PEG bis-AP hydrogels and semi-IPNs containing 
varying amounts of HA. 
 
The hydrolytic degradation of PEG-bis-AP hydrogels and semi-IPNs containing 
varying amounts of HA was characterized on the basis of mass loss.  The addition of HA 
did not significantly affect mass loss observed at varying time points during the study, 
although semi-IPNs containing 0.12% and 0.18% HA were completely degraded at 32 
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days versus 35 days for semi-IPNs containing 0.06% HA and control hydrogels (Figure 
4.10).   
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Figure 4.10 - Mass loss of 6 % w/v PEG-bis-AP hydrogels and semi-IPNs containing 
varying amounts of HA. 
 
4.3.4 Contribution of HAse activity to fibroblast spreading in PEG-AP/HA semi-
IPNs 
In order to determine the contribution of HA enzymatic degradation to increased 
fibroblast spreading within HA-containing semi-IPNs, fibroblasts were encapsulated in 
PEG-bis-AP semi-IPNs containing 0.12% HA and cultured under routine conditions and 
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in the presence of two HAse inhibitors, neomycin trisulfate and L-ascorbic acid-6-
palmitate.  The presence of either inhibitor eliminated fibroblast spreading within HA-
containing semi-IPNs (Figure 4.11).  The addition of comparable concentrations of each 
inhibitor to cultures on fibroblasts in tissue culture wells did not alter cell viability, 
spreading, or time to confluence relative to untreated controls (data not shown).  Reverse 
hyaluronan gel zymography confirmed substantial decreases in HAse activity of cell 
lysates obtained from cells cultured in the presence of both inhibitors relative to untreated 
controls (Figure 4.12).   
 
 
Figure 4.11 - Confocal analysis of fibroblast morphology and spreading within (200 µm 
depth) 6 % w/v PEG-bis-AP based semi-IPN with 0.12 % w/v hyaluronic acid after 48 
hours culture in normal media (A) and media containing 0.1mM Neomycin sulfate (B) 
and 0.1mM L-Ascorbic acid 6-palmitate (C). 
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Figure 4.12 - Reverse HA gel zymography of extracts derived from fibroblasts 
encapsulated within 6% w/v PEG-bis-AP based semi-IPN containing 0.12% hyaluronic 
acid cultured with and without the presence of hyaluronidase inhibitors.  Lane 1-
molecular weight standard, lane 2-routine culture media, lane 3-extracts of fibroblasts 
cultured in routine media, lane 4-extracts of fibroblasts cultured in media containing 
0.1mM Neomycin sulfate, lane 5-extracts of fibroblasts cultured in media 
containing.0.1mM L-Ascorbic acid 6-palmitate. 
 
4.4 Discussion 
 Fibroblasts (~10µm diameter) encapsulated within hydrolytically degradable 
PEG-bis-AP hydrogels with nanometer-scale mesh size maintained a rounded 
morphology for up to 4 weeks of in vitro culture, consistent with results reported by 
others [224]. Cell shape is strongly correlated with biochemical function.  Specifically, 
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rounded cell morphology is associated with limited proliferation and migration [255], key 
cellular processes in the early stages of tissue formation. In an attempt to introduce cell 
mediated degradability and enhance cell proliferation and migration, we have developed 
semi-IPNs based on synthetic, hydrolytically degradable PEG-bis-AP macromers and 
unmodified, enzymatically degradable ECM components such as collagen, gelatin, and 
HA.  All materials were selected based on their well characterized biocompatibility.  
Hydrolytic degradation of ester bonds within the PEG network is expected to yield 
polyacrylic acid, lactic acid, and PEG.  The lactic acid will be metabolized by the body, 
whereas the polyacrylic acid and the PEG will be eliminated by renal clearance [256]. 
Enzymatic degradation of collagen, gelatin, and HA produces simple amino acids and 
sugars that can be recycled in cellular metabolic pathways.   
 Among the three ECM components tested, PEG-bis-AP semi-IPNs containing HA 
supported extensive fibroblast spreading with the development of a multi-polar 
morphology within 48 hours.  PEG-bis-AP semi-IPNs containing HA also supported 
significant increases in cell number, in contrast to control PEG-bis-AP hydrogels which 
exhibited significant decreases in cell number.  Although fibroblasts are not as sensitive 
to apoptosis as epithelial or endothelial cells, these results may indicate that prolonged 
restriction to a rounded morphology is detrimental to their survival.  Collagen- and 
gelatin-containing semi-IPNs did not support fibroblast spreading even at 2 and 4 week 
time points (data not shown).  Thus, incorporation of HA uniquely supported a transition 
from a rounded to spread morphology and corresponding proliferative phenotype needed 
in the early stages of regeneration of many tissues.  Several previous studies have 
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examined the effects of addition of native ECM material to synthetic hydrogels.  
Incorporation of collagen within a crosslinked network formed from acrylated Tetronic 
copolymers improved cell adhesion and spreading on the surface of the gels [244]. 
However, encapsulated hepatocytes maintained a rounded morphology [243]. The 
extensive remodeling observed in PEGylated fibrinogen networks [224] may result from 
much higher concentrations of protein and its covalent incorporation into the network.  In 
the present studies, the concentration of ECM components in the semi-IPNs was kept low 
in order to minimize effects on the physical properties of the networks.   
 Incorporation of HA may increase cellular activity through several potential 
mechanisms affecting both the structure of the crosslinked network and cellular 
biochemical processes.  Since fibroblast dimensions are several orders of magnitude 
greater than the typical mesh size of PEG diacrylate networks, the mesh size must 
increase either locally or throughout the material to facilitate cell spreading.  Hydrogel 
porosity can be increased through the incorporation of leachable compounds, and it is 
plausible that HA functions in this manner.  Increased cell density was observed at the 
sample edges after 2 weeks in culture (data not shown).  This may result from localized 
leaching near the sample edges or from incomplete polymerization due to oxygen 
inhibition at the sample edges which were in contact with the ambient atmosphere.  
However, confocal analysis confirmed that cell spreading occurred throughout the 1 mm 
sample thickness. Since diffusional release of macromolecules from crosslinked hydrogel 
networks is dependent on molecular weight and limited release of intermediate size 
proteins such as IgG (150kDa) has been reported [257], it is unlikely that leaching of high 
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molecular weight HA significantly contributed to the increased cell spreading observed 
throughout the bulk of the semi-IPN materials. 
 Alternatively, HA could affect cellular activity by changing the network 
physical/mechanical properties.  Although significantly increased swelling was observed 
in all HA-containing semi-IPNs, the corresponding change in mesh size is insufficient to 
affect fibroblast spreading.  Similarly, the increases observed in semi-IPN mechanical 
properties were relatively small compared to order of magnitude changes previously 
shown to affect cell spreading and proliferation [258, 259].  Incorporation of HA also did 
not significantly affect hydrolytic degradation rate at early time points.  Another potential 
mechanism is localized increases in mesh size resulting from HA degradation.  HA can 
be degraded by both enzymatic and non enzymatic mechanisms [260].  Many studies 
have reported free radical-mediated depolymerization of HA [261, 262], which could also 
occur as a result of the free radical crosslinking method used in these studies.  Enzymatic 
degradation of HA is mediated by the family of HAse enzymes.  Although the precise 
mechanisms of HA degradation are still under investigation, the current model is based 
on extracellular binding of HA by membrane-bound hyal-2, which cleaves high 
molecular weight HA into approximately 20kDa fragments [263, 264].  Following 
internalization by CD44 or receptor for HA mediated motility (RHAMM), HA is further 
degraded into small oligosaccharides by hyal-1 and -2 in the lysosomal compartment at 
acidic pH (3.7 – 4.0) [265]. The contribution of enzymatic HA degradation was 
investigated by culturing fibroblasts in HA-containing semi-IPNs in the presence of two 
HAse inhibitors, neomycin trisulfate hydrate (0.1mM) [251] and L-ascorbic acid 6-
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palmitate (0.1mM) [250].  Substantial reductions in HAse activity at approximately 
50kDa were detected by reverse HA gel zymography developed at lysosomal pH as 
previously described [266].  The absence of HAse activity at pH 7.6 is consistent with the 
reported optimal activity of hyal-1 and -2 at lysosomal pH, however, hyal-2 activity at 
physiological pH has been reported using highly sensitive fluorescent substrates [267].  
HAse inhibition was accompanied by the complete elimination of fibroblast spreading, 
demonstrating that enzymatic degradation of HA is a necessary mechanism of fibroblast 
spreading in HA-containing semi-IPNs.   
 Exposure to high molecular weight HA and its degradation products may also 
have multiple effects on cellular biochemical activity that vary as a function of HA 
molecular weight, concentration and cell phenotype [268].  HA binding through the cell 
surface receptors CD44, RHAMM, and ICAM-1 plays a vital role in the regulation of 
morphogenesis, wound healing, metastasis, and inflammation [265, 269, 270].  However, 
PEG/HA semi-IPNs without RGD peptides did not support fibroblast spreading (data not 
shown), indicating that HA binding contributes little to cell spreading and additional, 
exogenous adhesive ligands are required.  An HA-rich pericellular sheath is vital for 
vascular smooth muscle cell proliferation and migration [271].  At high concentrations, 
high molecular weight HA has been shown to inhibit cell proliferation [268], while low 
concentrations of oligomeric HA stimulate proliferation [260].  HA also has been shown 
to stimulate the migration of epithelial cells and cardiac fibroblasts [272, 273], while 
inhibiting endothelial migration [274].  Based on these studies, high molecular weight 
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and degraded HA may also affect fibroblast proliferation and spreading, however, these 
effects are secondary to the facilitation of enzymatic degradation.  
  
4.5 Conclusion 
In conclusion, these studies demonstrate that incorporation of HA to form semi-
IPNs with synthetic, hydrolytically degradable PEG diacrylate macromers improves 
fibroblast spreading and proliferation, and that cell-mediated, enzymatic HA degradation 
is the critical underlying mechanism.  Addition of low levels of HA achieves substantial 
changes in cellular activity, while causing only relatively small changes in the network 
physical properties.  This approach to accelerating the early stages of cellular remodeling 
may be useful for a variety of hydrogel-based tissue engineering approaches for vocal 
fold, vascular, and soft tissue applications.  In addition, the angiogenic activity of low 
molecular weight HA degradation products released from the gels may also enhance their 
in vivo efficacy relative to conventional hydrogels [275].  
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CHAPTER 5 
MECHANO-MIMETIC HYDROGELS FOR VOCAL FOLD LAMINA PROPRIA 
REGENERATION 
 
5.1 Introduction 
Voice is produced through the conversion of aerodynamic energy from exhalation 
to acoustic energy for sound production by the vibrating vocal folds and the upper 
respiratory tract. Voice is a primary “tool of trade” for teachers and sales personnel who 
comprise 4.2 and 13% of the US workforce [16]. Dysphonia (voice and speech 
impairment) characterized by increased effort to sustain phonation, decreased vocal 
quality, and total voice loss affects approximately 23% of the voice-dependent US 
workforce [14]; and may jeopardize job security, employment opportunities, and social 
interaction [225, 226].  
The quality of voice depends on the biomechanical properties of the vocal fold 
tissue which derive from its ECM organization and composition [6]. The human vocal 
folds are multi-layered tissues comprised of a matrix rich lamina propria anchored to the 
vocalis muscle, and covered by a squamous epithelium. The fibroblast is the primary 
ECM producing cell type in the vocal fold tissue and is responsible for maintaining tissue 
homeostasis and regulating injury response [2]. The squamous epithelium and the 
superficial lamina propria together form the vocal mucosa which is abundant in 
hyaluronic acid, and proteoglycans like fibromodulin, decorin and versican which 
regulate the water content of the tissue and impart viscous shear properties to it [3, 4]. 
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The vocal mucosa vibrates at frequencies between 100 – 1000Hz, and amplitudes of 
~1mm [5].  In terms of mechanical properties the human vocal mucosa is characterized as 
a viscoelastic solid [276].  The intermediate and deep layers of the lamina propria 
together form the vocal ligament. The vocal ligament ECM is comprised mainly of 
elastin fibers which impart flexibility to the tissue, and collagen fibers which impart 
resistance to tensile stresses [6, 7].  The human vocal ligament shows non-linear stress-
strain properties, characterized by 20 – 40kPa elastic modulus in the low strain linear 
region (0 – 15% strain), and values increasing to 600kPa in the high strain region (40% 
strain) [63].  It has been previously reported that the human vocal ligament can withstand 
a maximum of 60% strain [63, 277].  However, the human vocal ligament operates at low 
strain levels (0 – 15%) during normal phonation [8].   
Vocal fold damage can be brought about by a multitude of factors like chronic 
misuse of voice, surgical intubation, and surgical treatment of infectious laryngeal 
diseases, laryngeal cancer, and benign pathologies like vocal folds polyps, nodules and 
edema [13, 14].  Traumatic or surgical injury of the lamina propria elicits a wound 
healing response that is characterized by the replacement of native parenchymal matrix 
with fibrous scar tissue.  This change in the ECM composition leads to alterations in the 
tissue biomechanics which subsequently leads to dysphonia.  
Voice therapy combined with the administration of steroids is the first line of 
therapy when presented with vocal fold defects and scars [13, 278]. However, voice 
therapy is ineffective when presented with scars in combination with pathologies like 
vocal polyps, nodules and edema despite rigorous adherence to the prescribed habits [19]. 
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Synthetic, non degradable materials like pHEMA hydrogels [23], Teflon [20-22], ePTFE 
[24, 25], calcium hydroxyapatite [26], dacron [27], polydimethylsiloxane [28, 31] have 
been injected into the vocalis muscle in an attempt to overcome scarring-induced glottic 
incompetence through vocal fold medialization.  However, physiological limitations such 
as migration from the site of implantation, foreign body granuloma formation, and 
fibrous encapsulation posed by these materials, and the theoretical advantages of natural, 
degradable biomaterials injected into the lamina propria have led to the use of materials 
like collagen, fat, fascia and HA for vocal fold augmentation purposes. In human 
subjects, though evaluations after six months of collagen injections indicated 
improvements in vibrational amplitude of the mucosal wave and amelioration of glottic 
incompetence, no perceptual improvement (acoustic analyses) was recorded [32]. 
Autologous fat [33, 35, 36] and fascia [37] injections yielded positive results short term 
but reports of these studies are inconsistent in terms of evaluations of glottic closure, 
amplitude of the mucosal wave and the effect on the stiffness of scar tissue. Injectable 
crosslinked HA gels (Hylan B gels) have been shown to improve mucosal wave 
amplitudes and glottic closure for approximately 12 months [38-40].  Material resorption 
and need for re-injection were the disadvantages associated with the use of natural 
materials like collagen, fat, fascia, and HA [41].  Current regeneration strategies have 
investigated the use of crosslinked composites of polyethylene glycol diacrylate 
(PEGDA)/derivatized HA [42, 43], composite collagen hydrogels [44], and HA-based 
microgels [279] as scaffolds for cell transplantation and matrix formation, as well as the 
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administration of hepatocyte growth factor (HGF) [46-48] and basic fibroblast growth 
factor (bFGF) [49] to reduce scarring during natural healing.  
Previous studies by Titze et al. [11] highlighted the importance of the vibratory 
epigenetic stimulus in the vocal fold tissue. In vitro bioreactor experiments demonstrated 
that fibroblasts cultured in 3D, macroporous, elastomeric scaffolds under vibratory 
conditions exhibited significant differences in ECM-related gene expression relative to 
static controls, including increases in HA synthase 2 and proteoglycan genes consistent 
with the biochemical composition of the human vocal mucosa.  Our overall hypothesis is 
that rapid restoration of the vibratory microenvironment will minimize scarring and 
facilitate tissue-specific matrix production, ultimately leading to restoration of normal 
phonation. Towards this end, the objective of this study was to create hydrogel 
formulations matching the viscous and elastic mechanical properties of the vocal mucosa 
and vocal ligament, respectively.  These hydrogels will serve as:- (1) a model for 
studying the effects of ECM and biomechanics on fibroblast biology (2) potential 
injectable scaffolds for lamina propria regeneration. 
 
5.2 Materials & Methods 
5.2.1 Materials 
 Polyethylene glycol (PEG, MW=3934) was purchased from Fluka (Seelze, 
Germany) and 2-chloropropionyl chloride, 4-chlorobutyryl chloride, triethylamine, 
dichloromethane (HPLC grade), anhydrous sodium sulfate, and sodium acrylate were 
obtained from Aldrich (St. Louis, MO, USA). Dimethyl formamide (extra dry) and ethyl 
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ether were purchased from Acros (Morris Plains, NJ) and Fisher Chemical (Fair Lawn, 
NJ), respectively. 2-hydroxy-1-(4-(hydroxyethoxy) phenyl)-2-methyl-1-propanone (I-
2959) was obtained from Ciba Specialty Chemicals (Basel, Switzerland).  A 10% (w/v) 
stock solution of I-2959 was prepared in 70% ethanol. Adult normal human dermal 
fibroblasts (NHDF, CC-2511) obtained from a 39 year old Black woman were purchased 
from Biowhitaker (Rockland, ME, USA). DMEM F-12 50/50,1X with L-glutamine, 
15mM HEPES/trypsin EDTA (0.05% trypsin/0.53mM EDTA in HBSS), and 
penicillin/streptomycin were obtained from Mediatech (Herdon, VA, USA).  Bovine 
growth serum was purchased from Hyclone (Logan, UT, USA).  Hyaluronic acid (HA, 
MW=1.4 x 10
6
) was purchased from Genzyme (Cambridge, MA, USA). 
 
5.2.2 Synthesis of PEG-bis-(2-acryloyloxy propanoate) (PEG-bis-AP) and PEG-bis-
(2-acryloyloxy butyrate) (PEG-bis-AB) macromers 
 PEG-diacrylate macromers (PEG-bis-AP, Fiure 5.1A and PEG-bis-AB, Figure 
5.1B) containing ester bonds with varying susceptibility to hydrolytic degradation were 
synthesized by a two-step reaction as previously described [245].  In the first step, an 
intermediate product was synthesized by activating the PEG hydroxyl groups with di-
functional chemical intermediaries (2-chloropropionyl chloride or 4-chlorobutyryl 
chloride) to form ester linkages with variable alkyl spacers. PEG-bis-AB, and PEG-bis-
AP were synthesized by adding terminal acrylate groups to the intermediate products by 
nucleophilic substitution between the terminal alkyl chloride groups and sodium acrylate.  
Final acrylation efficiencies of ~87 and ~94% for PEG-bis-AP and PEG-bis-AB, 
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respectively, were calculated from 
1
H-NMR (Bruker 300 MHz, CDCl3) spectra based on 
the ratio of peak integrals derived from acrylate and PEG backbone protons.   
 
 
Figure 5.1 Chemical structures of PEG-bis-AP (A) and PEG-bis-AB (B) 
 
5.2.3 Synthesis of methacrylated HA (GMHA) 
GMHA (Figure 5.2) was synthesized by reacting sodium hyaluronate solubilized 
in double distilled water with a 20-fold molar excess of glycidyl methacrylate in the 
presence of triethylamine and tetrabutylammonium bromide as previously described 
[280].  The GMHA was precipitated in acetone, and dialyzed against double distilled 
water for 48 hrs.  An ~7% degree of methacrylation was calculated from the 
1
H-NMR 
(D2O) spectra (Figure 5.3) based on the ratio of peak integrals derived from the 
methacrylate and HA carbohydrate protons, as previously described [281]. 
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Figure 5.2 Chemical reaction scheme for GMHA macromers 
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Figure 5.3 Structure and 
1
H-NMR spectra of GMHA macromer 
 
5.2.4 Cell culture 
NHDF were routinely cultured in 182 cm² T-flasks using DMEM F-12 50/50,1X 
with L-glutamine and 15mM HEPES enriched with 10% v/v bovine growth serum and 
50U/ml penicillin and 50µg/ml streptomycin.  Culture medium was changed once every 
two days and cells were passaged weekly.  All experiments were performed with cells 
from the 4
th – 6th passages. For hydrogel encapsulation, monolayers of fibroblasts (ca. 
95% confluence) were trypsinized, centrifuged, resuspended, counted in a 
hemacytometer, and adjusted to a final concentration of 1.6 x 10
7
cells/ml. 
 
b a 
c 
a 
b 
c 
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5.2.5 Hydrogel/Semi-IPN photopolymerization 
Varying concentrations of PEG-bis-AP, PEG-bis-AB, PEG-bis-AB/AP (50:50 
blend), and GMHA macromer solutions were prepared in 1X-PBS (0.1M, pH 7.4) and 
sterile filtered.  During PEG-based semi-IPN synthesis, 0.12%w/v native unmodified HA 
was added to the PEG-bis-AP/AB macromer solution as explained previously [282].  A 
fibronectin-derived cell adhesion peptide, (GRGDS, Bachem, PA, USA) was conjugated 
to acrylate-PEG-NHS (MW=3400, Nektar) as previously described [216].  GRGDS-
PEG-acrylate was prepared as a stock solution in 1X PBS (10µmol/ml) and sterile 
filtered.  The macromer solutions with 0.1% w/v I-2959 initiator were photopolymerized 
between glass microscope slides separated by a 1 mm Teflon spacer by exposure to low 
intensity UV illumination (365nm, 10mW/cm
2
, Black-Ray B100-AP, Upland, CA) for 
7½ minutes (PEGDA hydrogels) and 6½ minutes (GMHA hydrogels) per side .  For cell 
encapsulation studies, acrylate-PEG-GRGDS and NHDF were included at final 
concentrations of 2.5µmol/ml and 4 x 10
6
cells/ml, respectively. 
 
5.2.6 Mechanical characterization of photocrosslinked hydrogels 
5.2.6.1 Elastic Modulus 
Mechanical characterization of the PEG-based hydrogels was performed using 
hydrogels synthesized from the PEG-bis-AB macromer.  PEG-bis-AB hydrogels (6, 8, 
and 10% w/v) were photopolymerized and cut into dumbbell shaped samples (gauge 
length 30mm, gauge width 5mm, and thickness 1mm).  The samples were equilibrated in 
1X-PBS overnight before testing.  The samples (n = 4/group) were subjected to uniaxial 
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tensile testing using two different strain rates : (a) single cycle, 15% strain at 5mm/min 
and (b) multiple cycle (20 cycles), 15% strain at 1Hz using a 10N load cell in the MTS 
Synergie 100 (MTS Systems Corporation) at room temperature.  Also, the 6% w/v PEG-
bis-AB hydrogels were tested to failure at the 5mm/min strain rate.  The sample ends 
were covered with small pieces of KimWipe to improve clamping stability, and each 
sample was tested twice to prevent errors due to sample slippage.  Stress-strain curves 
were plotted, and elastic modulus was calculated as the slope of the of the curve stress-
strain curve (0 – 15% strain).  The PEG-bis-AB hydrogels were tested at room 
temperature since testing at 37°C would require the samples to be immersed in a buffer 
solution maintained at 37°C.  In our experimental setup, during tensile testing the 
hydrogel samples were held in position using a Kim Wipe at both clamp ends to facilitate 
effective gripping (prevent slippage).  Immersion of the test samples in any kind of liquid 
medium will result in significant inability to clamp the sample in place during the test.  
Hence the tensile tests were carried out at room temperature and not at 37°C.  We believe 
that ~10°C increase in testing temperature will not have a significant effect on the elastic 
modulus of the material.   
 
5.2.6.2 Dynamic viscosity & Elastic shear modulus 
GMHA hydrogel samples were exposed to small amplitude oscillations over 
frequency sweeps from 0.01 to 15 Hz in conditions similar to those used to investigate 
the rheological properties of the human vocal mucosa [12]. Rheological characteristics as 
a function of polymer concentration (0.5, 1, 1.5, 2, 2.5 & 3% w/v) were investigated in a 
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stress controlled “ARES” Rheometer using parallel plate geometry.  The hydrogel 
samples were placed in the gap (0.8mm) between the stationary upper plate and the 
rotating lower plate (diameter = 8mm), and the temperature was maintained at 37 ± 0.1ºC 
by a „Peltier‟ water cooling system.  In order to determine the region of linearity, strain 
sweep tests were performed at fixed oscillation frequency (1Hz). Rheological tests were 
performed in the linear strain region (strain amplitude – 0.01rad), over a frequency range 
of 0.01 – 15Hz, covering 25 frequencies over 3 decades. The dynamic viscosities of the 
varying % w/v GMHA hydrogels were calculated by dividing the observed values of the 
loss moduli by the corresponding angular frequencies tested.  The elastic shear moduli of 
the varying % w/v GMHA hydrogels were also recorded and plotted at all frequencies 
tested.   
 
5.2.7 Degradation studies 
PEG-bis-AP, PEG-bis-AB/AP50:50, and PEG-bis-AB hydrogels (6% w/v) were 
photopolymerized, equilibrated with water for 24 hours to remove any unpolymerized 
macromer, lyophilized, and weighed (Wd0). Samples were incubated with 4ml of 1X-
PBS containing 0.01% sodium azide (Sigma) in scintillation vials under shaking at 37ºC.  
Buffer was changed once every two days. At weekly intervals, samples (n = 3/group/time 
point) were collected, washed with distilled water three times, lyophilized, and weighed 
(Wdt).  Percent mass loss was calculated as ((Wd0 – Wdt)/Wd0) x 100.  Mass loss 
(degradation) studies were not separately conducted for the GMHA hydrogels since the 
rate of degradation of these hydrogels depends on the amount of HAse produced by the 
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encapsulated cells.  Also, the degradation of GMHA hydrogels in the presence of HAse 
has been previously reported by Leach et al [280].  
 
5.2.8 Encapsulated fibroblast viability, morphology, and proliferation 
NHDF were encapsulated in 6% w/v PEG-bis-AB/AP50:50 semi-IPNs containing 
0.12% w/v HA [282] and 2% w/v GMHA hydrogels (n = 3 samples/experimental group).  
Samples were cultured in 12 well plates for 1-28 days.   
 
5.2.8.1 Viability assessment 
After 7 days in culture, hydrogel samples were stained with 1µM fluorescein 
diacetate (FDA, Molecular Probes, Eugene, OR) and 2.5µM propidium iodide (PI, 
Molecular Probes), rinsed with PBS, visualized and imaged by fluorescence microscopy 
(Zeiss Axiovert 200).  
 
5.2.8.2 Confocal analysis of morphology 
After 14 days in culture, samples from each group were fixed in 4% 
paraformaldehyde in PBS, permeabilized with 0.1% Triton X-100, and stained with 
Alexa 594-phalloidin (Molecular Probes).  Samples were visualized and imaged using a 
Zeiss Confocal LSM510 microscope.   
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5.2.8.3 Fibroblast proliferation 
Hydrogel/Semi-IPN samples from each group were collected at days 1, 7, 14 and 
28, rinsed twice with sterile PBS, snap-frozen in an ethanol-dry ice bath, and stored at -
80ºC.  DNA solubilization and quantitation were based on modifications of previously 
described methods [247]. Briefly, the samples were subjected to 3 freeze-thaw cycles in 
1.4ml of 10mM EDTA, pH 12.3. Once the hydrogels were completely dissolved, the pH 
was neutralized by the addition of 100µl 1M potassium phosphate (monobasic) solution. 
Total DNA content was measured using the Picogreen DNA-binding dye (Molecular 
Probes) and a fluorescence microplate reader (Tecan GENios, excitation: 485nm, 
emission: 535nm).  DNA content was converted to cell number based on a DNA standard 
curve prepared from serial dilutions of NHDF.   
  
5.2.9 Encapsulated fibroblast ECM production 
5.2.9.1 Sample preparation 
NHDF were encapsulated in 6% w/v PEG-bis-AB/AP50:50 based semi-IPNs 
containing 0.12% w/v HA and 2% w/v GMHA hydrogels (n=6 samples/hydrogel type).  
Samples were cultured for 14 and 28 days (n=3 per time point), rinsed with sterile PBS, 
and fixed in 4% w/v paraformaldehyde.  The fixed hydrogel samples were infiltrated, 
embedded and sectioned partly as explained elsewhere [283].  Briefly, the hydrogel 
samples were cryoprotected by rinsing with 5% sucrose in PBS for an hour followed by 
infiltration with increasing concentrations of sucrose in PBS (mixing 5% and 20% 
sucrose in PBS in the ratios 2:1, 1:1 and 1:2) for 3 hrs each.  The cryoprotected samples 
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were then infiltrated with an ascending series of mixtures of sucrose in PBS and OCT 
(2:1, 1:1 and 1:2 ratios) for 6 hrs each at room temperature under constant vacuum. This 
step was followed by embedding in the OCT mold using 100% OCT solution. 8µm thick 
cryosections were cut and transferred to microscope slides for immunohistochemistry and 
toluidine blue O staining.  
 
5.2.9.2 Immunohistochemistry 
The cryosections were fixed in chilled acetone, incubated for an hour at room 
temperature with rabbit, α-human collagen type 1 IgG primary antibody (Chemicon, 
dilution 1:400), rinsed, and incubated 1 hour with secondary antibody (goat, anti-rabbit 
IgG, Alexa Fluor 488, dilution 1:220).  Samples were coverslipped using Vectashield 
(Vector laboratories, Burlingame, CA) mounting medium containing DAPI for 
counterstaining cell nuclei.  
 
5.2.9.3 Toluidine Blue O staining 
Sulfated GAGs (s-GAGs) were stained by incubating the cryosections in an 
aqueous Toluidine Blue O solution (0.0714% toluidine blue O, 0.0714% pyronin Y, and 
0.143% borax) for 6 minutes as previously described [44]. 
The slides were digitally imaged and analyzed using a Zeiss Axiovert 200 
microscope. 
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5.2.10 Statistical analysis 
All comparisons were made between binary data sets using two-tailed, unpaired t-tests 
and “p” values less than 0.05 were considered statistically significant. 
 
5.3 Results 
5.3.1 Mechanical Characterization of photocrosslinked hydrogels 
Hydrogels/Semi-IPNs described here were aimed at restoring mechanical integrity 
and function for the vocal fold lamina propria.  Due to the distinct biomechanical 
properties of the vocal mucosa and the vocal ligament, a two component system 
comprised of methacrylated HA (viscous, vocal mucosa) and PEG-diacrylate (elastic, 
vocal ligament) was developed.  Variation of polymer concentration was investigated to 
identify formulations approximating the native tissue biomechanics. 
 
5.3.1.1 Tensile testing 
Uniaxial tensile tests showed that PEG-bis-AB hydrogel elastic modulus 
significantly increased with increasing macromer concentration (Figure 5.4).  PEG-bis-
AB hydrogels prepared at 6% w/v concentration were found to exhibit elastic modulus 
approximating the mean value (33.1 ± 10.4kPa ) reported for native human vocal 
ligaments at low strains (0 – 15%) [63].   
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Figure 5.4 Elastic modulus of the human vocal ligament [63] and varying concentrations 
of the PEG bis-AB hydrogels. * indicates statistically significant differences relative to 
the human vocal ligament. 
 
Figure 5.5 shows the typical stress–strain hysteresis cycles for tensile loading – 
unloading deformation of 6% w/v PEG-bis-AB hydrogels, tested to 15% strain at 1Hz.  
The linear stress-strain curve of the PEG-based hydrogels is consistent with previously 
reported stress-strain curves at low strain levels (0 – 15%) of the vocal fold ligament 
specimens tested [63, 103, 277, 284] and other biological soft tissues [285].  At higher 
strain levels the human vocal ligament indicated a non linear stress-strain response [63, 
103, 277, 284].  Preconditioning is observed for excised biological tissues, with the 
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stress-strain hysteresis cycles shifting downward from the 1
st
 cycle and stabilizing at the 
15
th – 20th cycle due to stress relaxation [63, 277] and re-alignment of elastic and collagen 
fibers following excision.  However, preconditioning is not pronounced in the PEG-based 
synthetic hydrogels tested since stabilization of the loading-unloading curves occurs 
between the 1
st
 and the 2
nd
 cycles.  The sharp reduction in stress levels at peak strain 
(15% strain) during the unloading curve of 1
st
 cycle may be attributed to severing of 
weak crosslinks within the hydrogel mesh after which the material stabilized and 
exhibited repeatable loading-unloading curves between the 2
nd
 and the 20
th
 cycles.  
Linear curves with hysteresis, due to viscous energy loss were observed for all the 
samples tested.  Similar viscoelastic behavior was observed for all the 6% w/v PEG-bis-
AB hydrogels tested.    
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Figure 5.5 Typical loading – unloading cycles of the 6% w/v PEG-bis-AB hydrogels 
under tensile strain (strain rate = 1 Hz). The phenomenon of hysteresis is demonstrated, 
for the 2
nd
 cycle and the 20
th
 cycle tested.  
 
The 6% w/v PEG-bis-AB hydrogels tested at 5 mm/min exhibited linear stress-
strain characteristics until failure (46 ± 2% strain) as shown in figure 5.6.   
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Figure 5.6 Typical stress-strain curve for 6% w/v PEG-bis-AB hydrogels strained until 
failure. 
 
5.3.1.2 Rheological testing 
Dynamic viscosities calculated over the range of the tested frequency sweep (0.01 
– 15Hz) indicated that the 0.5 – 3% w/v concentrations of GMHA hydrogels 
demonstrated a shear thinning response similar to many soft tissues (Figure 5.7).  Our 
results indicated that as the macromer concentration increased the magnitude of dynamic 
viscosity increased over the entire frequency range tested.  GMHA gels prepared at 
concentrations ranging from 1.5 – 2.5 % w/v exhibited dynamic viscosities consistent 
with the range of properties reported for native human vocal mucosa.   
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Figure 5.7 Dynamic viscosities of varying concentrations of GMHA hydrogels. 
 
However, the 1.5 – 2.5% w/v GMHA hydrogels exhibited elastic shear modulus 
higher than that reported for the native human vocal mucosa (Figure 5.8).   
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Figure 5.8 Elastic shear moduli of varying concentrations of GMHA hydrogels. 
 
The dynamic viscosity of native HA, GMHA macromer, and crosslinked GMHA 
hydrogels was also tested at fixed 2% concentration.  Uncrosslinked GMHA macromers 
exhibited an approximately order of magnitude decrease in dynamic viscosity relative to 
the native HA, while crosslinking substantially increased dynamic viscosity relative to 
both native HA and uncrosslinked GMHA (Figure 5.9).  
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Figure 5.9 Dynamic viscosities of 2% w/v unmodified HA solution, GMHA solution and 
GMHA hydrogels. 
 
5.3.2 Degradation studies  
While the GMHA hydrogels are susceptible to enzymatic degradation, the PEG-
diacrylate macromers were synthesized to contain ester bonds with varying susceptibility 
to hydrolytic degradation.  The mass loss of three different photocrosslinked hydrogel 
formulations (PEG-bis-AP, PEG-bis-AB/AP50:50, and PEG-bis-AB) at 6% w/v 
concentration was examined on a weekly basis.  The 6% w/v PEG-bis-AP, PEG-bis-
AB/AP50:50, and PEG-bis-AB hydrogels degraded completely within 7, 11, and 18 weeks 
respectively (Figure 5.10).   
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Figure 5.10 Mass loss of 6 % w/v PEG-bis-AP, PEG-bis-AP/AB50:50 blend and PEG-bis-
AB hydrogels. 
 
5.3.3 Fibroblast viability and proliferation in PEG-bis-AB/AP50:50 based semi-IPNs 
and GMHA hydrogels 
 NDHF were encapsulated within 2% w/v GMHA hydrogels, and 6% w/v PEG-
bis-AB/AP50:50 blend semi-IPNs (containing 0.12% w/v HA) containing immobilized 
RGD cell adhesion peptides by photopolymerization.  Fibroblasts encapsulated in the 6% 
w/v PEG-bis-AB/AP50:50 semi-IPNs exhibited spreading and the development of 
polarized morphology with multiple thin processes as shown in figure 5.11A. Fibroblasts 
encapsulated within the 2% w/v GMHA hydrogels exhibited spreading and a stellate 
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morphology as shown in figure 5.11B. High levels of viability were observed in all 
samples.  Confocal microscopy was performed to ensure that fibroblast spreading was 
occurring within the three-dimensional bulk of the materials as opposed to at the surface.  
Fibroblasts exhibited a spread, polarized morphology throughout the volume of the PEG-
bis-AP/AB50:50 blend semi-IPNs indicated by figure 5.11C which is a representative 
confocal image section taken at 200 µm within the semi-IPN.  Cell spreading and cell-
cell aggregation was detected throughout the bulk of the GMHA hydrogel as shown in 
figure 5.11D.  
In order to determine whether the observed changes in fibroblast morphology 
corresponded with changes in cellular bioactivity, fibroblast proliferation was determined 
based on measurements of DNA content at 1, 7, 14, and 28 days.  No significant 
difference was observed in the number of encapsulated fibroblasts at the day 1 time point 
among the PEG-bis-AB/AP50:50 semi-IPNs (0.12% w/v HA) and GMHA hydrogels as 
shown in figure 5.12.  After 7, 14, and 28 days in culture, a significantly increased 
number of fibroblasts was observed in both PEG-based and GMHA gels relative to day 1.  
However, both the hydrogel types exhibited a significant decrease in cell number at day 
28 relative to day 14.  
 
 145 
 
Figure 5.11 Viability and morphology of fibroblasts encapsulated in 6% w/v PEG-bis–
AB/AP 50:50 blend semi-IPNs containing 0.12 % w/v HA (A) and 2% w/v GMHA 
hydrogels (B) visualized by staining with fluorescein diacetate/propidium iodide after 7 
days in culture.  Confocal analysis (200µm depth) of fibroblast morphology and 
spreading within 6 % w/v PEG-bis-AB/AP 50:50 blend semi-IPNs containing 0.12% w/v 
HA (C) and 2% w/v GMHA hydrogels after 14 days in culture (D).  All scale bars 
represent 200µm. 
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Figure 5.12 Fibroblast proliferation within 6% w/v PEG-bis-AB/AP 50:50 blend semi-
IPNs containing 0.12% w/v HA (A) and 2% w/v GMHA hydrogels (B). * indicates 
statistically significant differences relative to the corresponding cell number at day1. # 
indicates statistically significant differences in cell numbers between days 14 and 28. 
 
5.3.4 ECM synthesis 
Encapsulated fibroblast synthesis of collagen (Figure 5.13) and s-GAGs (Figure 
5.14) in PEG-based semi-IPNs (A,B) and GMHA hydrogels (C,D) was histologically 
examined at 14 (A,C) and 28 days (B,D) in culture.  The ECM deposition in the PEG 
based semi-IPNs and the GMHA hydrogels was observed to be pericellular in nature.  
However, there was a noticeable difference in the spatial organization of both  
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Figure 5.13 Immunohistochemical staining of collagen (green) and cellular nuclei (blue) 
in 6% w/v PEG-bis-AB/AP 50:50 blend semi-IPNs (A,B) and 2% w/v GMHA hydrogels 
(C,D) after 14 (A,C) and 28 (B,D)  days in culture.  All scale bars represent 100µm. 
 
collagen and s-GAG deposition by the encapsulated fibroblasts with respect to the 
different materials. In the PEG based semi-IPNs, the newly synthesized matrix was 
relatively homogeneously dispersed, whereas in the GMHA hydrogel matrix its spatial 
distribution was highly variable with regions of low and high density.  The fibroblasts 
encapsulated in the GMHA hydrogels exhibited increasing aggregation at later time 
points (day 28).  As a result the matrix produced by these cells appears to be concentrated 
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at various locations in the hydrogel bulk associated with dense clusters of aggregated 
cells as shown by the nuclear counterstaining in Figure 5.13D.   
 
 
Figure 5.14 Histological staining of s-GAGs (dark purple) in 6% w/v PEG-bis-AB/AP 
50:50 blend semi-IPNs (A,B) and 2% w/v GMHA hydrogels (C,D) after 14 (A,C) and 28 
(B,D) days in culture.  All scale bars represent 100µm. 
 
5.4 Discussion 
Vocal fold injury initiates a wound healing response resulting in alterations in 
ECM composition and tissue biomechanics.  The functional outcome of vocal fold 
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scarring is dysphonia due to increased phonation threshold pressure (subglottic pressure 
required to initiate vibration) and reductions in vibrational amplitude of the mucosal 
wave.  Clinical signs include decreased voice intensity, vocal fatigue, breathlessness, and 
increased phonatory effort [18].  Treatment of the scarred vocal folds is one of the most 
challenging voice problems faced by otolaryngologists today [18] since none of the 
current injectables and surgical techniques directly address restoration of the complex 
ECM composition and biomechanical properties. 
At birth, the human vocal fold is a homogeneous structure lacking the complex 
layered organization and variable ECM composition observed in the adult [286, 287].  
Recent analyses of pediatric human vocal folds from subjects ranging from near birth to 
adolescence indicate that the vocal folds undergo extensive postnatal development and 
maturation into the early teens [58, 82].  Consistent with the recognized contributions of 
externally applied mechanical forces in the development and homeostatic maintenance of 
many soft connective tissues, these results suggest that the complex mechanical forces 
imposed during voice development may be an important epigenetic mechanism 
regulating tissue ECM composition and biomechanics.  As a basis for restoring structural 
integrity and phonation-associated mechanical stimulation to the injured vocal folds, we 
investigated the formulation of mechano-mimetic hydrogels approximating the 
mechanical properties of the two major vocal fold components, the vocal mucosa 
(viscous – GMHA) and the vocal ligament (elastic – PEG-diacrylate).  These materials 
were evaluated by rheological and tensile testing methods applied to characterization of 
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the native tissue layers [63, 288], and tested for their ability to support encapsulated cell 
viability, proliferation, and ECM synthesis.  
Due to favorable properties such as non toxicity, non immunogenicity, 
biocompatibility, and elastic mechanical properties following covalent crosslinking, PEG 
was chosen to restore/regenerate the elastic properties of the vocal ligament.  
Photopolymerized PEG-based hydrogels have also been shown to exhibit strong 
adherence to tissue surfaces through mechanical interdigitation and hydrogen bonding 
[216, 289]. Literature review suggests that the greatest stress applied to the vocal fold 
tissues is the longitudinal tensile stress in the vocal ligament. The mean elastic modulus 
of the human vocal ligament reported for the low-strain regions of the biphasic stress-
strain curve was 33.1 ± 10.4kPa [63].  The 6% w/v PEG-bis-AB hydrogels provided an 
elastic modulus of 26.4 ±
 
3.65kPa.  Though the 6% w/v PEG-bis-AB hydrogels provided 
an elastic modulus which approximated that of the human vocal ligament at low strain 
levels (0 – 15%) it did not show a biphasic stress-strain curve which is characteristic of 
the human vocal ligament [63, 277] and other soft tissues [285].  The 6% w/v PEG-bis-
AB hydrogels exhibited a linear stress-strain curve till failure at 46 ± 2% strain.  The 
linear and non linear patterns exhibited at low and high strains correlate to the unique 
collagen ultrastructure of the human vocal ligament [113].  The helical collagen fibers 
function as a buffer at low strains so that elongations of the vocal ligament occur without 
much resistance [113].  At high strains, the unique collagen structure absorbs the stress 
and serves as a shock absorber along the length of the fibers.  The lack of a biphasic 
stress-strain curve may be perceived as a limitation of these PEG-based hydrogels.  
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However, since the vocal fold operates at low strain levels (0 – 15% strain) [8] during 
normal phonation we propose the use of the 6% w/v PEG-based hydrogels during the 
acute phase of wound healing during which the patient may be advised against strenuous 
vocal activity.  It must be noted that only the PEG-bis-AB hydrogels were subjected to 
uniaxial tensile testing whereas the PEG-bis-AP/AB blends were used for cell culture 
studies.  The only difference between the 6% w/v PEG-bis-AP, PEG-bis-AB, and PEG-
bis-AP/AB hydrogels is the rates of degradation.  We have previously reported that a 
slight variation in chemistry that causes significant differences in degradation rates does 
not affect mechanical properties of these PEG-based hydrogels [245].  The relatively 
small mesh size of hydrolytically degradable PEG-based hydrogels initially restricts cell 
spreading which may be detrimental to cell growth and tissue formation.  We have 
previously shown that incorporation of 0.12% w/v HA substantially increases cell 
spreading and proliferation without significantly altering the elastic properties [282].   
The abundance of HA in the vocal mucosa imparts viscous shear properties to the 
vocal fold tissue, and helps produce and sustain vibration over a vast range of frequencies 
(100 – 1000Hz) [7].  HA also plays a vital role in wound healing [269].  In the 
acute/proliferative phase of adult wound healing, fibroblasts migrate into the site of 
injury, and actively synthesize ECM consisting mainly of type I collagen [126].  The 
balance between matrix macromolecules (collagen vs HA) produced during the 
proliferative phase is one critical difference between scar formation (adult wounds) and 
regenerative-type wound healing (early fetal wounds) [128].  HA being a space 
occupying molecule in the ECM, influences collagen fibrillogenesis [127].  Adult dermal 
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wound healing is characterized by scar formation attributed to decreased/degraded HA 
levels by day 10 [129].  Scarless fetal wound healing is attributed to consistent elevated 
levels of HA leading to regenerative repair [128, 130, 269].  It has been reported that HA 
levels in the vocal fold wounds decrease to subnormal levels after day 5 of injury 
resulting in vocal folds scarring [131].  Therefore, our GMHA hydrogel scaffolds may 
help to sustain HA levels throughout the wound healing process, and potentially reduce 
scar formation through regulating collagen fibrillogenesis. On comparing our data with 
literature studies of the viscous shear properties of the human vocal mucosa, we observed 
that the magnitude of dynamic viscosity of the 1.5 – 2.5% GMHA hydrogels at all the 
tested frequencies lies in the same range as that of the human vocal mucosa [103, 195, 
276, 288].  The broad range of the magnitude of dynamic viscosity of the vocal mucosa 
(100 – 1000Pa.s) has been attributed to intersubject differences in sex and age [288].  
However, the elastic shear modulus of the 1.5 – 2.5% GMHA hydrogels at all the tested 
frequencies is slightly higher than the average values reported for the human vocal 
mucosa [276].  This may not be perceived as a limitation of the GMHA hydrogels since 
the elastic shear modulus data reported for the human vocal ligament has a high degree of 
variability.   
Rheological studies indicated an order of magnitude difference among the 
magnitude of dynamic viscosities of the 2% w/v unmodified HA solution, 2% w/v 
GMHA solution, and 2% w/v GMHA hydrogels at all the frequencies tested. This 
suggests a decrease in the molecular weight of the GMHA macromer (in comparison to 
native unmodified HA), likely attributable to degradation during the methacrylation 
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process. The degree of reduction in the molecular weight of the GMHA conjugates was 
not quanitified using other methods since it is beyond the scope of the present study, and 
subsequent covalent crosslinking achieved mechanical properties approximating the 
native vocal mucosa.  Rheological tests were not performed at physiologically relevant 
frequencies (>100 Hz) since at these frequencies the inertial effects of the sample and the 
rheometer‟s plate become significant due to which the stress-strain linearity cannot be 
maintained.  However, it has been previously reported that low frequency data can be 
extrapolated to physiologically relevant frequencies based on constitutive modeling or 
time-temperature superposition [276]. 
Data from our degradation tests as well as previous studies [245] demonstrated 
the ability of PEG-based macromers synthesized with chemical intermediaries containing 
variable length alkyl spacers to form hydrogels with controlled variation in hydrolytic 
degradation rate.  At 6% w/v, the PEG-bis-AP and PEG-bis-AB compositions and their 
50:50 blend provided degradation times ranging from 7 – 18 weeks.  Previous studies 
using naturally-derived matrices have observed 2 – 3 week time-frames for in vivo 
degradation following implantation into animal models of vocal fold injury [42, 43].  As 
the optimal kinetics of scaffold remodeling and degradation has not been fully 
determined, the synthetic component described here for the vocal ligament offers a range 
of possibilities.  The mass loss of GMHA hydrogels was not characterized unlike the 
PEG-based hydrogels since these HA based hydrogels are subject to enzymatic (HAse) 
degradation which depends on the number of cells encapsulated within the hydrogels.  
Any mass loss studies conducted with encapsulated cells would confound results due to 
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the presence of cells and neo-matrix produced by the encapsulated/proliferating cells.  
However, the enzymatic degradation of GMHA hydrogels in the presence of HAse has 
been previously reported by Leach et al [289, 290].  In case of our proposed in vivo 
application the degradation of the GMHA hydrogels solely depends on the amount of 
HAse produced by the transplanted/endogenous cells. 
A significant increase in encapsulated fibroblast number at days 7 and 14 in both 
6% PEG-based semi-IPNs and 2% w/v GMHA hydrogels indicated the cytocompatibility 
of these materials.  The reduction in cell number at day 28 can be attributed to semi-
IPN/hydrogel degradation, which resulted in the release of cells and their adhesion to the 
underlying culture substrate (data not shown).  Histological and immunohistochemical 
analysis demonstrated that both 6% w/v PEG-based semi-IPNs and 2% w/v GMHA 
hydrogels supported the synthesis and accumulation of type I collagen and s-GAGs.  
Since the final application involves the use of the 2% w/v GMHA hydrogel as a scaffold 
for the vocal mucosa that is comprised mainly of proteoglycans/GAGs, the production of 
collagen in these materials may be viewed as a negative observation.  This result suggests 
that tissue-specific mechanical properties may not be sufficient to completely direct 
tissue-specific ECM production by the encapsulated cells.  However, previous work 
showing that externally applied vibration significantly upregulated MMP-1 and HA 
synthase 2, but not type I collagen suggests that vibratory stimulation may be an effective 
tool in combination with these materials to more effectively regulate ECM composition 
[11]. 
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5.5 Conclusion 
These studies demonstrate that appropriate formulations of chemically modified 
PEG and HA can produce hydrogel matrices with mechanical properties consistent with 
the native human vocal mucosa and ligament.  These degradable matrices may be 
crosslinked in the presence of cells and support cell viability, proliferation, and ECM 
synthesis.  Bearing in mind the slight limitations of these materials and the significance 
of mechanical forces associated with phonation, it is expected that physiologically 
relevant mechanical stimulation will further improve scaffold remodeling and tissue-
specific ECM expression.  Future studies will investigate the gene and protein expression 
of fibroblasts encapsulated in 2% w/v GMHA hydrogels, cultured in a vibrational 
bioreactor at physiologically relevant frequency and amplitude. 
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CHAPTER 6 
THE EFFECT OF VIBRATION ON GENE AND MATRIX EXPRESSION OF 
FIBROBLASTS ENCAPSULATED IN HYALURONIC ACID HYDROGELS 
 
6.1 Introduction 
Voice is critical to the quality of life and is the primary “tool of trade” for 25% of 
the US work force (teachers, singers, sales personnel etc) [1].  Phonation (voice 
production) is a co-ordinated biological process involving the vocal folds, lungs, brain, 
peripheral nervous system, and muscles of the respiratory tract synergistically 
transducing aerodynamic energy from exhalation to acoustic energy.  The vocal folds are 
the dynamic mechanical element of the phonatory system and possess a spatially 
organized ECM composition that is fundamental to the tissue biomechanics and in turn 
the quality of voice [2].  The human vocal folds are multi-layered, consisting of a 
squamous epithelium, lamina propria composed of fibroblasts and ECM, and the 
thyroaretenoid muscle.  The squamous epithelium and the superficial lamina propria 
together form the vocal mucosa.  The vocal mucosa is abundant in HA, small 
proteoglycans like fibromodulin and decorin, and large proteoglycans like versican that 
regulate the water content of the tissue and impart viscous shear properties to it [2-4, 92].  
The intermediate and deep layers of the lamina propria together form the vocal ligament. 
The intermediate layer is abundant in elastin fibers which impart flexibility and 
distensibility to the vocal fold tissues during repeated deformation from phonation [2, 3, 
92, 110].  The deep layer is abundant in collagen fibers which are relatively inextensible, 
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resist and transmit tensile stresses and are responsible for the maximum dimensions of 
the vocal fold tissues [2, 92, 119].  The vocal mucosa is the vibratory element of the 
structurally/functionally differentiated vocal fold tissue that sustains high frequency 
vibration during phonation.  The human vocal fold mucosa vibrates at frequencies of 100 
– 1000Hz, at amplitudes of ~1mm during phonation [5].  Vocalization times can vary 
between 1 to 2hrs per day for heavy voice users like classroom teachers and opera singers 
[9-12].     
The most commonly/severely afflicted site in terms of vocal pathologies is the 
vocal mucosa.  Injuries to the vocal mucosa brought about by chronic vocal tissue 
overuse, laryngeal cancer, chemical or thermal injury, non phonatory mechanical trauma, 
and attempted repair lead to a wound healing response which is characterized by 
conversion of the GAG-based tissue to fibrous scar tissue [13-15, 123].  Structural 
changes due to changes in ECM composition of the vocal mucosa lead to altered 
vibratory biomechanics which ultimately causes dysphonia.  Dysphonia characterized by 
increased effort to sustain phonation, decreased vocal quality, and total voice loss affects 
approximately 23% of the voice-dependent US workforce [16]; and may jeopardize job 
security, employment opportunities, and social interaction [225, 226].  It is estimated that 
approximately 9% of the population suffers from voice related problems at any given 
point in time [15].  Scarring induced dysphonias are currently treated by voice therapy 
and surgical augmentation procedures.  Current treatment techniques, although effective 
in improving short term voice quality, have been unable to achieve complete restoration 
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of normal voice due to their inability to bring about regeneration of the native vocal fold 
tissue architecture/ECM composition.   
The ECM composition and biomechanical properties of many human tissues are 
regulated by their mechanical environment during both developmental morphogenesis 
and adult homeostasis [50, 51].  Using 3D culture systems and bioreactors, application of 
physiologically relevant mechanical stimulation has been shown to elicit tissue-specific 
ECM expression and increases in corresponding mechanical properties relative to static 
controls.  Examples include application of cyclic strain to smooth muscle cells [291] and 
fibroblasts [292], and dynamic compression/hydrostatic pressure to chondrocytes [293, 
294]] and annulus fibrosus cells [295, 296].  While the effects of cyclic 
strain/compression have been widely investigated, the response of cells to vibratory 
stimulation has been relatively less explored.  Tanaka and co-workers reported increased 
expression of osteocalcin and MMP-9 by osteoblasts cultured in collagen gels subjected 
to various vibratory regimes relative to static controls [55].  Titze and co-workers [11] 
observed significant increases in mRNA expression of proteoglycan/GAG genes in 
tracheal fibroblasts cultured under vibratory stimulation within 3D, porous, elastomeric 
tecoflex substrates.   
Our long-term hypothesis is that rapid restoration of the vibratory 
microenvironment using mechano-mimetic scaffolds will facilitate vocal mucosa-specific 
ECM deposition by the resident/infiltrating cells, ultimately leading to improved 
functional outcomes by reducing fibrotic scarring during the acute stage of wound 
healing.  Towards this end, we have previously reported the preparation of injectable 
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GMHA hydrogels with rheological properties approximating those of the native human 
vocal mucosa [297].  However, fibroblasts encapsulated within GMHA hydrogels 
synthesized an ECM rich in both collagen and s-GAGs under static conditions.  The 
objective of this study was to investigate the ability of physiologically relevant high 
frequency vibration to stimulate vocal mucosa-like gene expression and ECM 
accumulation by human fibroblasts encapsulated in mechano-mimetic GMHA hydrogels.   
 
6.2 Materials & Methods 
6.2.1 Materials 
 Sodium hyaluronate (MW = 1.4x10
6
) was purchased from Genzyme (Cambridge, 
MA).  Polyethylene glycol diacrylate (PEGDA) (MW=258) and tetrabutylammonium 
bromide, triethylamine, and glycidyl methacrylate were obtained from Aldrich (St. Louis, 
MO, USA).  Dichloromethane (HPLC grade) was obtained from Acros organics (NJ, 
USA).  Acetone was purchased from Fisher Chemical (Fair Lawn, NJ).  2-hydroxy-1-(4-
(hydroxyethoxy) phenyl)-2-methyl-1-propanone (I-2959) was obtained from Ciba 
Specialty Chemicals (Basel, Switzerland).  A 10% w/v stock solution of I-2959 was 
prepared in 70% ethanol. Adult normal human dermal fibroblasts (NHDF, CC-2511) 
obtained from a 39 year old Black woman were purchased from Biowhitaker (Rockland, 
ME, USA). DMEM F-12 50/50,1X with L-glutamine, 15mM HEPES/trypsin EDTA 
(0.05% trypsin/0.53mM EDTA in HBSS), and penicillin/streptomycin were obtained 
from Mediatech (Herdon, VA, USA).  Bovine growth serum was purchased from 
Hyclone (Logan, UT, USA).   
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6.2.2 Synthesis of GMHA  
GMHA was synthesized by reacting sodium hyaluronate solubilized in double 
distilled water with a 20-fold molar excess of glycidyl methacrylate in the presence of 
excess triethylamine and tetrabutylammonium bromide as previously described [280].  
The GMHA was precipitated in acetone, dialyzed against double distilled water for 48 
hours, and recovered by lyophilization.  An ~7% degree of methacrylation was calculated 
from the 
1
H-NMR (D2O) spectra based on the ratio of peak integrals derived from the 
methacrylate and HA carbohydrate protons, as previously described [281]. 
 
6.2.3 Cell culture 
NHDF were routinely cultured in 175 cm² T-flasks using DMEM F-12 50/50,1X 
with L-glutamine and 15mM HEPES enriched with 10% v/v bovine growth serum and 
50U/ml penicillin and 50µg/ml streptomycin.  Culture medium was changed once every 
two days and cells were passaged weekly. All experiments were performed with cells 
from the 4
th – 6th passages. For hydrogel encapsulation, monolayers of fibroblasts (ca. 
95% confluence) were trypsinized, centrifuged, resuspended, counted in a 
hemacytometer, and adjusted to a final concentration of 1.6 x 10
7
cells/ml. 
 
6.2.4 Bioreactor construction 
A vibrational bioreactor module comprising a modified 75cm
2
 T-flask and a voice 
coil actuator (BEI Kimco) was constructed partly as explained previously [11].  The 
vibrational bioreactor assembly is shown in figure 6.1.  A sinusoidal waveform from a 
function generator (BK Precision, CA) was fed to the input terminal of a reed switch.  
 161 
The reed switch was connected at the collector terminal (+5V from a PC) of a NPN 
transistor, the base terminal of which was connected to the output from a custom 
Labview program (National Instruments) and an analog output board running on a PC.  
The variables controlled by the Labview software were the total number of work days, 
active vibration intervals (on and off times) and inactive (rest) time per day.  The output 
from the reed switch stimulated the voice coil which ultimately controlled the vibration 
actuator bar.  The voltage level of the sinusoidal wave was set so as to maintain 1mm 
vibrational amplitude at the actuator bar which was verified using a digital stroboscope 
before every experiment.  
 
 
Figure 6.1 A vibrational bioreactor module with a modified 75cm
2
 T-flask. 
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6.2.5 Bioreactor cell culture 
                                 6.2.5.1 Tecoflex film fabrication 
The cell encapsulated hydrogel samples were crosslinked to elastomeric Tecoflex 
films mounted on “U” shaped plastic frames (40mm x 15mm).  Briefly, Tecoflex SG-
80A (Thermedics) was dissolved in methylene chloride at a 5% concentration and films 
were made by solvent casting.  The Tecoflex films were subjected to oxygen plasma 
treatment for 8 mins at 300mTorr afterwhich they were immersed in PEGDA (MW=258) 
for 30 mins to introduce free vinyl groups on the film surface.  
 
6.2.5.2 Hydrogel photopolymerization and vibrational culture 
4% w/v GMHA macromer solution was prepared in sterile 1X-PBS (0.1M, pH 
7.4).  A fibronectin-derived cell adhesion peptide, (GRGDS, Bachem, PA, USA) was 
conjugated to acrylate-PEG-NHS (MW=3400, Nektar) as previously described [216].  
GRGDS-PEG-acrylate was prepared as a stock solution in 1X PBS (10µmol/ml) and 
sterile filtered.  For cell encapsulation studies, the final concentrations of GMHA, 
acrylate-PEG-GRGDS, and NHDF were 2%, 2.5µmol/ml, and 4x10
6
cells/ml, 
respectively, unless mentioned otherwise.  The cell-macromer-peptide suspension 
(200µl) containing 0.1% w/v I-2959 initiator was crosslinked on the  modified Tecoflex 
film by exposure to low intensity UV illumination (365nm, 10mW/cm
2
, Black-Ray 
B100-AP, Upland, CA) for 6½ minutes (Figure 6.2A).  N=4 hydrogel samples were 
mounted between the support pins in the bioreactor flask (figure 6.2B, C and D) and the 
frames cut to allow the samples to move freely in the axial and longitudinal directions.  
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The hydrogel samples were allowed to equilibrate to the new environment overnight 
before the vibratory stimulus was applied.  The samples were then stimulated by a 
100Hz, 5.3Vrms sinusoidal waveform from a function generator in a 2sec on/2sec off 
regimen for 4hours/day.  N=4 fibroblast encapsulated hydrogel samples cultured in a 
Petri dish under static conditions served as controls.   
 
 
Figure 6.2 A 2% w/v GMHA hydrogel encapsulated with cells and immobilized on an 
elastomeric Tecoflex film by photopolymerization (A), different views of GMHA 
hydrogels mounted in a modified 75cm
2
 T-flask of the vibrational bioreactor module (B), 
(C), and (D). 
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6.2.6 Encapsulated fibroblast viability, morphology, and proliferation within the 2% 
w/v GMHA hydrogels 
6.2.6.1 Viability assessment 
After 5 and 10 days in culture, hydrogel samples (N=4/time point) from both the 
vibrational and static groups were collected from the study, rinsed three times with sterile 
1X-PBS, and stained with 1µM fluorescein diacetate (FDA, Molecular Probes, Eugene, 
OR) and 2.5µM propidium iodide (PI, Molecular Probes).  The samples were once again 
rinsed with sterile 1X-PBS, visualized, and imaged by fluorescence microscopy (Zeiss 
Axiovert 200).  
 
6.2.6.2 Confocal analysis of morphology 
After 1, 3, 5, and 10 days in culture, samples (N=4/time point) from both the 
vibrational and static groups were fixed in 4% paraformaldehyde in PBS, permeabilized 
with 0.1% Triton X-100, and stained with Alexa 594-phalloidin (Molecular Probes).  
Samples were visualized and imaged using a Zeiss Confocal LSM510 microscope.   
 
6.2.6.3 Fibroblast proliferation 
N = 4 hydrogel samples each from the vibratory and static groups were collected 
at days 1, 5, and 10, rinsed twice with sterile PBS, snap-frozen in an ethanol-dry ice bath, 
and stored at -80ºC.  DNA solubilization and quantitation were based on modifications of 
previously described methods [247].  Briefly, the samples were subjected to 3 freeze-
thaw cycles in 1.4ml of 10mM EDTA, pH 12.3. Once the hydrogels were completely 
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dissolved, the pH was neutralized by the addition of 100µl 1M potassium phosphate 
(monobasic) solution. Total DNA content was measured using the Picogreen DNA-
binding dye (Molecular Probes) and a fluorescence microplate reader (Tecan GENios, 
excitation: 485nm, emission: 535nm).  DNA content was converted to cell number based 
on a DNA standard curve prepared from serial dilutions of NHDF and compared to the 
cell number at the end of day 1.   
 
6.2.7 Gene expression 
The hydrogel-encapsulated fibroblast samples (N=4 samples/time point) from 
both the vibrational and static groups were harvested from culture after 1, 3, 5, and 10 
days; and stored in 1ml Trizol reagent (Aldrich) at -80 °C.  The frozen hydrogel samples 
were thawed, homogenized, centrifuged at 13,000g for 15mins at 4°C, and the 
supernatant removed and collected in clean PCR tubes.  Total RNA was isolated 
according to the manufacturer‟s protocol and finally redissolved in 20µl RNAse-free 
water.  The samples were treated with RNAse-free DNAse I (Turbo, Ambion) to 
eliminate genomic DNA contamination.  Using a UV spectrophotometer, concentration 
and purity of the total RNA was determined based on absorbance at 260nm and 280nm.  
Samples containing 1µg of total RNA was reverse transcribed to cDNA in a 20µl reaction 
using the Retroscript cDNA Synthesis Kit (Ambion), and the Rotorgene 3000 light 
thermal cycler (Corbett Research, Mortlake, NSW, Australia).  Realtime PCR was 
performed using custom-designed sense and anti-sense primers (Table I) and the 
QuantiTect SyBr Green PCR kit (Qiagen).  Briefly, after an initial heat activation at 95°C 
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for 15 minutes, cDNA products were amplified through 35 cycles, each consisting of a 
denaturation step at 94°C for 15 seconds, an annealing step at 54°C for 20 seconds, and 
an extension step at 72°C for 20 secs.  Melt curve analysis was performed at the end of 
all reactions to verify formation of single product.  Amplification efficiencies were tested 
using serial dilutions of cDNA covering four orders of magnitude and found to range 
from 0.94-1 for all products.  Relative expression levels of target genes were quantified 
by the ΔΔCT method using β2microglobulin (β2M) as an internal control and the day 1 
static samples as reference condition (calibrator) [298].  Data for days 3 and 5 represent 
the combined results of two independent experimental replicates. 
 
 
Table 6.1 Target Genes and Primers for Real Time RT-PCR Analysis. 
 
Target gene  Accession ID Sense primer  Antisense primer 
Collagen 1 NM_000088.2 Tgctggtgctcctggtactc tccagagggaccttgtttgc 
Elastin NM_000501.1 Gccctacaccacagggaaac accgaactttgctgctgctt 
HA Synthase 2 NM_005328.1 cataaagaaagctcgcaacacg cacacttcgtcccagtgctc 
Decorin NM_001920.3 Gtgtcagccggattgtgttc gcaggtgtggaaaggaggag 
Fibromodulin NM_002023.3 Tgataaggtgggcaggaagg tggttgtggtcgagatggag 
MMP-1 NM_002421.2 Tgctgaaaccctgaaggtga cttggcaaatctggcgtgta 
Beta-2-
microglobulin 
NM_004048.2 Tgtgctcgcgctactctctc cggatggatgaaacccagac 
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6.2.8 Encapsulated fibroblast ECM production 
In order to quantify ECM production by the encapsulated fibroblasts, N=4 
samples/time point from both the vibrational and static groups were collected from the 
study after 5 and 10 days of culture.  The samples were digested using 1ml HAse 
(40U/ml) per hydrogel under constant agitation for 4hours.  Following digestion, the 
samples were transferred to 2ml tubes, and stored at -80°C. 
 
6.2.8.1 s-GAG synthesis (DMMB Assay) 
s-GAG accumulation was measured using the 1,9-dimethylmethylene blue 
(DMMB) assay as previously described [299].  Briefly, the assay was performed by 
adding 20µl of the sample to 200µl of the DMMB reagent stock solution (16mg DMMB 
+ 5ml 95% ethanol + 3ml formic acid + 25.6ml NaOH + 966.4ml distilled water, pH 3.5) 
in a 96-well plate. DMMB dye binding to s-GAGs produced a pink color which was 
measured by absorbance at 525 nm using a microplate reader (Bio-Tek Instruments, 
Winooski, VT) and was quantified relative to a linear standard curve prepared from 
chondrotin-4-sulfate standards (0 – 100µg/ml).  The absorbance of cell-free 2% w/v 
GMHA hydrogels was subtracted from the absorbance values of vibrational/static groups 
in order to account for absorbance of the GMHA material alone.  For data analysis, s-
GAG values were normalized to total DNA values. 
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6.2.8.2 Collagen synthesis (Hydroxyproline analysis) 
Collagen accumulation by the encapsulated fibroblasts in both the vibratory and 
static groups was quantified by the hydroxyproline assay as previously described [300].  
The total collagen content was calculated based on the estimation that hydroxyproline 
makes up about 13.2% of the total collagen [301].  The total collagen values were 
normalized to total DNA values. 
 
6.2.9 Rheological characterization of cell-free and cell-encapsulted 2% w/v GMHA 
hydrogels following 10 day vibrational bioreactor culture 
In order to investigate the effect of the vibrational regimen and neo matrix 
synthesis on the mechanical properties of the 2% w/v GMHA hydrogels, two cell-
encapsulated hydrogel groups (4x10
6
cells/ml and 2x10
6
cells/ml), and cell-free hydrogels 
were photopolymerized and exposed to vibratory stimulation for 10 days.  The hydrogel 
samples (vibrational samples and static controls) from both the cell-encapsulated and 
cell-free experiments were collected after 10 days in culture, rinsed two times with 1X-
PBS sterile PBS, and immediately subjected to rheological testing under conditions 
similar to those used to investigate the rheological properties of the human vocal mucosa 
[12].  Rheological characteristics as a function of mechanical stimulus and 
presence/absence of cells were investigated in a stress controlled “ARES” Rheometer 
using parallel plate geometry.  The hydrogel samples were placed in the gap (0.8mm) 
between the stationary upper plate and the rotating lower plate, and the temperature was 
maintained at 37 ± 0.1ºC by a “Peltier” water cooling system.  In order to determine the 
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region of linearity, strain sweep tests were performed at fixed oscillation frequency 
(1Hz).  Rheological tests were performed in the linear strain region (strain amplitude – 
0.01rad), over a frequency range of 0.01 – 15Hz, covering 25 frequencies over 3 decades. 
The dynamic viscosities of the 2% w/v GMHA hydrogels tested were calculated by 
dividing the observed values of the loss moduli by the corresponding angular frequencies 
tested.  The elastic shear moduli of the 2% w/v GMHA hydrogels tested were also 
recorded and plotted at all frequencies tested.   
 
6.2.10 Statistical analysis 
All data sets are represented in terms of means ± standard deviation with n=4.  All 
data sets were statistically compared by ANOVA using Tukey‟s method for post hoc 
testing with “p” values less than 0.05 considered significant. 
 
6.3 Results 
6.3.1 Encapsulated fibroblast viability, morphology, and proliferation in 2% w/v 
GMHA hydrogels 
 Fibroblasts were encapsulated within 2% w/v GMHA hydrogels containing 
immobilized RGD cell adhesion peptides by photopolymerization and cultured under 
static or vibratory conditions for up to 10 days.  Encapsulated fibroblast viability was 
observed to be substantially greater in the static controls at day 5 (Figure 6.3A) and day 
10 (Figure 6.3C) than in the corresponding vibrational samples (Figures 6.3B and D).  
Cell viability was largely uniform throughout the bulk of the hydrogel constructs.  
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Fibroblasts in the static controls exhibited clustering and aggregation (Figure 6.3C) in 
various areas throughout the bulk of the hydrogel constructs to a much higher degree than 
in the vibrational samples (figure 6.3D) at the same time point.   
 
 
 
Figure 6.3 Viability of fibroblasts encapsulated in 2% w/v GMHA hydrogels and 
cultured under static (A,C) and vibratory (B,D) conditions for 5 (A,B) and 10 days (C,D).  
Cells were stained with fluorescein diacetate (green)/propidium iodide (red).  All scale 
bars = 200µm. 
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Confocal microscopy was performed to visualize fibroblast morphology within 
the 3D hydrogel networks.  Encapsulated fibroblasts exhibited spreading within 3 days 
(data not shown) and development of stellate morphology at day 5 in the static controls 
(Figure 6.4A) and the vibrational samples (Figure 6.4B).  Stellate cell morphology 
persisted for the entire duration (day 10) of the experiments in the static (Figure 6.4C) 
and the vibrational samples (Figure 6.4D).    
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Figure 6.4 Confocal microscopy images (200µm depth) of fibroblast morphology and 
spreading within 2% w/v GMHA hydrogels.  Samples were stained with Alexa 594-
phalloidin and imaged after culture under static (A,C) and vibratory (B,D) conditions for 
5 (A, B) and 10 days (C,D).  All scale bars = 200µm. 
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The cell number (DNA content) of the hydrogel constructs at days 5 and 10 is 
shown in figure 6.5.  Relative to the initial cell number measured at day 1, significant 
increases in cell number were observed in 5 day static controls and 10 day static and 
vibrational groups.  Although cell proliferation was observed in the 10 day vibrational 
group (relative to day 1), cell numbers measured in vibrational samples were significantly 
lower than corresponding static controls at both time points (days 5 and 10) assayed.  
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Figure 6.5 Time course fibroblast proliferation within the 2% w/v GMHA hydrogels 
under vibratory stimulus and static conditions.  * indicates significant differences relative 
to the corresponding cell number at day 1.  # indicates significant differences relative to 
the corresponding static control at the same time point.   
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6.3.2 Gene expression 
Fibroblast mRNA expression levels of several ECM-related genes relevant to the 
human vocal mucosa were examined after 1, 3, 5, and 10 days of culture under vibratory 
and static conditions.  In general, fibroblasts exposed to vibratory stimulation exhibited 
increased expression of HA Synthase 2 (Figure 6.6A), decorin (Figure 6.6B), 
fibromodulin (Figure 6.7A), and MMP-1 (Figure 6.7B) relative to static controls for 
corresponding time points at days 1, 3, and 5.  In addition, significant temporal increases 
in HA synthase 2 (day 3 and 5), fibromodulin (day 3), and MMP-1 (day 5) were observed 
relative to day 1 among sample groups exposed to vibration.  Interestingly, expression 
levels of all 4 genes in vibration-treated sample groups were significantly reduced at day 
10 relative to days 3 and 5.  In contrast to these results, expression levels of type I 
collagen and elastin were relatively insensitive to vibratory stimulation.  Reduced 
collagen and elastin expression levels were observed in samples exposed to vibratory 
stimulation relative to static controls at all time points, although the differences were only 
significant at day 5 (Figure 6.8E and F).    
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Figure 6.6 mRNA expression levels of HA Synthase 2 (A) and decorin (B).  * indicates 
significant difference relative to day 1 of the corresponding group.  # indicates significant 
differences relative to the corresponding static control at the same time point.  ** 
identifies significant differences observed among other experimental groups. 
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Figure 6.7 mRNA expression levels of Fibromodulin (A) and MMP-1 (B).  * indicates 
significant difference relative to day 1 of the corresponding group.  # indicates significant 
differences relative to the corresponding static control at the same time point.  ** 
identifies significant differences observed among other experimental groups. 
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Figure 6.8 mRNA expression levels of Collagen I (A) and Elastin (B).  * indicates 
significant difference relative to day 1 of the corresponding group.  # indicates significant 
differences relative to the corresponding static control at the same time point.  ** 
identifies significant differences observed among other experimental groups. 
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6.3.3 ECM expression 
Consistent with the significant upregulation of HA Synthase 2 and proteoglycan 
genes at days 1, 3, and 5, the amount of proteoglycan accumulation (normalized to cell 
number) measured in the hydrogel constructs at days 5 and 10 was significantly higher in 
the vibrational groups relative to the static controls (Figure 6.9).  Also, proteoglycan 
levels in the vibrational groups significantly increased between days 5 and 10.   
 
0
10
20
30
40
50
60
70
Day 5 Day10
P
ic
o
g
ra
m
s 
o
f 
s-
G
A
G
s 
p
er
 c
el
l
Static Vibration **
#
#
 
Figure 6.9 Picograms of sulfated-GAGs per encapsulated cell in the 2% w/v GMHA 
hydrogels after 5 and 10 days of static and vibrational culture.  # indicates significant 
differences relative to the corresponding static control.  ** indicates a significant 
difference among experimental groups.  
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Total collagen accumulation (normalized to cell number) measured in the 
hydrogel constructs at days 5 and 10 was significantly lower in the vibrational group 
relative to the static controls (Figure 6.10).  In addition, total collagen levels measured in 
the vibrational groups significantly decreased from day 5 to day 10. 
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Figure 6.10 Picograms of collagen per encapsulated cell in the 2% w/v GMHA hydrogels 
after 5 and 10 days of culture.  # indicates significant difference relatives to the 
corresponding static control.  ** indicates a significant difference among experimental 
groups.   
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6.3.4 Rheological characterization of cell-free and cell-encapsulted 2% w/v GMHA 
hydrogels following 10 day vibrational bioreactor culture 
In order to investigate the effect of physiologically relevant high frequency 
vibration on the mechanical properties of the 2% w/v GMHA hydrogels, 10 day 
experiments were performed using cell-free and cell-encapsulated hydrogel constructs.  
Dynamic viscosities (Figure 6.11) and elastic shear moduli (Figure 6.12) calculated over 
the range of the tested frequency sweep (0.01 – 15Hz) indicated that the cell-free static 
contols and the corresponding vibrational samples were similar.  However, the dynamic 
viscosities of the cell-encapsulated vibrational samples were significantly lower than the 
corresponding static controls and the cell-free vibrational samples (Figure 6.11).  The 
elastic shear moduli of the cell-encapsulated vibrational samples were similar to that of 
the cell-free vibrational samples (Figure 6.12).  Interestingly, the elastic shear moduli of 
the cell-encapsulated static controls were significantly higher than that of the cell-free 
static controls (Figure 6.12).  However, when the encapsulated cell number was reduced 
by half, the difference in the magnitudes of dynamic viscosities (Figure 6.13) and elastic 
shear moduli (Figure 6.14) between the static controls and the vibrational samples 
became minimal over the range of frequencies tested.   
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Figure 6.11 Dynamic viscosities of cell-free and cell encapsulated (4x10
6
cells/ml) 2% 
w/v GMHA hydrogels (static controls and vibrational samples) cultured for 10 days.   
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Figure 6.12 Elastic shear moduli of cell-free and cell encapsulated (4x10
6
cells/ml) 2% 
w/v GMHA hydrogels (static controls and vibrational samples) cultured for 10 days.   
 182 
0.01
0.1
1
10
100
1000
10000
0.01 0.1 1 10 100
Frequency (Hz)
D
y
n
am
ic
 v
is
co
si
ty
 (
P
a.
s)
Static Vibration
 
Figure 6.13 Dynamic viscosity of cell encapsulated (2x10
6
cells/ml) 2% w/v GMHA 
hydrogels (static controls and vibrational samples) cultured for 10 days.  
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Figure 6.14 Elastic shear moduli of cell encapsulated (2x10
6
cells/ml) 2% w/v GMHA 
hydrogels (static controls and vibrational samples) cultured for 10 days.   
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6.4 Discussion 
 The highly differentiated organization of the vocal fold tissue helps to produce 
and sustain the high degrees of mechanical stresses (vibratory and cyclic strain) it is 
subjected to for many waking hours, daily, over an entire lifetime.  Proper vocal fold 
tissue function being a prerequisite to normal phonation, otolaryngologists when 
presented with voice related problems associated with vocal fold tissue injury, must 
investigate the effect of the wound healing process on the native vocal fold tissue 
architecture/ECM composition.  Previously, we have described 2% w/v GMHA 
hydrogels and 6% w/v PEG-based semi-IPNs aimed at restoring the architecture of the 
human vocal mucosa and the vocal ligament, respectively, which will facilitate long-term 
restoration of normal voice by preventing fibrosis during the acute stage of wound 
healing [297].  
In the current study fibroblasts encapsulated in 2% w/v GMHA hydrogels 
(viscous shear properties similar to the human vocal mucosa) were subjected to 
physiologically relevant high frequency vibrational stimulation (100Hz sine wave, 1mm 
amplitude) using a vibrational bioreactor.  The 2sec on/2 sec off regimen simulates a 
situation wherein an individual vocalizes and inhales alternately.  The 2 hours/day (net 
vibration on time) mechanical stimulation regimen is selected in order to approximate the 
2 hour average vocalization period for a classroom teacher in a 6 – 7hr working day [9-
12].  Our results indicated that physiologically relevant, high frequency vibration alters 
fibroblast viability, proliferation, expression levels of some ECM related genes, and their 
corresponding proteins.  Previously, Titze and co-workers have reported that although 
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6hours vibrational stimulation influenced the ECM deposition and spatial distribution of 
cells it did not have a significant effect on cell viability [11].  However, our results 
indicated that a net vibrational stimulation of 2 hours/day applied over 5 to 10 days 
resulted in significant reduction of cell viability [11].  The reduction in cell viability at 
days 5 and 10 can be attributed to the physical trauma inflicted on the encapsulated 
fibroblasts by the high frequency vibration over time.  Also, the vibratory regimen 
significantly stimulated fibroblast proliferation.  This is consistent with results reported 
previously by other researchers [11, 291, 302].  Real time RT-PCR analyses have 
indicated a temporal manner in the changes of mRNA expression levels of ECM related 
genes.  Upregulated mRNA expression levels (days 1 – 5) of HA Synthase 2, decorin, 
fibromodulin, and MMP-1 in response to vibrational stimulation is similar to the ECM 
composition of the vibratory component of the human vocal mucosa.  The reduction in 
gene expression levels at day 10 may be attributed to cellular adaptation to the vibrational 
regimen.  High frequency vibrational stimulation has a profound effect on the expression 
of proteoglycans, but contrastingly it has a very mild effect on the expression of 
structural proteins like collagen.  A significantly higher degree of proteoglycan-rich (s-
GAGs) ECM deposition in the vibrational group (relative to static controls) represents an 
overall upregulation of ECM synthesis in response to vibrational stimulation since a 
decreased cell density was observed in the vibrational group (relative to the static 
controls) at all times points assayed.    
Benign vocal fold lesions which represent the end of the wound healing cascade 
(nodules), or an incomplete process beyond the initial/acute inflammatory stage (polyps) 
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may place the vocal fold tissue at increased risk for repeated injury, leading to scarring 
[15].  In contrast to fetal wound healing (regenerative type), adult wound healing is 
characterized by scar formation attributed to decreased/degraded HA levels by day 10 
[129].  Vocal fold scarring in the initial stages is associated with disorganized collagen 
deposition [15] and decreased amounts of HA [15], decorin [303], and fibromodulin 
[304].  Collagen found in scarred vocal fold tissue is reduced in density in addition to 
having a disorganized/compromised architecture [134].  This can be attributed to the low 
levels of decorin in the scarred vocal fold tissue since decorin binds collagen and 
regulates fibrillogenesis [15].  It has been reported previously that HA levels in the vocal 
fold wounds decrease to subnormal levels after day 5 of injury resulting in vocal fold 
tissue scarring [131].  However, chronic vocal folds scars (2 to 6 months post injury) 
reveal HA levels similar to that of normal tissue [131-134].  Scarring brought about by a 
change in the ECM composition of the vocal mucosa during the acute phase of wound 
healing alters vibratory biomechanics of the tissue which ultimately results in dysphonia.  
Vocal fold scarring and associated pathologies are the most challenging voice related 
problems otolaryngologists are faced with today [18].  Apart from voice therapy, 
treatment of vocal fold scarring involves surgical techniques which rely mainly on 
implanting natural/synthetic biomaterials to improve vocal mucosa pliability and alleviate 
glottic incompetence.  However, none of the existing treatment techniques achieve long-
term success due to their inherent inability to restore the native tissue architecture/ECM 
composition.   
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Regenerative-type repair in fetal wounds is attributed to sustained high levels of 
HA throughout the wound healing phase [128, 130, 269].  Our results indicated that in 
addition to approximation of the viscous shear properties of the human vocal mucosa, the 
2% w/v GMHA hydrogel formulation may serve to sustain elevated levels of HA and 
proteoglycans at the site of injection during the acute phase of wound healing.  Also, 
exogenous HA is reported to decrease collagen synthesis and deposition in the ECM 
without affecting de novo HA synthesis [127].  Our results indicated a significant 
reduction in total collagen synthesized in the vibrational samples after 5 and 10 days of 
culture.  The upregulation of mRNA levels of HA Synthase 2, decorin, and fibromodulin 
and the corresponding proteins have an effect on collagen fibrillogenesis [127] as 
indicated by our results.  It is logical that increased proteoglycan synthesis and decreased 
collagen synthesis could play a vital role in averting scar formation.  Thereby, a 
significant increase in the proteoglycan content and a decrease in the collagen content of 
the vibrational samples relative to the static controls is an indication that the 2% w/v 
GMHA hydrogel formulations may prevent scarring and facilitate vocal mucosa specific 
ECM deposition under vibrational stimulation in vivo.   
Rheological analyses did not reveal any significant differences in the magnitudes 
of dynamic viscosities and elastic shear moduli between the vibrational samples and the 
static controls in the cell-free group over the range of frequencies tested.  Thereby, one 
may infer that the vibrational regimen had minimal effect on the crosslinking density of 
the GMHA hydrogels.  We hypothesize that reduction in the dynamic viscosities of the 
cell-encapsulated vibrational samples (relative to corresponding static controls) despite 
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significant upregulation of proteoglycan synthesis per cell, can be attributed to 
accelerated cellular remodeling of the hydrogel scaffold and faster ECM turnover rate 
over a 10 day time course under vibration.  During the eventual in vivo application, the 
neo-matrix synthesized by the transplanted/endogenous cells, will be held in place more 
efficiently due to bonding with the surrounding tissue.  Interestingly, the rate of cellular 
remodeling of the GMHA hydrogel matrix was reduced by encapsulating half the original 
cell number, as a result of which the difference in the dynamic viscosities and elastic 
shear moduli between the vibrational samples and the static controls was minimal.  
Higher magnitudes of elastic shear moduli recorded for the static controls relative to 
corresponding vibrational samples (original cell number) may be due to significant 
increases in the cell density and the amount of collagen synthesized per encapsulated cell 
in the static controls.   
Due to distinct biomechanical properties of the human vocal mucosa and 
approximation of these properties by the 2% w/v GMHA hydrogel formulation, use of 
these hydrogels was aimed at restoring mechanical integrity and vocal mucosa function 
following injury [297].  Our results suggested that restoration of the vibratory 
microenvironment using the 2% w/v GMHA hydrogels, will facilitate regeneration of the 
native human vocal mucosa ECM matrix composition and thereby normal phonatory 
behavior.  We are cognizant of the importance of the biological environment within the 
human body in terms of the occurrence of inflammation and its effect on scaffold 
degradation post implantation.  A classic case of inflammation may lead to minimal 
cellular infiltration/colonization and a thick collagen based capsule isolating the scaffold. 
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We hypothesize that this kind of adverse inflammatory reaction may not occur in 
response to vocal fold tissue augmentation using GMHA hydrogels since the vocal fold 
lamina propria is minimally vascular. 
 
6.5 Conclusion 
Through the use of a vibrational bioreactor to condition fibroblast differentiation, 
we have shown that the 2% w/v GMHA hydrogel encapsulated-cell formulation may help 
restore native vocal fold tissue (vocal mucosa) architecture following injury and thereby 
restore long-term normal phonatory voice.  Functional vocal mucosa regeneration 
following injury may provide a rational basis for the structural/functional design of 
engineering tissues for an eventual clinical application.  
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CHAPTER 7  
CONCLUSION AND RECOMMENDATIONS 
 
7.1 Conclusion 
The inability of current treatment techniques to restore long-term normal 
phonatory voice following scarring related vocal pathology, has given rise to the need for 
the “Vocal Fold Regeneration Project” in the Micro-Environmental Engineering 
Laboratory (µEEL).  This project is based on the hypothesis that rapid restoration of the 
mechanical microenvironment using mechano-mimetic scaffolds will facilitate vocal fold 
tissue-specific ECM production and ultimately restore normal phonation by preventing 
scarring sequelae.  Towards this end, we created in situ photopolymerizable, degradable, 
cytocompatible PEG-based semi-IPNs and GMHA hydrogels that approximated the 
elastic (vocal ligament) and rheological (vocal mucosa) properties of the highly 
differentiated human vocal fold tissue.   
During the course of our preliminary experiments and literature review we 
realized that the nanometer-scale mesh size of the PEG-based hydrogel networks restricts 
encapsulated cells to a rounded morphology that can inhibit cellular processes such as 
proliferation, migration, and ECM production that are essential for the early stages of 
remodeling and tissue formation.  Therefore, the first phase of the vocal fold regeneration 
project was dedicated to investigating an approach for accelerating cellular remodeling 
based on the creation of semi-IPNs composed of hydrolytically degradable PEG 
diacrylate macromers and native, enzymatically degradable ECM components (collagen, 
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gelatin and HA.  Among the three ECM components investigated, addition of HA at 
concentrations of 0.12% w/v and greater supported fibroblast spreading throughout the 3-
dimensional network and significantly increased proliferation relative to control 
hydrogels without HA.  Incorporation of HA resulted in relatively small changes in 
hydrogel physical/chemical properties such as swelling, degradation rate, and elastic 
modulus.  Fibroblast spreading was eliminated by the addition of HAse inhibitors, 
demonstrating that cell-mediated enzymatic degradation of HA is a necessary mechanism 
responsible for the observed increases in fibroblast activity.  By accelerating early 
cellular remodeling and growth, these PEG-based semi-IPNs may be useful vehicles 
for cell transplantation in a variety of tissue engineering applications in addition to 
vocal fold tissue repair. 
The objective of the second phase of this project was the development of 
mechano-mimetic, degradable hydrogels that may be photopolymerized in situ following 
vocal fold injury or surgery using minimally invasive techniques to fill vocal fold defects.  
PEG diacrylate based semi-IPNs (6% w/v) and GMHA hydrogels (2% w/v) were 
found to provide elastic and rheological properties consistent with the human vocal 
ligament and the vocal mucosa, respectively.  Cell culture studies indicated that these 
semi-IPN/hydrogel materials supported cell spreading, cell proliferation, and ECM 
deposition throughout the 3-dimensional crosslinked network.  
The third phase of this dissertation investigated the hypothesis that rapid 
restoration of the vibratory microenvironment will facilitate vocal mucosa-specific ECM 
production, and ultimately restore normal phonation. Towards this end, we assessed the 
 191 
ability of the 2% w/v GMHA hydrogels to support human fibroblast formation of vocal 
mucosa-like ECM in response to physiologically relevant high frequency vibration using 
a custom-made vibrational bioreactor.  Exposure of GMHA hydrogel-encapsulated 
fibroblasts to physiologically relevant high frequency vibration stimulated a pattern 
of ECM expression (upregulation of GAGs, downregulation of fibrous matrix 
proteins) consistent with the composition of the native human vocal mucosa.  Studies 
analyzing vibration-induced changes in hydrogel mechanical properties and quantitative 
analysis of proteoglycans and collagen synthesis following long-term vibrational 
bioreactor studies indicated that these GMHA hydrogels introduced into the human vocal 
mucosa during the acute phase of wound healing by minimally invasive methods may 
bring about regeneration of the native vocal mucosa-ECM composition, and thereby 
restore normal phonation.  
In the broad context of tissue engineering, the data presented in this dissertation 
indicates that GMHA- and PEG-based hydrogel/semi-IPN encapsulated fibroblasts may 
be useful, site-specific, autologous cell delivery matrices for a variety of soft tissue 
repair/regeneration applications.  The ability to tailor mechanical properties/degradation 
rates to suit the eventual application, which derives from the vast range of macromers 
(and possible blends) synthesized, in addition to metabolizable degradation products, 
lends versatility to these matrices.   Although several groups have investigated the effect 
of cyclic strain/compression on cell behavior, few have investigated the effect of 
physiologically relevant high frequency vibration on cellular function.  Through our 
vibrational culture studies over a 10 day time course, we have significantly contributed to 
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the understanding of the effect of physiologically relevant high frequency vibration on 
the gene/protein expression of cells cultured in 3-dimensional crosslinked substrates.    
 
7.2 Limitations 
These GMHA / PEG diacrylate-based hydrogels / semi-IPNs are not intended to 
soften existing mature scar tissue.  These materials are intended to fill critical size defects 
following some kind of injury or surgery in an attempt to reintroduce the vibrational 
stimulus that may help restoration of the normal tissue matrix composition.  In case of 
mature scars, the scar tissue can be excised followed by use of these GMHA / PEG-based 
hydrogels / semi-IPNs to fill the resulting defect.   
Few existing biomaterials can replicate the complex, nonlinear stress-strain 
response of the human vocal ligament.  For this application, PEG hydrogels were chosen 
based on their well-documented biocompatibility and elastic mechanical properties, 
which are consistent with the linear stress-strain properties of the vocal ligament at low 
strain levels (0-15%).  The mechanical properties of hydrogels in the swollen state are 
primarily a function of the crosslinking density, which may be controlled through 
variation of polymer molecular weight, concentration, and degree of functionalization 
[305, 306].  In this study, the crosslinking density and subsequent tensile properties of 
PEG-diacrylate hydrogels were manipulated through variation of macromer 
concentration.  At 6% w/v concentration, PEG hydrogels closely approximated the linear 
stress-strain response and elastic modulus reported for the human vocal ligament at low 
strains [63].  Although strain to failure approached physiological levels (Figure 5.6), the 
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nonlinear stress-strain response observed in native tissue between approximately 15 and 
45% strain was not achieved.  These results are consistent with the rubberlike behavior of 
such highly crosslinked polymer networks, which exhibit viscoelastic behavior only at 
very low temperatures [306].  The in vivo functional efficacy of these materials will be 
dependent on physiological strain levels experienced during phonation.  To our 
knowledge, no studies have obtained direct, empirical measurements of vocal ligament 
strains during phonation.  Previous reports in the literature have described physiological 
strain levels as ranging from 0 – 15% [8] to as high as 45 – 60% [277, 307].  Titze et. al. 
recently reported a mathematical model of vocal ligament vibration that extended 
conventional vibrating string models to include bending stiffness and variable cross 
section; this model predicted higher frequencies (1000 Hz) can be attained at lower 
strains (50%) than previously expected [308].  Based on this model, it is possible that at 
typical phonation frequencies (100 – 300 Hz) [12], ligament strains may remain close to 
the 15% range in which PEG hydrogels closely approximate the native tissue properties.  
In the present study, elastic shear modulus and dynamic viscosity of hydrogels 
crosslinked from methacrylated HA varied as a function of  macromer concentration. Due 
to HA‟s high molecular weight, these results are likely to be attributable to concentration-
dependent effects on both the covalent crosslinking density and polymer chain 
entanglement [101].  GMHA hydrogels crosslinked from 1.5 – 2.5% solutions exhibited 
dynamic viscosities approximating the range of values reported for native human vocal 
mucosa [103, 195, 288], which was highly variable due to intersubject differences 
attributed to age and gender [103].  However, the elastic shear moduli values were 
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several fold higher than the average values reported for human vocal mucosa [276].  
These results, consistent with other reports describing rheological analysis of chemically 
crosslinked HA hydrogels [43, 200], suggest that the degree of covalent crosslinking in 
these materials may exceed the molecular-bonding interactions in native tissue, resulting 
in increased stiffness.  Elastic modulus values above the physiological range may in fact 
be advantageous for in vivo applications.  Enzymatic degradation of naturally derived 
biomaterials during the acute inflammatory phase following implantation is likely to 
produce a transient decrease in mechanical properties before effective synthesis and 
organization of new matrix by colonizing or transplanted cells.  A limitation of our 
rheological testing is that data could not be obtained at physiologically-relevant 
frequencies.  Several studies have recently described equipment and methods for 
performing accurate rheological analysis at physiological frequencies [200, 309, 310]. 
Our rheological studies indicated approximately an order of magnitude difference 
between the dynamic viscosities of the 2% w/v unmodified HA solution and the 2% w/v 
GMHA solution at all frequencies tested.  Since HA viscosity is largely a function of 
molecular weight at fixed concentration [311], this observation probably indicates that 
some degree of HA degradation and reduction in molecular weight occurred during the 
methacrylation and purification processes.  Although partial degradation could pose a 
challenge to reproducibility, swelling and rheological properties of hydrogels prepared 
from various batches of GMHA were highly consistent (data not shown).  While at least 
two alternative synthetic routes using methacrylic anhydride and N-3-aminopropyl 
methacrylamide have been described [281, 312], the effect of these procedures on HA 
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molecular weight or rheological properties relative to the native polymer have not been 
reported. 
Normal human dermal fibroblasts (NHDF) were used in these studies as a model 
cell type.  Due to its limited intrinsic cellularity, cell transplantation may be important for 
efficient restoration of vocal fold ECM.  Limited cellularity combined with potential 
scarring complications following biopsy of healthy autologous tissue suggests that vocal 
fold fibroblasts may not be a feasible cell source for transplantation.  In contrast, dermal 
fibroblasts are readily available in vast quantities.  To our knowledge, no study at present 
has fully characterized the phenotypic differences between fibroblasts derived from the 
vocal folds relative to other tissues, or identified an optimal cell source for vocal fold 
transplantation.  We use these cells to demonstrate that our materials support cell 
proliferation and matrix synthesis, but do not claim that these cells behave identically to 
vocal fold fibroblasts. 
 
7.3 Recommendations 
  Based on observations and data analyses from our research till date, I would like 
to make the following recommendations aimed at furthering the scope of our research 
efforts.   
 
7.3.1 Specific aims 
Aim 1: To characterize the downregulation of newly synthesized collagen by 
the GMHA hydrogel encapsulated cells in response to high frequency vibration in 
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terms of the architecture/spatial organization.  Also, investigate the mRNA expression 
levels of TGF-β1, TGF-β1 receptor, hyal-1, hyal-2, lysyl oxidase, and HGF.  This is vital 
if we are to conclusively prove that restoration of the vibratory microenvironment using 
the GMHA hydrogels immediately following injury can prevent fibrotic scarring.  
  Aim 2: To investigate the effect of physiologically relevant cyclic strain on :- 
(a) the ECM synthesis of 6% w/v PEG-based semi-IPN encapsulated fibroblasts and 
(b) the mechanical properties of these PEG-based matrices following long-term 
bioreactor studies. 
 Aim 3: To model vocal overuse using the vibrational bioreactor and to 
investigate the gene/ECM expression of GMHA hydrogel encapsulated fibroblasts in 
response to the extended mechanical loading over a time course. 
Aim 4: To investigate the hypothesis that application of localized high 
frequency vibration is a potential anti-fibrotic treatment.  Briefly, high frequency 
vibration applied periodically to fresh wounds through carbon nanotubes (using DNA or 
electrolytes as a power source) encapsulated in GMHA/PEG based hydrogels may :- (a) 
stimulate infiltrating fibroblasts to produce native tissue-like ECM and (b) alter growth 
factor profiles in the wound which may help prevent fibrotic scarring. 
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